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Abstract 
 This study presents the mass spectrometry structural elucidations of the extracted 
heterogeneous lipid As mixtures, obtained from native lipopolysaccharides (LPSs) isolated 
from different types of the Vibrionaceae family. As this Gram-negative bacteria family is 
well known to cause many serious animal diseases and human diseases. This investigation 
was originally aimed to investigate the treatment of bacterial infected fish with phages as a 
potential treatment for pathogenic bacterial infections. 
 In this thesis, I shall discuss the electrospray ionization mass spectrometry (ESI-
MS) and low-energy collision induced dissociation tandem mass spectrometry analysis 
(CID-MS/MS); and MALDI-TOF-MS/MS (high-energy CID-MS/MS) of a heterogeneous 
mixture of lipid As. These lipids As were isolated from the rough lipopolysaccharide (LPS) 
of the mutant wild strain of the Gram-negative bacteria Aeromonas. liquefaciens SJ-19, 
Aeromonas. hydrophilla SJ-55, and Aeromonas. salmonicidia SJ-113. These strains of 
bacteria were grown in the presence of phages and were isolated by the aqueous phenol 
method from this series of LPS of the rough wild strain of Gram-negative bacteria. 
Hydrolysis of the different LPS was accomplished with 1% acetic acid, and purification 
was by chromatography (Gel filteration affinity) using Sephadex G-50 and SephadexG-15. 
These MS and MS/MS complex structural investigation were accomplished via the 
use of different hybrid MS instruments such as: ESI-MS with a fourier transform ion 
cyclotron (FTICR), a triple quadrupole (QqQ), and MALDI-TOF/TOF-MS instruments.  
In that respect, low- and high-energy CID-MS/MS (known as tandem-in-space) and 
FTICR-MS/MS (known as tandem-in-time) mass spectrometry analyses were chosen for 
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the structural elucidation of this different series of lipid As isolated from A. liquefaciens 
SJ-19, hydrophilla SJ-55, and salmonicidia SJ-113a. Excellent elucidation structural results 
were obtained by using low collision induced (CID-MS/MS) analyses of the various 
heterogeneous mixtures of lipid As precursor deprotonated molecules with the two different 
triple quadrupole (QqQ) and FTICR-MS/MS instruments. The concomitant uses of high-
energy CID-MS/MS obtained with the MALDI-TOF/TOF-MS instrument allowed the 
further elucidation of these complex biomolecules and can be effectively used for any 
structural identifaction studies. 
Identifying the exact structures of these microheterogenious lipid As, obtained from 
Gram-negative bacteria grown in presence of phages, were by using mass spectrometry and 
tandem mass spectrometry techniques using different MSMS instruments, allowed to 
conclude that the biosynthesis of these series of mutant rough LPSs were indeed affected 
and produced a heterogeneous mixtures of different lipid As. Finally, this structural 
elucidation study provided us with a better understanding of the stereospecific gas-phase 
mass spectral fragmentation pathways; also, the exact sequence of these series of lipid A 
obtained from the rough bacteria LPSs, which have not yet been precisely established. 
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Chapter 1 
 
Introduction 
1.1. Bacteria cell membrane 
Bacteria are well known as the causes of many serious human and animal diseases 
(Zhang-Sun et al., 2015, Silhavy et al., 2010, and Schwechheimer et al., 2015). There are 
various numbers of bacterial species associated with fish diseases, which are responsible 
for considerable economic losses for the aquaculture industry (Elaneed et al., 2005, Sullam 
et al., 2012, and Declercq et al., 2013).  
The bacteria cell envelope is composed of a multilayered component which protects 
their organisms from any unpredictable hostile environment. In 1884, Christian Gram 
classified the bacteria into two groups; the Gram-positive bacteria and the Gram-negative 
bacteria, depending on their cell wall structures (Silhavy et al., 2010). The Gram-positive 
bacteria cell envelope is differentiated from the Gram-negative bacteria in their structures, 
mostly in their outer membranes. However, the Gram-negative bacteria cell membrane 
composed of a thin cell wall containing a few layers of peptidoglycan surrounded by two 
lipids layers (inner and outer membrane) as it is shown in (Figure 1.1.1).  On the other 
hand, the Gram-positive bacteria cell membrane is composed of thick peptidoglycan layers 
and a phospholipid layer (inner membrane), with the absence of the outer membrane as it 
shown in (Figure 1.1.1) (Silhavy et al., 2010 and Mistou et al., 2016).  
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Figure 1.1.1: Illustration showing the structure of the Gram-positive and Gram-negative cell 
envelops. The Gram-negative bacteria outer membrane consists of a bilayer composed of 
lipopolysaccharide (LPS), the inner membrane and in between them the periplasm. Gram-positive 
bacteria outer membrane consists of the inner membrane and a thick peptidoglycan layer. This 
scheme was completely redrawn and was partially based on Silhavy et al., 2010. 
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A typical Gram-negative bacterial envelope consists of an outer membrane, an inner 
membrane, and the space between them is filled by the peptidoglycan and is called the 
periplasmic space. The outer membrane is composed of a bilayer containing a phospholipid 
layer and a lipopolysaccharide (LPS) layer (Figure.1.1.1). 
 
 
1.1.1. Lipopolysaccharides (LPS) 
Lipopolysaccharides (LPSs) are amphiphilic components in the outer leaflet of the 
external membranes of the Gram-negative bacteria cell membrane. LPS covers up to 75% 
of the cell surface (Molinaro et al., 2015). It is embedded in the phospholipid part of the 
bilayer membrane extending outward. LPS functions as a protective barrier for the bacteria. 
The LPS was also described as endotoxin by “the father of endotoxin”, the German 
Investigator R. Pfeiffer at the end of the 1800s. LPS plays a key role in the pathogenesis of 
Gram-negative infections in hosts by triggering the activation of the immune systems 
(Rietschel et al., 2003, and Silhavy et al., 2010).  
 LPS consists of three-domains: The O-specific polysaccharide (O-antigen), the 
core oligosaccharide, and Lipid A. The O-antigen is covalently associated with the core 
oligosaccharide (and both parts constitute the hydrophilic moiety). The core 
oligosaccharide glycosylate lipid A which is the hydrophobic moiety of the LPS (Figures 
1.1.1 and 1.1.2) (Silhavy et al., 2010, Molinaro et al., 2015, and Mistou et al., 2016). 
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Figure 1.1.2: Illustration showing the structure of the lipopolysaccharide (LPS) within the Gram-
negative bacteria cell membrane.  
 
 
 
 
 
 
 5 
 
1.1.1.1. The O-specific chain (O-antigen) polysaccharide  
        The O-specific chain (also called the O-antigen) is a repetitive polysaccharide polymer 
formed of repeating oligosaccharide units.  This O-antigen is exposed directly to the host 
during bacterial infection. The number of repeating oligosaccharide units of the O-
polysaccharide may vary from 4 to 50 units, and each unit is formed of 2-8 monosaccharide 
residues (Figure 1.1.3). O-specific chain structure and composition are different among 
numerous genera and bacterial serotypes (Matsuura 2013, and Shang et al., 2015). The 
presence or absence of O-antigen determines whether the bacteria LPS is considered rough 
or smooth. Full-length O-antigen chains would render the LPS smooth, whereas the 
absence of O-antigen chains would make the LPS rough. Semi-rough LPSs are composed 
of one O-chain unit attached to the core-lipid A oligosaccharide (Banoub et al., 2010, and 
Matsuura 2013). 
 
1.1.1.2. The core oligosaccharide  
 The core oligosaccharide is located between the O-antigen region of the LPS and 
lipid A region, and it is the most conserved region more than the highly variable O-specific 
chain (Brade et al., 1988). The core oligosaccharide is made up mainly of glucose, 
galactose and N-acetyl-D-Glucosamine (D-GlcNAc) forming an oligosaccharide. The core 
oligosaccharide can be divided into two regions: the outer core and the inner core. 
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Figure 1.1.3: Illustration showing the structure of the O-specific chain of E. coli O157:H7 LPS. 
This scheme was completely redrawn and was partially based on Shang et al., 2015. 
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Figure 1.1.4: Illustration showing the structure of the core-oligosaccharide. This scheme was 
completely redrawn and was partially based on Shang et al., 2015. 
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The outer core consists of hexoses residues that are attached to a 7-carbon sugar, namely 
the L-glycero-D-manno-heptose (LD-Hep) residue in the inner core by β-D-(1→3) bond and 
3-deoxy-D-manno-octulosonic acid (Kdo) residues at the O-6 position (Figure 1.1.4). 
These 7-carbon sugar can also be phosphryated as shown in (Figure 1.1.4) (Henderson et 
al., 2016, Shang et al., 2015). 
 
1.1.1.3. Lipid A 
Lipid A is the innermost region of the LPS, and its hydrophobic nature allows it to 
anchor to the bacterial outer membrane. Lipid A is required for the toxicity of Gram-
negative bacteria (Doerrler et al., 2006, and Ingram et al., 2010). Lipid A has the same role 
as a potent stimulus for the innate immune system. It is usually involved in the activation 
of cell-binding proteins such as Toll-like receptor 4 (TLR4)-MD-2 complexes which are 
responsible for the immune-stimulatory activity.  
It is known that the toxic lipid A is considered as one of the most effective 
immunostimulatory molecules of eukaryotic cells originating from bacteria and can be 
considered as a tool for vaccines, immuno-stimulant, suppressive agent (Doerrler et al., 
2006, Ingram et al., 2010, and Molinaro et al., 2015). The first lipid A structure has been 
approached by Westphal and Luderitz in 1954 and was finally confirmed in 1983 (Rietschel 
et al., 1999 and Molinaro et al., 2015). Since that time, researchers have been investigating 
the structure of lipid A. Basically, lipid A consists of two glucosamine (D-GlcN) units 
forming a disaccharide attached by the β-D-(1→6) linkage. All the remaining O-3, O-3′, N-
2 and N-2′ groups of this disaccharide backbone are acylated with fatty acids via both ester 
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and amide linkage, which will be termed as the throughout this thesis as the primary fatty 
acid. Both ester and amide linked acyl groups (or the primary fatty acyl group), contain a 
C-3 hydroxyl group fatty acids are commonly present in the hydroxylated form. Hence the 
hydroxyl group which can be esterified with additional fatty acid residues, formimg 
branched fatty acid acyl groups; therefore, the substituent acyl group of the principal fatty 
acid acy group, will be known as the secondary fatty acid.  Usually, the D-GlcN units of 
the lipid A may contain one or two phosphate groups usually phosphorylated at both the 
O-1 and the O-4′ position of the β-D-GlcpN-(1→6)-β-D-GlcpN disaccharide backbone. 
These features are often used as the basis for distinguishing and classifying Gram-negative 
bacteria (Figure 1.1.5) (Doerrler et al., 2006, Michaud et al., 2013, Maeshima et al., 2013, 
and Kelley et al., 2013). Variation in the lipid A structure increases by changes in acylation, 
phosphorylation, and glycosylation. These changes can be affected by factors such as pH, 
Mg2+ concentration, and the presence of cationic peptides (Zähringer et al., 1999, Caroff et 
al., 2003, El Aneed et al., 2005, Kilár et al., 2013, and Wang et al., 2015). 
There are many analytical methods to structurally characterize lipid A complexes, 
such as X-ray crystallography (Raetz et al., 2007), and NMR spectroscopy (Suda et al., 
2001, and Lukasiewicz et al., 2006). However, these techniques possess inherent 
insufficiencies, including requiring large quantities of isotope-labeling and crystallization 
issues (Molinaro et al., 2015). On the other hand, mass spectrometry (MS) has many 
advantages in sensitivity, specificity, speed, and specialty. For these reasons, MS plays a 
critical role in lipid A characterization and identification (Banoub et al., 2010 and Kilár et 
al., 2013). 
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Figure 1.1.5: Illustration showing the structure of lipid A. 
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1.1.2. Lipopolysaccharides (LPS) Biosynthesis 
LPS complex structure is reflected by its complicated biosynthesis and transfer 
processes. LPS synthesis has been studied most extensively in E. coli (Raetz et al., 2009, 
Wang et al., 2010, Molinaro et al., 2015, and Wang et al., 2015). These processes occur in 
different cellular regions (Figure 1.1.6).  
Although LPS is located on the surface of bacterial cells, its synthesis is initiated in 
the cytoplasm and is transferred to the surface of bacteria. Multiple catalyzed enzymatic 
reactions are involved in this biosynthesis. It has been proven that the biosynthesis of all 
LPSs originate form one selective precursor small molecule UDP-N-acetylglucosamine 
(UDP-GlcNAc) (Raetz et al., 2009, Whitfield et al., 2014, and Wang et al., 2015). 
This biosynthetic first step is mediated by a series of nine enzymes namely: LpxA, 
LpxB, LpxC, LpxD, LpxH, LpxK, LpxL, LpxM, and KdtA. All the enzymes involved in 
the LPS biosynthesis have relatively high specificity for their respective substrates.    
With respect to the biosynthesis of lipid A, it was shown that the creation of the 
building block component of lipid A is initiated by UDP-GlcNAc. As shown in 
(Figure1.1.6) the first three steps of the lipid A pathway occurs in the cytoplasm. The first 
step of lipid A biosynthesis is involved in the transfer of the R-3-hydroxymyristoyl moiety 
from R-3-hydroxymyristoyl-acyl carrier protein (ACP) to the glucosamine 3-OH group of 
UDP-GlcNAc. This transfer will occur by means of the acyltransferase (LpxA). In the 
second step, the product obtained is then deacetylated with the LpxC enzyme. 
Consequently, the third pathway, is initiated by the LpxD enzyme, which joins a second 
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hydroxymyristate moiety onto the lipid A precursor, and consume the same β-
hydroxymyristoyl-ACP substrate. The fourth and fifth steps in the lipid A biosynthesis 
pathway are catalyzed by the peripheral membrane proteins LpxH and LpxB.  As shown in 
Figure 1.1.6, the enzyme LpxH will create lipid X by cleaving most of the UDP moiety and 
replace it with a single phosphate group at the position O-1 on the remaining lipid portion. 
This is followed by a combination of the LpxB portion to lipid X form the preceding lipid 
metabolite, UDP-2,3-bis(β-hydroxymyristoyl)-D-glucosamine, to form lipid A 
disaccharide-1-P. Finally, the kinase LpxK phosphorylates lipid A disaccharide at the O-4 
position to form lipid IVA. 
The next step of the LPS biosynthesis is the assembly of the Kdo2-lipid A 
component, which takes place in the cytoplasm and on the inner surface of inner membrane 
These remaining steps are catalyzed by integral membrane enzyme as shown in (Figure 
1.1.6). Next, the enzyme KdtA is involved in the incorporation of either two or three 3-
deoxy-D-manno-octulosonic acid (Kdo) residues at the O-6 position of the lipid IVA to 
produce Kdo2-lipid IVA. Further catalyzed reactions occur by the enzymes LpxL and LpxM 
incorporate lauroyl, myristoyl, or palmitoyl chains to the Kdo2-lipid A, thus giving the final 
Kdo2-lipid A product six acyl chains.  
Respectively, the enzyme LpxL adds a secondary lauroyl residue (C12) and the 
LpxM enzyme adds a myristoyl residue (C14). Finally, the LpxP enzyme is involved in 
adding a palmitoyl residue (C16) to the glucosamine unit (Williams et al., 2007, Whitfield 
et al., 2014, Putker et al., 2015, and Wang et al., 2015). 
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Figure 1.1.6: Structure and biosynthetic pathway of LPS. The catalyzed reactions occur by 
various enzymes. The structure of lipid A is shown in detail, but structures of core 
oligosaccharides and O-antigen are simplified as symbols since there are many variations in 
these two regions. This scheme was completely redrawn and was partially based on Wang et al., 
2015 and Putker et al., 2015.  
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After the synthesis of the Kdo2-lipid A oligosaccharide, the core oligosaccharide is 
assembled on Kdo2-lipid A at the cytoplasmic surface of the inner membrane and then 
flipped from the inner leaflet of the inner membrane to the outer leaflet of the inner 
membrane by MsbA (Klein et al., 2009).  
Similarly, the O-antigen is accumulated on the cytoplasmic surface of the inner 
membrane. The enzyme Wzx flips the O-antigen from the cytoplasmic face to the 
periplasmic face of the inner membrane. Also, the enzyme WaaL is used to bind the O-
antigen and the core-lipid A together to create nascent LPS.   
All the LPS components are synthesized in the cytoplasm and periplasm, and then 
are transferred to the outer leaflet of outer membranes by the enzymes glycosyltransferases 
and polymerases. The enzymes LptA, LptB, LptC, LptF and LptG are involved to transport 
the nascent LPS from the periplasmic face of the inner membrane to the inner surface of 
the outer membrane, whereas the LptD and LptE enzymes are used to assemble LPS into 
the outer surface of the outer membrane (Figure 1.1.6) (Abeyrathne., et al., 2005, Whitfield 
et al., 2014, Putker et al., 2015, and Wang et al., 2015).  
Although complex multiplicity of enzymes is sequentially used during this 
biosynthesis, each bacterium has its unique way in synthesising and modifying their LPS 
structure, even its most conserved part lipid A.  
It is well known that the structure modification of lipid A might help the bacteria to 
evade recognition by the innate immune receptor TLR4 (Wang et al., 2015). Nevertheless, 
the incomplete biosynthesis of lipid A is mainly responsible for directing and regulating 
the type of fatty acid substitution of the lipid A (Raetz et al., 2007). 
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1.2. Bacteriophages 
Bacteriophages are a class of viruses that specifically infect bacteria, and act as 
intracellular parasites by multiplying inside bacteria and using their biosynthetic 
machinery. This infection leads to the lysis of the bacteria. Phage is a complex virus 
composed of protein coat that encapsulate a DNA or RNA genome and Tail (Figure 1.2.1). 
Bacteriophages were discovered by the British worker Twort and French-Canadian worker 
d’Hérelle in 1915. In 1917 d’Hérelle named in general viruses as “bacteriophages” and 
explored their ability to use them for treatment purpose (Viertel et al., 2014). 
Bacteriophages, or phages, have been used for the treatment of infectious diseases by 
researchers soon after their discovery in the early 20th century. After the discovery of 
antibiotics in the 1940s, the phage therapy slowed in the West, while it continued in 
countries such as the former Soviet Union and East Europe (Viertel et al., 2014 and 
Chanishvili. 2012). 
Lately, the lack of effective antibiotics and the increasing number of antibiotic-resistant 
bacterial infections lead to a re-emergence of interest in Western countries in phages as 
potential therapeutic agents (Viertel et al., 2014, Golkar et al., 2014, and Chanishvili. 
2012). Phages have considerable potential as conventional methods to replace the 
antibiotics. Phages with their infinite diversity have the potential to rapidly replicate 
independently at the site of infection, where they are mostly needed to lyse the pathogens. 
In addition, the phages can be found throughout nature, and they are environmentally 
friendly and harmless to human beings.  
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Figure 1.2.1: Structure of typical bacteriophages. This scheme was completely redrawn 
and was partially based on Hanlon. 2007. 
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Phages are highly specific to their hosts with no side effects, unlike the antibiotics which 
target both pathogens bacteria and beneficial. Based on natural selection, isolating and 
identifying phages are quickly processed compared to antibiotic development, which can 
take several years with high cost effects (Viertel et al., 2014, Golkar et al., 2014, 
Chanishvili. 2012, Perera et al., 2015, and Torres-Barceló., et al., 2016). 
 Phages have been used as substitutes for antibiotics in food safety, agriculture, fish 
culture, and farming settings to solve the spread of antibiotic-resistant bacteria. For 
example, recently the Food and Drug Administration (FDA) in the United States permitted 
commercial phage to treat common bacterial pathogens such as Salmonella (Torres-Barceló 
et al., 2016). Exportation of fish is one of the biggest assets to commercial wealth in 
Canada. There are various bacterial species causing fish diseases in aquaculture ventures. 
These marine and freshwater diseases are known to decrease the population of fish farm, 
both marine and freshwater (Elaneed et al., 2005, Banoub et al., 2010 and Torres-Barceló 
et al., 2016).  
Bacteriophages can offer natural treatment to eliminate specific foodborne bacteria 
in foods (Endersen et al., 2014). Bacteria can become resistant to both antibiotics as well 
as to the phages. Phages resistance rate is ten folds less than that of antibiotics. The 
resistance occurs by developing mutate phages which can be forestalled by using phages 
cocktails (preparations containing multiple types of phages) (Perera et al., 2015, and 
Torres-Barceló. et al., 2016). 
 
 18 
 
1.2.1: Lytic cycle and lysogenic cycle 
The life cycle of bacteriophages has been investigated to understand how viruses 
affect the cells and cause immediate death of the cell through cell lysis. The phage attaches 
basically to the host by the intermediacy of a specific bacterial surface fibers.  
Like most viruses, bacteriophages basically carry only the genetic information to 
replicate their nucleic acid and synthesis of their protein coats within the host cell. Next, 
the phages become part of the host chromosome and replicate within the cell genome by 
packaging its progeny phage particles inside the host (Figure 1.2.2).  
Bacterial cells can undergo one of two types of infections by phages named lytic 
infections and lysogenic infections. The lytic cycle is initiated by replication of the phage 
genome and the tail proteins, which are synthesized inside the host cell. The bacterial cell 
will lyse and the new produced phages will be released (as is shown in Figure 1.2.2).  
In the case of the lysogenic cycle, the phage genome inserts itself into the bacterial 
chromosome, and remains inactive to create a prophage which does not lysis the cell. 
During the host cell replication, prophages are replicated together with the bacterial host 
chromosome then switch into lytic production (Figure 1.2.2) (Hanlon., 2007, Oliveira et al. 
2012, Keen 2012, Feiner et al., 2015, and Hoai et al., 2016).  
It is well known that the biosynthesis of LPS is completely altered by infection with 
bacteriophages. The physical interactions between tailed phages and Gram-negative 
bacterial pathogens have been used as models in the development of phage therapeutic 
strategy (Drulis-Kawa et al., 2012, Kim et al., 2014, and Chaturongakul et al., 2014).  
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The main purpose of infecting Gram-negative bacteria with bacteriophages is to 
stop their growth by destroying their cell membranes by lysing. The bacterial receptors of 
the phages, which are responsible for the phage-bacteria interactions, are the phage tail 
proteins which associate with the bacterial glycolipid LPS (Chaturongakul et al., 2014, and 
Joo et al., 2015). 
Therefore, the proteins and LPS present in the bacterial outer membrane may both 
serve as bacteriophage receptors. The survival of phages depends only on their ability to 
infect their bacterial hosts without killing them. The interactions between the phages and 
the Gram-negative bacteria regulate the host specificity and the heterogeneity of all the 
components of the LPS (Joo et al., 2015, and Shin et al., 2012). Accordingly, it was 
interesting to look at the precise molecular structure of the outermost LPS layer, which is 
usually the receptor site for bacteriophages. 
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1.3. Mass Spectrometry 
MS was first introduced in the late 1880s by the physicist Eugen Goldstein, by 
discovering a new type of radiation with positively charged gas particle streams travelling 
from the anode through channels towards the cathode (Goldstein 1913). In 1913, Sir Joseph 
John Thomson built the first mass spectrometer (MS) (Thomson 1913). In 1942 Aston used 
MS to determine the weight of the elements and their isotopic ratios (Aston 1942, and 
Downard 2007). In 1956 McLafferty demonstrated the first coupling between gas 
chromatography and mass spectrometry (McLafferty 1957). 
MS is an excellent analysis method that helps identify molecular structure of 
unknown/known analytes. There are different methods of ionization for MS analysis (- and 
+ ion modes) such as electron ionization (EI), Chemical ionization (CI), fast atom 
bombardment (FAB), and electrospray ionization (ESI). The ionization techniques can be 
used for molecular structure elucidation. After the ionization in the ion source of the mass 
spectrometer, the ions formed are then separated using electric or magnetic fields per their 
mass-to-charge ratio (m/z). In the mass spectrum, the x-coordinate represents the m/z values 
while the y-axis indicates the % relative ion abundances.  
Generally, the MS instrument is composed of three principal units; the ionization 
source, the mass analyzer, and the detector (Figure 1.3.1). The sample is injected into the 
ionization source by either direct injection or by various methods including 
chromatography (GC) (Kitson 1996), and high performance liquid chromatography  
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Figure 1.3.1: Components of a Mass Spectrometer including ion source, mass 
analyzer, and detector. 
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(HPLC) (Arpino 1989). The job of the GC and HPLC is to separate the analyts mixture into 
single molecules, which are ionized after entering the ionization chamber. After the analyte 
is introduced into the ionization source, it becomes a charged ionic species that may remain 
intact or fragment further into smaller ions. This process is followed by acceleration of all 
ions by a constant voltage, and accordingly the ions are sorted by their m/z values in the 
analyzer region. These analyte ions are then detected by the detector, in which every analyte 
molecule produces a characteristic (Figure.1.3.1).  
 
1.3.1. Ionization Methods   
Mass spectrometry can be used to study wide classes of molecules, ranging from 
small volatile species up to very large polar molecules. As they have different properties, 
e.g. molecular weight, volatility, polarity, bond strength, etc., all of them cannot be ionized 
by just one technique, but a wide range of ionization techniques are nowadays available.  
           In general, there are two major types of ionization techniques, hard and soft. Hard 
ionization techniques such as electron ionization (EI) impart high quantities of energy in 
the subject molecule producing large degrees of fragmentation (Portolés et al., 2011). The 
most common example of hard ionization is electron ionization, which was first described 
in 1918 by the Canadian-American Physicist Sir Arthur J. Dempster (Dempster et al., 
1918). In EI high energy electrons are used to affect the ion cloud of the analyte molecule, 
oxidizing it, typically by one electron. The electrons are produced by passing an electric 
current (70 eV) through a wire filament or the cathode. The ions produced will be attracted 
to the other side of the chamber toward an anode. The number of electrons emitted by the 
 24 
 
filament is controlled by the amount of the current applied. Following ionization, the 
charged analyte molecules can also fragment in the source due to excess energy imparted 
to the molecule beyond its ionization energy, and sometimes the identity of the molecular 
ion is lost. This drawback makes EI unsuitable for large biomolecules which cannot be 
vaporized (Luffer et al., 1990, and Portolés et al., 2011).  
Chemical ionization (CI) belongs to the “soft ionization techniques”. CI was 
developed due to some of the limitations associated with EI. In CI the interaction between 
energetic electrons and neutral molecules, such as methane form charged reagents such as 
CH5
+. The reagents will interact with the analytes by either donating or abstracting a proton 
forming either the protonated and/or deprotonated species, or adducts which help 
determining and confirming the molecular weight of the analytes (Munson et al., 1966, 
Fenn 2003). 
 Ionization of the intact analyte that do not produce extensive-ions is soft an 
ionization technique. These ionization methods included fast atom bombardment (FAB) 
also known as liquid secondary ion mass spectrometry (LSIMS). FAB and/or LSIMS is a 
technique that is involved in focusing a fast, high energy primary current beam of neutral 
atoms/molecules or ions which strike a sample film placed on a metal support, to produce 
ions. The beam kinetic energy will be transferred to the sample and cause desorption of 
secondary ions which are extracted and focused towards the mass spectrometer. FAB or 
LSIMS requires the use of a matrix, most commonly glycerol. The presence of the matrix 
ions enhances this desorption; though it complicates the interpretation of the mass spectrum 
(Barber et al., 1981 and Morris et al., 1981).   
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Equally, matrix assisted laser desorption ionization (MALDI) was developed by 
focusing a laser to strike a sample that was co-crystallized with a matrix chosen, partially, 
on its ability to absorb the laser radiation (Tanaka et al., 1988). More on MALDI will be 
discussed in section 1.3.1.1.  
There is a quite new branch of mass spectrometry, called atmospheric ambient mass 
spectrometry consisting of direct sampling and ionization of the analytes at ambient 
conditions with no or minimal effort for sample preparation. The best example of ambient 
ionization is electrospray ionization (ESI) technique, which was developed by Fenn. ESI 
became one of the most popular ionization techniques for proteins and other biomolecules 
due to its ability to produce multiply charged ions, which permitted determination of their 
molecular weights with instruments whose mass range is limited.  In ESI, singly and multi-
charged ions are produced when a high voltage is applied to a liquid forced through a metal 
capillary and forming a spray (Fenn et al., 1989). A high temperature carrier gas (usually 
N2) nebulizer is used to evaporate the solvent molecules from the analyte ions prior to 
entering the analyzer.  
In 1975 Carroll developed the atmospheric pressure chemical ionization (APCI) as 
an ionization method (Carroll et al., 1974). In APCI a corona discharge voltage is applied 
to the formed spray which then creates ions (Carroll et al., 1974 and Zaikin et al., 2006). 
The corona discharge voltage is placed on a needle inside the source.  
Desorption electrospray ionization (DESI) is also an atmospheric pressure ion 
source. In DESI the ions are produced by using an aqueous spray directed at an insulating 
sample or an analyte deposited on an insulating surface. The samples are spotted onto a 
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surface, which makes it applicable to solid samples, liquids, frozen solutions, and to 
adsorbed gases. It has been demonstrated that DESI ions are formed outside the mass 
spectrometer source by desorption of the analyte, and then the ions detected once they are 
drawn into the mass spectrometer (Takáts et al., 2004 and Chen et al., 2005).  
Direct analysis in real time (DART) ionization was introduced by Cody (Cody et 
al., 2005). In DART direct detection of various chemical analytes present on solids surface, 
liquids and gases can be achieved without the need for sample preparation. In the DART 
source, a gas (usually He or N2) flow containing metastable particles from the ion source 
onto a sample and is responsible for the desorption and ionization (Cody et al., 2005 and 
Chernetsova et al., 2011).  
Many other novel ionization techniques belong to the ambient ionization ionization 
group. Some new examples are: extractive electrospray ionization (EESI) (Chen et 
al.,2006), low temperature plasma probe (LTP) (Harper et al., 2008), paper spray ionization 
(PSI) (Yang et al., 2011), and many others (Alberici et al., 2010 and Martin et al., 2014). 
It should be mentioned with all honours, that in 1987, Tanaka discovered the matrix-
assisted lasers desorption/ionization (MALDI) and Fenn developed the electrospray (ESI), 
and they received jointly the Nobel Prize in 2002 (Tanaka et al., 1988; Fenn et al., 1989).  
In the introduction of this thesis, I will present the two major types of the soft 
ionization in more detail namely: ESI and MALDI.  
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1.3.1.1. Matrix-Assisted Laser Desorption Ionization (MALDI) 
MALDI is a soft ionization technique that was derived from laser desorption mass 
spectrometry (LD-MS), which is an efficient method to produce gaseous ions by focusing 
a pulsed laser on a sample surface. The laser pulses can ablate material from the surface of 
the solid analyte and then ionize the sample. The evolution of LD-MS into MALDI-MS 
occurred with the realization that a matrix was necessary for helping the ionization of the 
analytes and without gas-phase fregmentation. The use of a MALDI matrix play a critical 
role in terms of providing and promoting both desorption and ionization mechanisms. In 
the first step, the sample is dissolved in a solvent containing the analyte solution and the 
matrix. The most common matrices used are: 2,5-dihydroxybenzoic acid (DHB) (Karas et 
al., 1990), sinapinic acid (SA) (Beavis et al., 1989), α-cyano-4-hydroxycinnamic acid 
(CHCA), and 2,4,6-trihydroxyacetophenone (THAP) (Figure 1.3.2) (Beavis et al., 1992). 
The analyte and the matrix are usually allowed to co-crystalize before analysis, though the 
necessity for crystalizing matrices is debatable. 
Following the introduction of the MALDI plate into the source of the mass spectrometer, 
the second step occurs under high vacuum conditions and is initiated by irradiation with 
the laser beam. Usually in all MALDI instruments, the analytes are ionized by using a laser, 
commonly the nitrogen laser operating at 337 nm. Upon, absorption of the laser irradiation, 
the matrix is heated and becomes energized, which leads to the excitation of the matrix 
molecules by donating or extraction a proton, henceforth producing protonated and 
deprotonated molecules, respectively (Hoffmann et al. 2007, and Schiller et al., 2007). 
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Figure 1.3.2: The chemical structures of four commonly used matrices in MALDI-MS analysis. 
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Figure 1.3.3: Representations showing the procedure of desorption/ionization of the 
analytes by a laser beam during MALDI. This scheme was completely redrawn and was 
partially based on Downard, 2004. 
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During laser irradiation (hν), the molecules of the matrix (MH) are excited according the 
following equation (M is the matrix) 
MH + hν → [MH]* 
 
Following excitation, the heated and ionized matrix transfers its energy to the analyte and 
proton which causes its desorption, ionization and ejection into the gas phase. The desorbed 
ionized molecules are then transferred into the gas-phase as either protonated, 
deprotonated, or charged adducts (Figure 1.3.3).  
MALDI is well suited for most of the mass analyzers such as the time-of-flight 
(TOF), various hybrid QqTOF, IT-TOF and Fourier transform ion cyclotron resonance 
(FTICR) analyzers. MALDI-TOF-MS has become a useful analytical tool mainly in the 
analysis of biomolecules, because, the TOF analyzer can analyze ions over a wide mass 
range (Cotter 1992, Chen et al., 2016). 
 
1.3.1.2. Electrospray ionization (ESI) 
ESI is one of the best soft techniques of ionization at atmospheric pressure. In 
electrospray, the analyte is dissolved in conventional solvents such as methanol, acetonitrile 
and water prior introduction in the ionization source either from an HPLC column and/or 
direct introduction via a syringe (Gaskell. 1997). After injection of the analyte in the source, 
ESI is produced by applying a strong electrical field through a metal capillary tube and the 
counter electrode of the ionization source by applying a potential difference 2-6 kV. 
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Figure 1.3.4: The atmospheric pressure electrospray ionization process occurs by emission of 
charged droplets forced into the capillary which is highly charged capillary. This scheme was 
completely redrawn and was partially based on Fenn 2003. 
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This electric field induces a charge accumulation at the liquid surface located at the end of 
the capillary tube and will create charged droplets. A gas injected coaxially facilitates the 
formation of the ion spray which occurs by forcing and transfering the ions from solution 
into the gaseous phase, before entrance in the analyzer. A heated gas (most often N2) 
injected at a low flow rate and/or through the skimmers helps solvent molecule evaporation 
and formation of a spray. The sizes of the charged droplets are continuously reduced by 
solvent evaporation. The charged ions in the droplet will migrate to the outward surface 
due to Coulombic repulsion forces (Figure 1.3.4). This will lead to increases the surface 
charge density and a decrease of the droplet radius. (Gaskell 1997, and Kebarle et al., 2000). 
As the droplets continue to evaporate, the diameters of the droplets carry on shrinking until 
it reaches the Rayleigh charge limit.  At this point, release of the charged analyte ions occur 
into the gas phase (as shown in Figure 1.3.4) (Kebarle et al., 2009 and Konermann et al., 
2014).  
There are different mechanisms proposed for biomolecule ESI ionization: the most 
common two are the ion evaporation model (IEM) and the charged residue model (CRM). 
In the IEM, the ejection of the analytes from the droplet surface accrues via field emission 
(Figure 1.3.5). It was shown that IEM of unfolded proteins causes the formation of high 
ESI charge state ions. In the charged residue model (CRM), the free ions are formed upon 
droplet evaporation to dryness, this ESI process is known to form singly charged ions 
(Figure 1.3.5). CRM is known to be the dominant mechanism for higher mass biological 
molecules. Whereas, IEM is the preferred mechanism of formation of gas phase ions of  
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Figure 1.3.5: Schematic representation of the formation of ions during electrospray ionization. 
This scheme was completely redrawn and was partially based on Metwally et al., 2016. 
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small molecules, that are singly charged (Figure 1.3.4) (Fenn et al., 1989, Smith et al., 
2006, Konermann et al., 2014, and Mehmood et al. 2016).   
ESI is the most common ionization method of biological molecules, due to its 
ability to transfer large intact biomolecules in their ion form into the gas phase, without 
destroying their structure. Even non-covalent interactions can be conserved during 
thelectrospray ionization process. Moreover, the ability of ESI charged ions to be singly or 
multiply charged makes it a powerful technique in biomolecule research. Obtaining 
multiply charged ions can improve the sensitivity at the detector, and it allows the analysis 
of high-molecular-weight molecules to be measured by using the mass-to-charge ratio m/z 
(Hilton et al., 2012, Smith et al., 2006, Fenn. 2003, and Brodbelt. 2014). 
 
1.3.2. Mass analyzers 
 The gas phase ions produced in the ionization source are transferred in the mass 
analyzer, where the ions are separated based on their mass-to-charge (m/z) ratios.  As there 
are various types of ions sources, there are several types of mass analyzers that have been 
developed since 1990s. The choices among the different mass analyzers reside in the type 
of analyte molecules or biomolecules that need to be separated and/or the type of 
information desired (Griffiths et al., 2008). 
             Each mass analyzer has its advantages and its limitations. Different types of mass 
analyzers will be discussed in this introduction with a description of their principles. Once 
the ions are formed in the ion source, they are accelerated towards the mass analyzer where 
their separation according to their m/z occurs. To fulfil their aim, analyzers use forces which 
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influence ion movement, and; a) a magnetic field; b) an electric field; c) TOF and d) 
radiofrequency a radiofrequency (Downard. 2004). 
 Analyzers can be divided into two main groups: those based on ion separation in 
space, sometimes also referred to as beam-type analyzers, and those separating ions in time. 
Double sector instruments, having a magnetic and an electric field, quadrupole and time of 
flight belong to the first group. In this case ions travel for some centimeters (roughly 30-
100 cm in quadrupole) or meters (roughly 2-5 m in sectors or 2-17 m in TOF) and along 
the way they are submitted to one or two of the forces described above (Burgoyne et al., 
1996, Steel et al., 1998, Cotter et al., 1999). Analyzers separating ions in time are trapping 
devices: ion traps (linear or tridimensional ion trap), Orbitrap, and Fourier Transform Ion 
Cyclotron Resonance (FTICR). In these cases, the ion path may be from cm to meters long, 
depending on trapping time (Marshal et al., 1991, and Makarov. 2000). Usually, analyzers 
measure either single full scan of ions such as the case in sectors, quadrupole and ion trap, 
the flight time of the ions (TOF) and/or the frequencies (frequency of axial oscillations 
(Orbitrap), cyclotron frequency (FT-ICR). In the last case, the Fourier transform 
mathematical operations are applied for generating mass spectra from time domain 
transients produced by the image current (Marshal et al., 1991). 
 
1.3.2.1. Quadrupole (Q) analyzer 
The quadrupole analyzer is widely used as a "mass filter" and it is a device which 
separates the ions by their (m/z) using the stability of the trajectories in oscillating electric 
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fields. It is composed of four parallel electrical rods capable of separating ions based on 
(m/z). The polarities of each pair of opposite rods are different and also alternate. Basically, 
the operation of the quadrupole depends on applying a direct current (DC) potential and a 
radiofrequency (RF) potential between these rods, which leads to the ion oscillation 
between the rods as they move along the z-axis (Figure 1.3.6).  In fact, when these two 
opposite rods have an applied potential of (U+Vcos(ωt)) and the other two rods have a 
potential of -(U+Vcos(ωt)), where Φ is the voltage applied to the rods, U is a DC voltage, 
and Vcos(ωt) is an AC voltage. The following equation defines the voltage across the rods: 
 
Φ = + (U+Vcos ωt) and Φ = - (U+Vcos ωt) 
 
The applied voltages affect the trajectory of ions traveling down the flight path 
centered between the four rods. For given DC and AC voltages, only ions of a certain mass-
to-charge ratio pass through the quadrupole filter and all other ions are thrown out of their 
original path. A mass spectrum is obtained by monitoring the ions passing through the 
quadrupole filter as the voltages on the rods are varied (Steel et al., 1998, Downard. 2004, 
Hoffmann et al. 2007, and March et al., 1989).  
When the ions are accelerated lengthwise the z axis, they enter the space between 
the quadrupole rods and they maintain their velocity along this axis. Nonetheless, they are 
also submitted to acceleration along x and y axes that result from the forces induced by the 
electric fields, according to the following equation: 
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Φ is a function of Φ 0: 
 
 
 
 
After differentiation and rearrangement of the above equation, we can derive the equations 
of motion (Paul equation): 
 
 
 
 
 
 
 
Please note that if the trajectory of an ion is stable only when the values of x and y never 
reach r0, this means that ion will never hit the rods. To obtain the values of either x or y 
during the time, these equations need to be integrated. The following equation was 
established in 1866 by the physicist Mathieu to describe the propagation of waves in 
membranes: 
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Figure 1.3.6: Schematic diagram of quadrupole mass analyzer and the x, y, and z axis where 
ions drift through the array of rods. This scheme was completely redrawn and was partially 
based on Downard, 2004. 
 
 
 
 
 
 
 39 
 
                          
 
 The Mathieu equation can only be solved numerically. The important characteristic 
of the solutions of this equation indicate that there are only stable (real) for a certain range 
of values of U and V. The regions of stable solutions are shown below as a function of U 
and V. The Mathieu stability diagram in two dimensions (x and y) is shown in Figure 1.3.7. 
Regions of simultaneous overlap are labeled A, B, C, and D. Stability areas for an ion along 
x or y (above) and along x and y (below); u represents either x or y. The region (shaded 
grey) where the stable solutions of both (a) [x-motion] and (b) [y-motion] intersect is where 
the quadrupole mass filter operates (March. 1997). 
 In summary, the general principle of operation of the quadrupole mass filter can be 
pictured qualitatively as follows: light m/z ions can follow the alternating component of the 
field. For the x-direction, these ions will stay in phase with the RF drive, gain energy from 
the field and oscillate with increasingly large amplitude until they encounter one of the rods 
and are discharged. Consequently, the x-direction is considered as the effective high-pass 
mass filter in which only high m/z values will be transmitted to the other end of the 
quadrupole without striking the x-electrodes. On the other hand, in the y-direction, heavy 
ions will be unstable because of the defocusing effect of the DC component, but some 
lighter ions will be stabilized by the AC component if its magnitude is such as to correct 
the trajectory whenever its amplitude tends to increase.  
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Figure 1.3.7: The Mathieu stability diagram in two dimensions (x and y). Regions of simultaneous 
overlap are labeled A, B, C, and D. Stability areas for an ion along x or y (above) and along x and 
y (below); u represents either x or y. Reproduced (modified) from March, R.E et al., 1989 with 
permission. 
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For these reasons, the y-direction is a low-pass mass filter: only low masses will be 
transmitted to the other end of the quadrupole without striking the y electrodes. By a 
suitable choice of RF/DC ratio, the two directions together give a mass filter which can 
resolve individual atomic masses. 
The quadrupole analyzer possesses many advantages such as the low cost, small 
size, robustness, transmission efficiency, and ease of maintenance. On the other hand, 
quadrupole analyzers have limitation in terms of mass range (2000 to 4000 Da) and 
resolving power (1 FWHM), and the ability to perform MS/MS analysis on their own 
(Downard. 2004). 
 
1.3.2.2. Time-of-flight (TOF) analyzer 
The TOF analyzer is a device that separates the formed ions after ionization, 
according to their m/z values and their velocities. After exit from the source, all ions are 
accelerated by a constant electric field and hence possess the same kinetic energy. 
Following entrance in the field-free region of the TOF analyzer.  the ions possessing 
different masses will be separated according to their flight velocities.  
The determination of the mass-to-charge ratios will be achieved by measuring the 
time that the ions move through the field-free region between the source and the detector. 
Consequently, the ions are accelerated by the same voltage (Vs), and travel through the 
analyzer (d) reaching the detector without using any other acceleration source or process. 
Once the ion leaves the ion source with a mass (m) along with a total charge q = Ze, it 
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would ultimately have an additional kinetic energy (KE). The connection between both the 
mass/charge ratio as well as the time of flight can be expressed as: 
 
KE = 1/2mv2 = qVs 
 
The TOF analyzer has many advantages including fast acquisition rates, spectral 
continuity, exceptional dynamic range, and nearly unlimited upper-mass limit (mass range) 
without sacrificing speed or sensitivity. Nevertheless, the poor resolution sometimes 
obtained with this type of instrument, has been a major flaw compared to other mass 
analyzers. The factors that affect the mass resolution are the following: the length of the 
ion formation pulse (time distribution), the size of the volume where the ions are formed 
(space distribution) and the variation of the initial kinetic energy of the ions (kinetic energy 
distribution). This drawback can be improved with using two major developments called 
delayed pulsed extraction and the potential use of the reflectron sytem. The delayed ion 
extraction corrects the (KE) dispersion of the ions with the same m/z ratio and thus 
improves the resolution of the TOF analyzer without degradation of sensitivity compared 
with conventional extraction (Mamyrin & Shmikk, 1979). In addition, the resolution 
drawback can be overcome by availing of the reflectron. The use of an electrostatic ion 
mirror is introduced (also called the reflectron) to increase both the resolving power and 
hence, accuracy in measurement of the mass. The uses of the reflectron system were 
originally proposed by Mamyrin (Mamyrin et al., 1973). With the reflecton system the ions 
having same m/z values and nearly different kinetic energies, are introduced in the analyzer 
in almost the same time and reach the detector at the same time (Figure 1.3.8). 
 43 
 
 
  
 
 
 
 
 
 
Figure 1.3.8: Schematic description of a TOF instrument equipped with a reflectron. ● = 
ions of a given mass with correct kinetic energy; ο = ions of the same mass but with a 
kinetic energy that is too low. This scheme was completely redrawn and was partially based 
on Downard, 2004. 
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To sum it up, as ions traveling in a longer path of the reflectron, we can obtain better 
resolution as well as accurate mass measurements (Figure 1.3.8) (Mamyrin et al., 1973 and 
Clauser et al., 1999).   
 
1.3.2.3. Fourier-transform ion cyclotron resonance mass spectrometry 
(FTICR-MS) 
 
Since the introduction of the Fourier-transform ion cyclotron resonance analyzer 
(FTICR) in 1974 by Comisarow and Marshall, the interest in using this instrumentation has 
increased consequently (Dietmar et al., 2000, Nikolaev et al., 2014, and Junot et al., 2010). 
FTICR-MS is considered as to possess the highest mass resolution, and accuracy coupled 
to high sensitivity of analysis. 
 The functioning principle of the FTICR analyzer depends on the frequency 
measurement of the ion in the ICR cell which is subjected to a magnetic field (cyclotron 
frequency). To convert ion motion into their cyclotron motion, a magnetic field is 
necessary. This magnetic field is provided either with a permanent magnet, electromagnet, 
or a superconductive magnet. The permanent magnets and electromagnets only produce 
weak magnetic field strengths. However, once we increase the strength of the magnetic 
field, the performance of the FTICR-MS instrument improves as well as the mass resolution 
(Marshall et al., 1998). For these reasons, there has been an increase in the use of strong 
superconductive magnets, such as magnets with field strengths of 11.5 T (Tesla) or even 
20 T.  
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Figure 1.3.9: Schematic illustration of a Bruker FT-ICR mass spectrometry. This scheme was 
completely redrawn and was partially based on (Laskin et al., 2003). 
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The Fourier transform ion cyclotron resonance mass spectrometer (FTICR-MS or 
FT-MS) used in this research consists of several main subunits in the instrument: an ion 
source (usually electrospray source), various ion optics to transfer the ions into the 
magnetic field as the RF-Only quadrupole ion guide, which direct the ions into the (ICR)  
cell or Penning trap (Figure 1.3.9) (Dietmar et al., 2000, Laskin et al., 2003, and Downard, 
2004).  
The heart of FTICR analyzer is the ICR cell, where the measurements of the (m/z) 
ratio of an ion accumulate. The ICR cell is composed of three opposing pairs of plates. 
These plates are called the trapping, the exciting, and the detecting plates (as shown in 
Figure 1.3.10). Trapping the ions in the ICR cell enhances the time of detection and thus 
sensitivity and resolution. The ions can be trapped and stored for up to hours in the ICR 
cell by applying a small voltage to the trapping plates (usually +/− 1-2 Volts, depending on 
the polarity of the ions). At the same time the excitation plates and the detection plates are 
held at ground potential (Dietmar et al., 2000).  
Ions can be stored for long periods in the analyzer cell only in a very high vacuum 
environment. The ultrahigh mass resolution analysis occurs at a pressure of (10−6 to 10−10 
mbar). The several processes that occur in the FTICR analyzer can be summarized as 
follows. Once the ions enter the ICR cell, they will experience harmonic oscillations in the 
electric field between the trapping plates. In order to create a trapping motion, the ions are 
submitted to a strong magnetic field (B) induces them into a stable cyclic motion 
represented by the cyclotron frequency.  
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   Figure 1.3.10: Schematic diagram of an ion cyclotron resonance (ICR) analyzer. This scheme 
was completely redrawn and was partially based on Marshall et al., 1998. 
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In a magnetic field (B), ions of charge (q) and velocity (ν) experience the Lorentz force 
(FL). This (FL) force is perpendicular to both the ions velocity and the magnetic field lines. 
 
FL = qν x B 
 
The Lorentz force (FL) is directed inward and balanced by the centrifugal force (FZ), which 
is directed outward (as illustrated in Figure.1.3.11). The ion mass is represented by (m), the 
ions velocity (νxy) in the x-y-plane and the orbital radius (r). 
 
F = mʋ2/r 
 
Both forces will balance the ions and then stabilize them. 
 
qʋB = mʋ2/r or qB = mʋ/r 
 
A complete circular trajectory can be represented by (2πr) having a frequency (ʋ): 
 
ʋ = ω/2πr 
 
Hence, the angular velocity (ω) becomes equal to: 
 
 
ωc = 2πʋ = ʋ/r = qB/m 
 
The frequency and the angular velocity of the ion depend on the ratio (qB/m). 
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Figure 1.3.11: Schematic diagram of cyclotron motion of ions in the magnetic field induced by 
the. Counterbalance of the centrifugal force Fz and Lorentz force FL. This scheme was completely 
redrawn and was partially based on Schmid et al., 2000. 
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Nevertheless, the radius of the ion trajectory increases in proportion to the velocity. 
If the radius becomes larger than the cell radius, the ion will be expelled (Marshall et al., 
1991, Schmid et al., 2000, and Marshal et al., 2002). Each different ion rotates with its 
unique frequency in a small radius. The ions with the same m/z will experience increasing 
in their kinetic energy (KE), and will be exited coherently as “ion packets” to a larger 
radius, and this happens by increasing the applying voltages of the excitation plates. 
 In the ICR cell, once particular ions with the same m/z values are excited with an 
electromagnetic wave having the same frequency, they will move coherently in a larger 
radius packet and became closer to the detection plates. It should be noted that the higher 
kinetic energy of the irradiation translates into larger radius motion. As we have two 
trapping plates connected by a circuit with a cyclotron frequency characteristic of the ions 
with the same m/z value, the creation of an image charge in the detection plates occurs.   
This image current is formed when the ions packet passes by one plate and then by the 
second plate. Consequently, the time domain signals are detected and then converted into 
a mass spectrum.  
To summarize the described FTICR sequential steps of ions separation, we can say 
that after that the ions are trapped in the ICR cell, they are excited by a resonant excitation 
pulse into a coherent orbit. The excitation amplifier is then turned off and the ions continue 
to orbit at their final radius. Ions moving near electrodes cause an image charge to form on 
these electrodes to balance the ions electric field. In the case of a circular orbit, this image 
charge will oscillate at the ion characteristic resonant frequency, and hence can be detected 
by a sensitive preamplifier circuit, digitized, and stored in computer memory.  
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The complex wave detected as a time-dependent function will transfer into a 
frequency-dependent intensity function through a Fourier transform (FT) (Marshall, 1985, 
Marshall et al., 1998, Shi et al., 1999, Marshal et al., 2002, and Junot et al., 2010). 
FTICR is considered as one of the most effective tools for the analysis of biological 
molecules identification. Recently, FTICR with its sensitivity, full width half mass FWHM 
resolution, dynamic range, and resolution has been utilized for the identification of lipid A 
studies (Schmidt et al., 2000, Nikolaev et al., 2014, and Junot et al., 2010). 
 
1.3.4. Tandem mass spectrometry: 
Tandem mass spectrometry (MS/MS) is a powerful technique of structural 
investigation allowing unravelling the exact structure, sequencing, and identity of the 
analyte. Tandem mass spectrometry involves multiple separation steps of the ion and their 
fregmenation rather than a single step, by using more than one mass analyzer (Figure 
1.3.12). 
The main principle of tandem mass spectrometry technique is depicted in 
Figure1.3.12. In the first analyzer, the isolation of the ions occurs to select one ion of a 
given mass called “the precursor ion”. The mass selected precursor ions pass through a 
region where they are activated by increasing their kinetic energy and causes them to 
fragment apart to produce product ions. This is usually achieved by collision of the 
precursor ions with a neutral gas, a process called collisional activation or collision induced 
dissociation (CID). Also, increasing the pressure in the collision cell increases the CID-
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fragmentation of the precursor ions. Accordingly, the precursor ion will be fragmented into 
product ions. The product ions are then sorted by the second analyzer which separates these 
ions based on their m/z values, which then can be detected by the detector (McLafferty et 
al., 1983, and Busch et al., 1988).  There are various methods to activate the precursor ions 
and increase their internal energy in order to dissociate and fragment the precursor in order 
to provide structural information.  
The most commonly used activation method in the tandem mass spectrometry (MS) 
is collision induced dissociation (CID) (Wells et al., 2005). McLafferty and Jennings were 
the first researchers that have introduced the tandem mass spectrometry technique and the 
collision induced dissociation (CID) analysis (McLafferty et al., 1967, and Jenning et al., 
1968). When a solid material is used for the activation of the ion, then this technique is 
called surface-induced dissociation (SID) (Cooks et al., 1994). In addition, electron capture 
dissociation (ECD) was also introduced as another MS/MS fragmentation technique, in 
which they use a direct introduction of low-energy electrons to interact with the gas-phase 
ions (Zubarev et al., 1998). Like ECD, electron-transfer dissociation (ETD), transfers 
electrons to induce fragmentation of large, multiply-charged cations (Hart-Smith et al., 
2014). CID remains the most common ion activation method. CID methods are distributed 
into three types based on the collision energy and activation time scale; high energy, low 
energy, and very low energy.  
 
 
 
 53 
 
 
 
 
 
 
 
 
Figure 1.3.12: Schematic diagram of the main components of tandem mass spectrometry 
(MS/MS). 
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Recently, there have been enormous advances in developing hybrid tandem mass 
spectrometers. The purpose of these instruments is to combine the strength of different 
analyzer to enhance the separation of the precursor ion and product ions. In these types of 
instrument, the first analyzer function as an ion focusing device that guides the precursor 
ion to other components of the device. Almost all possible combinations of several different 
types of analyzer have been reported (ex, triple quadrupole instrument  
(QqQ), ion trap-quadrupole (IT-Q-TOF), or a quadrupole linked to a Time-of-flight (QqQ-
TOF-MS) hybrid instruments. 
 
1.3.3.1 CID-QqQ-MS/MS (Low-energy) 
It has been shown that the time scale of the CID-activation is based on the rapidity 
of energy deposition on the precursor ion, which in fact translates into how fast this 
precursor ion dissociates or rearranges (McLuckey et al., 1997). Therefore, low- energy 
CID methods are slow when multiple collisions occur. The low-energy collision in tandem 
mass spectrometry analyses usually occur in the 1–100 eV range. Usually, within few 
hundred microseconds to a few milliseconds, activation of tens to hundreds collisions 
occur. Therefore, these collisions happen with long intervals between individual each 
individual collision which leads to more activation and dissociation. This is exemplified in 
Table 1.3.1 which presents three time regimens for activation methods used in MS/MS. 
This type of low-energy CID is commonly used in triple quadrupoles (QqQ) (Figure 
1.3.13). The product ions formed by dissociation of the precursor ion can experience further  
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Figure 1.3.13:  Triple Quadrupole mass spectrometry. This scheme was completely redrawn 
and was partially based on McLafferty et al., 1983. 
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Figure of merit 
 
High-energy CID 
  (fast activation) 
 
Low-energy CID 
   (slow activation) 
 
Very low-energy CID 
(very slow activation) 
 
Instruments used 
Magnetic/electric 
sectors, TOF/TOF 
Tandem quadrupoles,  
   (e.g., QqTOF, QqQ) 
Quadrupole ion trap, 
FT‐ICR  
 
Collision energy 
 
2–10 keV 
 
1–200 eV 
 
1–20 eV 
 
Collision number 
 
1-5 
 
10-100 
 
100s 
 
Activation time scale 
 
1-10 µs 
 
0.5-1 ms 
 
10-100 ms 
 
Instrument time scale 
(kinetic window)/minimum 
observable reaction rate 
 
10-100 µs/106-104 s-1 
 
0.1-1 ms/104-103 s-1 
 
10 ms-1s/102-1 s-1 
 
Efficiency 
 
<10% 
 
5–50% 
 
50–100% 
 
Table 1.3.1. Summary of the typical parameters for the three commonly used CID regimens. 
 
 
 
 
 
 
 
 57 
 
activation by subsequent collisions and then also dissociate at higher gas pressures. Once 
the product ions are formed, they can be reactivated by collision and can fragment further. 
This step can be repeated to provide MSn spectra. 
In this thesis, I will discuss the advantages and disadvantages of implementing the 
CID analysis. During the CID-process, after collision with the neutral collision gas, the 
precursor ion kinetic energy is transferred into internal energy, which caused the precursor 
ion to dissociate into various product ions. This technique is called collision-induced 
dissociation or collision-activated dissociation (CID or CAD) (McLafferty et al., 1983, and 
Shukla et al., 2000). 
 
1.3.3.2. CID-MS/MS (Very Low Energy) 
 
Very low collision energy MS/MS experiments occur in the order of few eV 
collision energies and hundreds of collisions are required, whereas, as precursor ion 
activation time needs to be much longer, (hundreds of milliseconds to second). 
Consequently, very low-energy CID-MS/MS analyses are considered to occur with very 
slow activation and slow heating methods (Table 1.3.10) (Gauthier et al., 1991). It is 
commonly used in trapping devices, such as quadrupole ion traps (IT) and Fourier-
transform ion cyclotron resonance (FTICR) instruments. 
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1.3.3.2.1. QIT-MS/MS  
Quadrupole ion trap (QIT) consists of central doughnut-shape ring electrode and a pair of 
end cap electrodes (Figure 1.3.14). Ions will enter through the end-cap electrode and then 
directed to the detector, by applying appropriate DC (U) and RF (V) voltages to electrodes 
to create a dynamic parabolic region inside the trapping volume. In a quadrupole ion trap 
(IT), the isolation and acceleration of precursor ions are achieved by using the ‘‘on- 
resonance’’ excitation method. In the “on resonance method”, the isolated precursor ion is 
excited by applying a small potential across the end-caps. Ion activation times of the order 
of tens of milliseconds can be used without significant ion losses, therefore, multiple 
collisions can occur. The product ions are detected by subsequent ejection from the trap 
(Figure 1.3.13) (Wieboldt et al., 1997, and Stafford, 2002). 
 
1.3.3.2.2 CID-FTICR-MS/MS  
When an FTICR-MS instrument is used for MS/MS experiments, the ions are 
directed to the ICR cell where they are exposed to a very low pressure (10-10 mbar).  An 
electric field (AC) can be applied to excite the desired ions or to expel the not wanted ions 
by discharge on the wall. The selected ions can then be fragmented by using a collision gas 
which induces the fragmentation. The product ions are then formed close to the centre and 
detected. The processes of selection, fragmentation, and detection, can be performed 
repetitively. This will allow the increase in sensitivity, the resolution and more importantly 
can provide MSn capability, without reloading ions from the source. In FTICR-MS high 
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Figure 1.3.14: Schematic diagram of quadrupole ion trap mass analyzer (QIT). This scheme 
was completely redrawn and was partially based on Downard, 2004. 
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resolution can be obtained on both precursor and product ions (Wieboldt et al., 1997, and 
Stafford, 2002).  
It should be noted that in many FTICR tandem mass spectrometers collision 
activation is a stepwise process. Initially, the ions enter the ICR cell with low kinetic 
energies and are trapped effectively without any fragmentation. The chosen precursor ions 
are excited, gain higher kinetic energy and move to larger radii. This excitation is followed 
by either one of the following processes: collision-induced dissociation (CID), sustained 
off-resonance irradiation collision-induced dissociation (SORI/CID), infrared multiphoton 
dissociation (IRMPD), and electron capture dissociation (ECD) (Scigelova et al., 2011, and 
Brodbelt. 2014). 
In this thesis, we will use SORI/CID technique in order to produce the fragment 
ions. Therefore, we will discuss the advantages and disadvantages of implementing the 
SORI/CID.  
 
1.3.3.3. MALDI-TOF-TOF-MS/MS analysis (High energy) 
 When using MALDI-TOF-TOF-MS/MS instruments, high collision energy CID 
possessing very high translational energy is usually used to fragment the precursor ions into 
product ions.  Henceforth, the precursor ions with a kinetic energy of a few keV can enter 
the collision cell under low-vacuum conditions. It should be noted that this high-energy 
CID-MS/MS is considered as a fast method of activation as the deposited energy is related 
to the number of collisions. For these reasons, the use of single or a few (5–10)  
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Figure 1.3.15:  Schematic representation of MALDI-TOF/TOF-MS/MS. This scheme was 
completely redrawn and was partially based on Sleno et al., 2004. 
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collisions are typically used to input high energy (Table 1.3.10), (McLuckey et al., 1997). 
As previously mentioned, the high-energy collision cell is located between two TOF mass 
analyzers (as illustrated in Figure 1.3.15) (Sleno et al., 2004).  
 
1.3.3.4. Different types of MS/MS analysis  
There are various types MS/MS experiments that can be performed (Figure 1.3.16). 
The first type is the product-ion scan (or CID-MS/MS experiment) which is one of the four 
main scan experiments, and the most common mode of MS/MS operation. The product ion 
scan spectrum contains only those product ions that are formed from a mass-selected 
precursor ion. The first mass analyzer is used to transmit only the selected precursor ion, 
and the second mass spectrometer is scanned over a required m/z range.  
Another type of MS/MS scan used is the precursor-ion scan. That type of scan 
allows the identification of all the precursor ions that fragment to a common product ion. 
This can be achieved by adjusting the second mass analyzer to transmit a chosen product 
ion, and then the first mass analyzer will scan over a certain m/z range to transmit only 
those precursor ions that fragment to produce the chosen product ion. 
Additionally, a natural-loss scan is another scan type, in which all the precursor ions 
endure the loss of a specified common neutral species. Both mass analyzers are scanned at 
the same time, but with a mass offset that associates with the mass of the specified neutral 
group. This scan is typically suitable for closely related compounds, which is often result 
in forming the same product ion. 
 63 
 
 Finally, the fourth scan type is multiple-reaction monitoring (MRM) scanning in 
which both mass analyzers can simultaneously measure a set of preselected analyte m/z 
precursor ion →m/z product ion transition. Monitoring more than one reaction is termed 
multiple-reaction monitoring (MRM). Both type of reaction monitoring is suitable for 
quantitative measurements of analytes within complex mixtures (Figure 1.3.16) 
(McLafferty. 1981, and Lin et al., 2014). 
 
1.3.3.5. Definition of tandem in-space and in-time  
Tandem mass spectrometry was developed as a tandem-in-space method when 
using sector mass spectrometers. Later, it was expanded as consecutive arrangements of 
mass/energy analyzers, where the selection of the precursor ion and the formation of the 
product ions could be performed by two or more analyzers that were coupled together 
sequentially, such as multiple quadrupoles (Q) (Yost et al., 1978), time-of-flight (TOF) 
(McLafferty et al., 1980) and various combinations.  
This was followed by the development of tandem-in-time instruments, in which the 
selected precursor ion was dissociated consecutively within the same space by using a 
radiofrequency, such as the quadrupole ion trap (March et al., 1995), and the ion cyclotron 
resonance (ICR) mass spectrometers (Cody et al., 1982). During the trapping process, the 
precursor ions contain relatively low-kinetic energy, and following excitation, their energy 
is activated by multiple collision activation methods which convert their internal energy to 
translational energy (Melvin et al., 1974, and Schmid et al., 2000). 
 64 
 
In this thesis, I will employ both types of the described tandem mass spectrometry 
instruments. The most common type of tandem-in-space mass spectrometer used in this 
investigation will be performed with a low-energy CID a triple quadrupoles instrument 
such as (ESI-QqQ-MS/MS).  
In addition, low-energy collision dissociation tandem-in-time mass spectrometer 
will be used with an by ESI-FTICR-MS/MS (McLuckey et al., 1992, Harrison et al., 1999, 
Hakansson et al., 2003, and Vukelića et al., 2007). For high-energy tandem mass 
spectrometric analysis, CID-MALDI-TOF/TOF-MS/MS will be used.  
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            Figure 1.3.16: Block diagram of scan modes of MS/MS. This scheme was completely 
redrawn and was partially based on Sleno et al., 2004. 
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1.3.4. Characterization of Lipid A by mass spectrometry and tandem 
mass spectrometry. 
Mass spectrometry (MS) has been developed as one of the premier tools for 
elucidation of lipid A structures. The amphiphilic nature of lipid A species makes them 
intensely difficult to separate and ionize. The number and the length of lipid A fatty acids 
vary among different species. For example, the analysis of lipid A isolated from the LPS 
of B. parapertussis pagP using MALDI-TOF- and ESI-FTICR-MS (- ion mode), revealed 
the presence of a singly deprotonated GlcN disaccharide di-phosphorylated hexa-acylated 
lipid A structure, containing two phosphate groups at O-1 and O-4ˊ and six fatty acids, 
including two (C14:0(3-OH)) acyl chains, one (C14:0), two (C16:0) acyl chains, and one 
(C10:0(3-OH)) acyl chains (Hittle et al., 2015). Also, ESI-FTICR-MS (- ion mode) of lipid 
A isolated from the LPS of the Salinivibrio sharmensis, revealed the presence of a singly 
deprotonated GlcN disaccharide di-phosphorylated hexa-acylated lipid A structure, 
containing two phosphate groups at O-1 and O-4’ and six fatty acids, including three 
(C14:0(3-OH)) acyl chains and one (C12:0(3-OH)) acyl chains (Carillo et al., 2013).  
While MALDI-QqTOF-MS (- ion mode) analysis of the lipid A obtained from LPS 
of H. alvei 1192 revealed the presence of a singly deprotonated GlcN disaccharide di-
phosphorylated hexa-acylated forms of lipid A carrying four (C14:0(3-OH), one (C14:0) 
and one (C12:0) fatty acids, containing two phosphate groups at O-1 and O-4ˊ 
(Lukasiewicz et al., 2010). The chemical structure of lipid A isolated from LPS of the A. 
salmonicida SJ-83, was investigated using ESI-QqTOF-MS hybrid instrument (negative-
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ion mode) afforded a major doubly charged ion and its corresponding singly charged ion 
as a minor species. The GlcN disaccharide structure was composed of di-phosphorylated 
hexa-acylated lipid A structure, containing two phosphate groups at O-1 and O-4ˊ and six 
fatty acids, including four (C14:0(3-OH)) acyl chains, (C14:0) acyl chins, and one (C12:0) 
acyl chains (El-Aneed et al., 2005). 
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1.4. The objective of the thesis 
The main purpose of this research is focused on the uses of several types of tandem 
mass spectrometry techniques (tandem-in space, tandem in-time, high- and low-energy 
collision induced dissociation tandem mass spectrometry analysis) to investigate the 
structure of a series of lipid As extracted from different type of bacteria of the 
Vibrionanaceae family. In this thesis, it should be clarified that the investigated series of 
lipid As, were obtained from LPSs isolated from the outer membrane of the Gram-negative 
bacteria pathogen Aeromonas Liquefaciens SJ-19, hydrophilla SJ-55, and Salmonicidia SJ-
113. In addition, it should be mentioned that the bacteria were infected with one type of a 
bacteriophage virus (ATCC # PTA-8357). This voluntary infection of this series of bacteria 
was completed, to investigate the possible physical interactions, between the phages and 
the bacteria in order to understand, whether this phage-bacteria interaction, affected the 
biosynthesis of the outer membrane LPSs. This study initially was aimed for the possible 
development of phage therapeutic strategy in the aquaculture industry.  
Most of the published studies on infection of bacteria with phages, have been 
mainly focused on elucidating the respective structures of the O-specific antigens and core 
oligosaccharide portions of the affected virus induced LPSs structures which results from 
the interactions of the phage receptors and the LPS outer cell surface, membrane (Perry et 
al., 1979, Banoub et al., 2010, Rakhuba et al., 2010, and Viertel et al., 2014). 
In that respect, it should be mentioned, that to our knowledge, that there has never 
been any work published on the variation of the lipid A structures following the isolation 
of LPSs from bacteria infected with bacteriophages, this was never investigated before. For 
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these reasons, the effect of the bacteriophages on the bacteria, and specifically on the 
structures of this series of Lipi As will be investigated by MS techniques and evaluated in 
this document.  
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Chapter 2 
 
 
Materials and Methods 
 
 
The original strain of Aeromonas liquefaciens, hydrophilla, and salmonicidia were 
obtained from Dr H. N. Atkinson (The South Australian School of Technology Oceans, 
Australia). The cultures were grown to medium-to-late stationary phase in Trypticase Soy 
Broth without added glucose (Baltimore Biological Laboratories Inc.) for almost 20 h at 
25°C. The bacteriophage product used in our studies is ListShield™; AP2 for A. 
liquefaciens, AH1 for A. hydrophilla, and AHER1 for A. Salmonicidia. Following 
individual infection with the (ATCC # PTA-8357) phage, each species was divided into 
three bacterial colonies which are then selected from biochemically pure cultures of 
Aeromonas liquefaciens SJ-19, hydrophilla SJ-55, and salmonicidia SJ-113.  
It should be mentioned that for these Gram-negative bacteria the overall strain of 
these species were isolated as morphologically different clones. The first series of clones 
(Strain 19a), (Strain 55a), and (Strain 113a), grew when infected with the phage, and were 
referred to as phage resistant. The second series of clones (Strain 19b), (Strain 55b), and 
(Strain 113b), when cultivated in the presence of the same phage, were unable to be 
reproduced, and were referred to as phage sensitive.  
These strains were added to the collection of the Northwest Atlantic Fisheries 
Center, St. John’s as (SJ-19, SJ-55, SJ-113) (original), and (SJ-19a, SJ-55a, SJ-113a) 
(resistant). These organisms were initially plated on Trypticase Soy Agar (Baltimore 
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Biological Laboratory, Baltimore, MD, USA) to check purity and colonial morphology. 
Stock cultures were grown in Trypticase Soy Broth without dextrose, divided into 1 mL 
aliquots, and frozen and stored at (-80 °C). The protocol for medium-scale culture of the 
bacteria in the presence of phages was generally identical for each strain (Michon et al., 
1984, and Almostafa et al., 2016).  
 
2.1. Purification of the lipopolysaccharides 
 The extractions of the LPSs were achieved using the hot-phenol method (of 
Whestphal and Jann) and freeze-dried. The stored cells (10 g) were suspended in deionized 
water (175 ml) and heated to 70° C. The addition of an equal volume of heated phenol (90 
%) to the mixtures was finalized by stirring the mixtures for 20 min at 70° C. Then the 
mixtures were cooled on ice and centrifuged using Sorvall SS-34 rotor (3500 rpm, 1475 x 
g). The isolation was for the aqueous layers by aspiration and the procedure was repeated 
twice.  
The aqueous layers were combined and dialysed against water to remove any traces 
of phenol. Consequently, the evaporation (under vacuum) was done to reduce the water 
volume of the combined water mixtures and finally centrifuged at 39,000 rpm (105,000 x 
g) for 3 h.   
The LPSs were finally lyophilized and isolated and further purified using 
polymyxin-coated Affi-prep beads (Bio-Rad Laboratories, Richmond, CA, USA). Fifteen 
milligrams of LPSs were suspended in 15 ml of phosphate-buffered saline (PBS, PH=7.4). 
LPSs solutions were mixed with washed polymyxin beads (the beads were originally 
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washed first with 0.1 M NaOH and then with distilled water. The mixtures were incubated 
overnight with agitation using an orbital shaker (1500 rpm). The mixtures were then 
centrifuged (2500 x g) for 10 min and the supernatants were collected. The beads were then 
washed twice with 15 ml and 5 ml 0.1 M NaOH. The supernatants were combined and 
LPSs were dialysed against water and finally lyophilized (Caroff et al., 2003, Banoub et 
al., 2010). 
 
2.2. Hydrolysis of the lipopolysaccharides 
LPSs (100 mg) were hydrolyzed with 1% acetic acid for 90 min at 100°C. Then, the 
LPSs were centrifuged at 3000 x g for 30 min induce the precipitation of lipid As, while the 
polysaccharides were present in aqueous media.  
Lipid As were removed and washed with water and the O-specific polysaccharide 
or the rough mutant core oligosaccharides were recovered from the supernatant by 
chromatography on Sephadex G-50 (Pharmacia Ltd.). Fractions were visualized using a 
differential refractive index detector (Waters Associates) (Banoub et al., 2010, Kilár et al., 
2013, Wang et al., 2015, and Almostafa et al., 2016). 
 
2.3. Gas chromatography-mass spectrometry (GC-MS) for fatty acid 
analysis  
GC-MS analysis was performed on a Varian Saturn 2000 GC MS/MS instrument 
equipped with a Zebron capillary column (30m x 0.25 mm). Helium was used as the carrier 
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gas. Lipid A was treated with 2 M HC1 in methanol (methanolysis) for 3 hrs at 100° C. 
Methyl esters were extracted into hexane and analyzed by GC-MS in comparison with 
standard methyl esters (Supeleo, Bellefonte, PA, USA). GC (1 µL injection) analysis of 
methyl esters was performed with the following temperature program: 100° C for 5 min, 
100° to 280° C at 5° C/ min, hold at 280° C for 5 min (Kitson et al., 1996, Portolés et al., 
2011, Banoub et al., 2010, and Almostafa et al., 2016). 
 
2.4. Mass spectrometric analysis of the extracted mixture of lipid As 
2.4.1. Electrospray triple-quadrupole mass spectrometry (ESI-QqQ-MS) 
of the extracted mixture of lipid As. 
 
Electrospray ionization mass spectrometry (ESI-MS) and low-energy collision-
induced dissociation (CID-MS/MS) analysis were performed using a Waters XEVO TQ-S 
(QqQ) system (Waters Corp., Milford, MA, USA) equipped with an ESI source operated 
in negative ion mode. The operating voltage on the ESI capillary was 2200 V and the cone 
voltage was set at 31 V. The ESI source was maintained at 75 °C and the desolation 
temperature at 200 °C.  
All the CID-MS/MS analysis were carried out with the same collision energy of 30 
eV. The Xevo TQ-S is equipped with a ScanWave™ collision cell (q), which provides 
enhanced product ion spectral acquisition capability. The mass accuracy of the reported 
masses is 0.01 m/z units based on the mass assignment of ±0.05 m/z units over a 24 h period 
(Kilár et al., 2013, and Almostafa et al., 2016). 
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The lipid As mixtures of the Gram-negative bacteria Aeromonas liquefaciens (SJ-
19a), hydrophilla (SJ-55a), and salmonicidia (SJ-113a) were dissolved in chloroform and 
methanol (1:1) and 0.1% trimethylamine/pure Milli-Q water, and (SJ-19a: 1.6 mg/mL), 
(SJ-55a: 1.7 mg/mL), and (SJ-113a: 1.4 mg/mL). Then they were directly injected (10 µl 
flow) into the ESI source in negative (-ve) ion mode.   
 
2.4.2. Electrospray quadrupole Fourier transform ion cyclotron mass 
spectrometry (ESI-FTICR-MS) of the extracted mixture of lipid As 
 
  Electrospray ionization Fourier transform ion cyclotron resonance (ESI-FTICR) 
mass spectrometry was performed in the negative ion mode using an APEX QE (Bruker 
Daltonik GmbH, Bremen, Germany) with a 7 Tesla actively shielded magnet. The samples 
were sprayed at a flow rate of 250 μL min–1. The capillary entrance voltage was set to 4 kV 
and nitrogen was used as drying gas at a temperature of 200 °C. The instrument was 
externally calibrated with appropriate standards. Sustained off-resonance irradiation 
collision induced dissociation (SORI-CID) experiments were performed by isolating the 
ions under study inside the ICR cell (P = 10–10 mbar) and exposing them to Ar at higher 
pressures (P ≈ 10–5–10–6 mbar). At these pressures, in the 250 ms excitation time, there are 
of the order of 10s to 100s of collisions (Brodbelt. 2014, and ALmostafa et al., 2016). 
The lipid As mixtures of the Gram-negative bacteria Aeromonas liquefaciens SJ-
19a, hydrophilla SJ-55a, and salmonicidia SJ-113a were dissolved in chloroform and 
methanol (1:1) and 0.1% trimethylamine/pure Milli-Q water, and (SJ-19a: 1.6 mg/mL), 
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(SJ-55a: 1.7 mg/mL), and (SJ-113a: 1.4 mg/mL). Then they were directly injected into the 
ESI source in negative (-ve) ion mode.   
 
2.4.3. Matrix-assisted laser/desorption ionization time-of-flight mass 
spectrometry (MALDI-TOF-MS) of the extracted mixture of lipid As 
 
2,5-dihydroxybenzoic acid (DHB) matrix was used at a concentration of 5 mg/ml 
in a 2:2:1 mixture (v/v/v) of methanol, acetonitrile, and water. Lipid A was used at a 
concentration of 2 mg/ml in a (1:1) mixture (v/v) of chloroform and methanol. The sample 
was prepared by mixing equal volumes of DHB solution and lipid A solution. The spot was 
done by using 1 µl of this mixed solution and spotted onto a MALDI plate and then left to 
crystallize and dry in desiccators before being loaded into the MALDI-MS instrument. 
 Mass spectra of the lipid A isolated from Aeromonas liquefaciens SJ-19a, 
hydrophilla SJ-55a, and salmonicidia SJ-113a were acquired in reflectron negative ion 
mode. The MALDI-TOF/TOF-MS spectrometer (MALDI 4800, Applied Bioscience) 
(MALDI-Quality™ Matrix Solutions, Agilent Technologies) was used for this experiment. 
The MS data were acquired in the mass range 600 to 1900 m/z. The MALDI-TOF/TOF-
MS instrument was equipped with a nitrogen laser (337 nm). All the spectra were 
accumulated as 600 individual laser shots. The accelerating potential was 25KV. The 
focusing guide wire was held at a potential 0.18%. The laser intensity of 4200 was used. 
The MALDI-TOF/TOF-MS possessed a high mass accuracy (5 ppm) and resolution of 
15000-25000 (FWHM). The minimum signal to noise ratio was 35. 
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High-energy collision dissociation MS/MS (CID-MS/MS) experiments were 
conducted using the same instrument. Product ion scans of selected masses were induced 
by a high CID collision cell. The resulting product ions were analyzed by the second TOF 
analyzer. The tandem mass spectrometric analysis was achieved with N2 as collision gas 
and at collision energy of 1 kV, which corresponds to the difference between the 
accelerating potential (8 kV) and the floating cell (7 kV) (Schiller et al., 2007, Lukasiewicz 
et al., 2006, Kilár et al., 2013, and Almostafa et al., 2016). 
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Chapter 3 
 
Mass Spectral analysis of the mixture of lipid An isolated from the LPS of 
A. liquefaciens SJ-19. 
 
Aeromonas Liquefaciens is a genus of Gram-negative, anaerobic, non-spore-
forming bacilli bacterium belonging to the Gram-negative Vibrionaceae family (Aoki et 
al., 1971, and Michon et al., 1984). This bacterium fits in a group of closely related motile 
Aeromonads, which mainly cause hemorrhagic septicemia in cultured pond-fish and 
salmonids (Michon et al., 1984 and Janda et al., 2010). The LPS of SJ-19a was obtained 
from the rough mutant Gram-negative bacteria A. liquefaciens grown in the presence of 
phage and it was classified as phage resistant.  
 
3.1. Gas chromatography-mass spectrometry (GC-MS) of the fatty methyl 
ester released from the lipid An mixture isolated from the LPS of the A. 
liquefaciens SJ-19. 
 
The qualitative analysis of fatty acids was carried out by GC-EI-MS to identify 
separately the amide and the ester-bound fatty acids. The (R)-3-hydroxytetradecanoic acid 
(C14:0(3-OH)) was identified as an amide-linked fatty acid, whereas the (R)-3-
hydroxytetradecanoic acid (C14:0(3-OH)) (3-hydroxymyristic acid) and dodecanoic acid 
(lauric acid) (C12:0) were identified as amide-linked fatty acids (Perry et al., 1979, Rebeil 
et al., 2004, and Almostafa et al., 2016). In addition to the methyl ester derivative of 3-
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methoxytetradecanoic acid, the fatty acid methyl esters obtained by trans-esterification with 
sodium methoxide also showed the presence of the (C14:0(3-OH)) acid, which was 
substituted by the tetradecanoic acid (C14:0) (myristic acid) in the native lipid A. Similarly, 
the (C14:0(3-OH)) acid was also shown to be substituted by lauric acid. The absolute 
configuration of the GlcN residues in lipid A was determined as D on the deacylated, 
dephosphorylated lipid A fraction, using (R)-2-butanol (Perry et al., 1979, Rebeil et al., 
2004, and Almostafa et al., 2016). 
 
3.2. ESI-QqQ-MS analysis of the extracted mixture of lipid An isolated 
from the LPS of A. liquefaciens SJ-19a 
 
The A. liquefaciens SJ-19a bacteria dissolved in chloroform and methanol was 
electrosprayed in the negative ion mode. The ESI-QqQ-ToF-MS is shown in (Figure 3.1.1). 
The lipid An component of the A. liquefaciens SJ-19a bacteria is not merely composed of a 
single lipid A entity. In reality, it is a complex mixture of many structurally-related 
components produced by the incomplete biosynthesis of this lipid A.  
The ESI-QqQ-MS (- ion mode) of the lipid An (where n=1-5) mixture showed the 
presence of inter-alia seven different fragment ions at m/z 1716.30, m/z 1688.19, m/z 
1506.10, m/z 1279.73, m/z 1097.63 m/z 892.56, and m/z 666.06. This indicates the presence 
of a heterogeneous mixture of lipid An (Scheme.3.1.1).  
We have assigned these fragment ions as the series of [Mn-H]
- deprotonated mono-
phosphorylated molecules, represented as the following: LipA1 at m/z 1716.30, LipA2 at 
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m/z 1688.19, LipA3 at m/z 1506.10, LipA4 at m/z 1279.73, and LipA5 at m/z 1097.63 (Figure 
3.1.1 and Table 3.1.1). In addition, we also observed two deprotonated molecules at m/z 
892.56 and m/z 666.06. It is important to note that our tentative structural assignments of 
this series of deprotonated molecules have relied on comparison with well know Lipid A 
structures by a manual and expert-driven process. This was done without help of any 
software such as LipidView™ Software produced by Sciex. It is vital to mention that this 
mixture of lipid An did not give any distinctive mass spectra when electrosprayed in the 
positive ion mode.  
From the above assignments, it became clear that the structures of the heterogeneous 
lipid An mixture contained a phosphate group which was located either on the O-4ʹ or O-1 
positions of the β-D-GlcpN-(1→6)-α-D-GlcpN disaccharide backbone of lipid A.  
From comparison with known literature, the deprotonated molecules were 
tentatively assigned that the 3-hydroxy-myristic acid (C14:0(3-OH)) fatty acid chains that 
acylate the various free positions of the β-D-GlcpN-(1→6)-α-D-GlcpN backbone of the 
fully biosynthesized LipA1; these fatty acid chains were certainly attached to the O-3, O-
3ʹ, N-2 and N-2ʹ positions of this lipid A.   
Also, it was proposed that two of these (C14:0(3-OH)) fatty acyl groups were 
substituted with either myristic and/or lauric acid (Scheme 3.1.1). By scrutinizing other 
known structures of lipid A, these two branched (Cl4:0(3-O-C12:0)) and (Cl4:0(3-O-
C14:0)) fatty acyl groups are probably located on the O-3ʹand N-2ʹ positions (or vice-versa) 
of the non-reducing end group of the β-D-GlcpN-(1→6)-α-D-GlcpN disaccharide backbone 
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of this lipid An mixture (Scheme 3.1.1) (Lukasiewicz et al., 2010, Banoub et al., 2010, Kilár 
et al., 2013, Brodbelt et al., 2014, and Almostafa et al., 2016). 
The deprotonated molecule [M1-H]
- at m/z 1716.30 was assigned as the mono-
phosphorylated hexa-acylated forms carrying four primary 3-hydroxy-myristic acid 
(C14:0(3-OH)) fatty acids, in which two of them were substituted by either lauric and /or 
myristic acids forming the branched fatty acids (Cl4:0(3-O-C12:0)) and (Cl4:0(3-O-
C14:0)). This series of fatty acyl groups can be distributed on the O-3, O-3ʹ, N-2, and N-2ʹ 
position, not necessary in that order (Scheme 3.1.1). 
 Similarly, the deprotonated molecule [M2-H]
- of LipA2 at m/z 1688.19 was 
attributed to the mono-phosphorylated hexa-acylated molecules. Accordingly, we presume 
that this molecule was formed by four (C14:0(3-OH)) 3-hydroxy-myristic acids, in which 
two of these fatty acids were esterified with two separate molecules of lauric acid (C12:0) 
at the 3-hydroxyl position of (C14:0(3-OH)) myristic acids. Once more, by comparing with 
other known structures of lipid A, these two branched (Cl4:0(3-O-C12:0)) fatty acids are 
probably located on the O-3ʹand N-2ʹ positions (or vice-versa) of the non-reducing end 
group of the LipA2 disaccharide backbone (Scheme 3.1.1).  
The most abundant deprotonated molecules at m/z 1506.10 and at m/z 1279.73 were 
tentatively assigned as LipA3 and LipA4. The deprotonated molecule [M3-H]
- of LipA3 at 
m/z 1506.10 was assigned as the mono-phosphorylated penta-acylated form of the β-D-
(1→6)-Glucosamine disaccharide carrying four primary 3-hydroxy-myristic acid 
(C14:0(3-OH)) fatty acids, in which one of them was substituted by lauric acids forming 
the branched fatty acids (Cl4:0(3-O-C12:0)), which we tentatively assigned to be located 
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at N-2ʹ of the non-reducing end residue of β-D-GlcpN-(1→6)-α-D-GlcpN disaccharide of 
LipA3 (Scheme 3.1.1).
  
The deprotonated molecule of LipA4 [M4-H]
- at m/z 1279.73 was assigned as 
containing a mono-phosphorylated tri-acylated form of the β-D-GlcpN-(1→6)-α-D-GlcpN 
disaccharide, carrying three primary 3-hydroxy-myristic acid (C14:0(3-OH)) fatty acids, in 
which one of them was substituted by lauric acids forming the branched fatty acids 
(Cl4:0(3-O-C12:0)), probably located at the N-2ʹ position of this lipid A. It should be noted 
that LipA4 at m/z 1279.73 appears to be related to the deprotonated molecules LipA3 at m/z 
1506.10, which can be formed by elimination of one myristic fatty acid (C14:0(3-O-
C14:0)) (-228 Da) from LipA3 (Scheme 3.1.1). 
 The deprotonated molecule [M5-H]
- at m/z 1097.63 was assigned as LipA5 mono-
phosphorylated tri-acylated β-D-GlcpN-(1→6)-α-D-GlcpN disaccharide containing three 3-
hydroxy-myristic acid (C14:0(3-OH)) fatty acids, which can be tentatively distributed on 
the O-3, N-2, and N-2ʹ positions (Scheme 3.1). Nevertheless, one can presume that the 
deprotonated molecule LipA5 at m/z 1097.63 can be related to the deprotonated molecules 
LipA4 at m/z 1279.73, and probably created by elimination of one lauric fatty acid 
(C14:0(3-O-C12:0)) (-182 Da). In addition, we have also observed the deprotonated 
molecule at m/z 892.56 which was tentatively assigned as [C-(C14:0)ketene-H]-. This latter 
deprotonated molecule was attributed to the deprotonated molecule mono-phosphorylated 
D-GlcN species containing a 3-hydroxy-myristic (C14:0(3-OH)) fatty and a branched 
(Cl4:0(3-O-C12:0)) fatty acid group located on N-2.  
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Another deprotonated molecule at m/z 666.06 was assigned as [C-(C14:0(3-O-
C14:0))ketene-H]-. This latter deprotonated molecule was recognized as the mono-
phosphorylated D-GlcN species, containing one branched (Cl4:0(3-O-C12:0)) fatty acyl 
group on the N-2 position (Scheme 3.1.1). It is reasonable to assume that the formation of 
these C-fragment ions at lower m/z values can be produced by the incomplete biosynthesis 
of the lipid A (Please understand, that these deprotonated molecules were named Fragment 
ions, to respect only the Domon and Costello nomenclature) (Domono and Cosetello 1988). 
Other logical reasons are: the partial degradation of lipid A during work-up, and the acid 
liability of some acyl chains and phosphate group at O-1 position during the acid 
hydrolysis. 
At this stage of this investigation, we have tentatively identified a series of complete 
and incomplete O-3, O-3’, N-2 and N-2 acylated the β-D-GlcpN-(1→6)-α-D-GlcpN 
disaccharide backbone of the lipid A1-5 structures sharing common properties. Once more, 
by analogy with known structures of lipid A, we have identified the presence of two primary 
hydroxytetradecanoic acids (14:0(3-OH)) at N-2 and O-3 positions present on the β-D-
GlcpN-(1→6)-α-D-GlcpN disaccharide backbone of this mixture of lipidA1-5. In addition, 
we have proposed the presence of branched fatty acid (C14:0(3-O-C14:0)) at the position 
O-3ʹ, and (Cl4:0(3-O-C12:0)) at the position N-2ʹ. All this series of LipA1-5 contained one 
phosphate group.The confirmation of our tentative assignments and the putative structures 
for the five deprotonated molecules LipA1 to LipA5 and the other various fragment ions 
were achieved by low-energy collision dissociation tandem mass spectrometry analysis. In 
this thesis we have followed the Domon and Costello carbohydrate nomenclature to define 
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and characterize all the deprotonated molecules produced by their gas-phase fragmentation 
in the ESI-MS and CID-MS/MS analysis (Domon and Costello 1988).  It is well known 
that the glycosidic cleavage can be induced by the ESI-MS and provides useful structural 
information and reveals the sugar sequencing of the lipid A backbone.   
 It is vital to mention that the structure of the lipid A isolated from the rough LPS 
from A.  Liquefaciens SJ-19 (original strain) was mainly composed majorly of one entity 
which was identified by ESI-MS and CID-MS/MS measured with a QqQ-mass 
spectrometer as the deprotonated molecule [M-H]- at m/z 1798.36. This deprotonated 
molecule was assigned as the O-1 and O-4ʹ bis-phosphorylated hexa-acylated forms of the 
β-D-GlcpN-(1→6)-α-D-GlcpN disaccharide carrying four primary 3-hydroxy-myristic acid 
(C14:0(3-OH)) fatty acids on the O-3ʹ, O-3ʹ, N-2 and N-2ʹ position. The O-3ʹ position of 
the myristyl group is substituted by myristic acid forming the branched (Cl4:0(3-O-C14:0)) 
fatty acyl group, whereas the N-2 myristyl group is substituted at the 3-position by lauric 
acid forming the (Cl4:0(3-O-C12:0)) branched fatty acyl group (Lukasiewicz et al., 2010, 
Banoub et al., 2010, Kilár et al., 2013, John et al., 2014, and Brodbelt et al., 2014). 
 
3.2.1. Low-energy CID-MS/MS analysis of the extracted mixture of lipid 
An isolated from the LPS of a A. liquefaciens SJ-19a using the QqQ-
MS/MS instrument 
 
   Low-energy CID-MS/MS (tandem-in-space) analysis using the triple quadrupole 
(QqQ) instrument conducted on the five-different precursor [M-H]- deprotonated mono-
phosphorylated anions at m/z 1716.30 (LipA1), m/z 1688.19 (LipA2),  
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Figure 3.1.1: ESI-QqQ-MS of the native lipid An extract from the LPS of A. liquefaciens SJ-19a.  
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m/z 1506.10 (LipA3), m/z 1279.73 (LipA4), and m/z 1097.63 (LipA5) afforded series of 
distinct and diagnostic product ions. It is well-known that the competitive hydrolysis of the 
primary and/or secondary fatty esters located on β-D-GlcpN-(1→6)-α-D-GlcpN 
disaccharide backbone of lipid A occurs in a step-wise fashion. Apparently, the ester-linked 
fatty groups at O-3 and O-3ʹ are more readily hydrolysable than the fatty acyl amide groups. 
This is due to the greater stability of the fatty acyl amide groups located at N-2 and N-2ʹ, 
which makes them more difficult to be released (Banoub et al., 2010, Kilár et al., 2013). In 
general, it is well known that the CID-MS/MS gas-phase fragmentation routes of lipid A 
derivatives are usually governed by cleavages arising from the glycosidic bond followed 
by inter-ring bond cleavages (Domon and Costello., 1988). 
The product ion scan of deprotonated molecules at m/z 1716.30 LipA1 allowed us to 
investigate the fatty acyl group distributions that were observed in ESI-QqQ-MS analysis 
of LipA1, as illustrated in (Figure 3.1.2). Accordingly, the CID-MS/MS of the deprotonated 
molecules at m/z 1716.30 produced the following series of product ions at m/z 1516.02, m/z 
1488.08, m/z 1226.92, m/z 1053.82, m/z 1017.12, and m/z 692.39 (Figure 3.1.2, Scheme 
3.1.2 and Table 3.1.2) (Lukasiewicz et al., 2010). The most abundant product ion at m/z 
1516.02 was assigned as the [M1-(C12:0)acid-H]
- ion, and was formed by the elimination 
of lauric acid from the branch (Cl4:0(3-O-C12:0)) fatty acids (-200 Da), which was 
attached to the N-2ʹ position of the lipid A disaccharide backbone. This product ion 
supports our suggested notion that the branched (Cl4:0(3-O-C12:0)) fatty acid group was 
acylating the N-2ʹ LipA1. Likewise, the product ion at m/z 1488.08 was assigned as the 
[M1-(C14:0)acid-H]
- ion, which was created by elimination of myristic acid form the 
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branched fatty (C14:0(3-O-C14:0)) acid acyl group located at O-3ʹ (-228 Da). The product 
ion at m/z 1226.92 was formed by the consecutive losses of the branched fatty (C14:0(3-
O-C14:0)) located on position O-3ʹ (-454 Da) and two molecules of water. This product ion 
was assigned as [M1-(C14:0(3-O-C14:0))acid-2H2O-H]
- ion (-490 Da). The product ion at 
m/z 1053.62 was formed by elimination of a molecule of the branched fatty (C14:0(3-O-
C14:0)) ketene (-436 Da) from the O-3ʹ position and by loss of a 3-hydroxyl myristic ketene 
(-226 Da) from O-3. This product ion was assigned as [M1-(C14:0(3-O-C14:0))ketene-
(C14:0(3-OH))ketene-H]- ion as shown in (Figure 3.1.2, Table 3.1.2, and Scheme 3.1.2). It 
is noteworthy to mention that the primary product ion at m/z 1053.62 will create the 
secondary product ion at m/z 1017.12 by elimination of two molecules of water from the 
hydroxyl groups located on both the O-3 and O-3ʹ positions. The product ion at m/z 692.39 
was formed by the glycosidic cleavages of the β-D-GlcpN-(1→6)-α-D-GlcpN disaccharide 
backbone, to afford the reducing D-GlcN-OH species obtained following consecutive 
losses of myristic (-210 Da) and lauric acid (-200 Da) molecules from the branched fatty 
acids (C14:0(3-O-C14:0)) and (C14:0(3-O-C12:0)) respectively located at O-3 and N-2 
positions. This product ion was assigned as [C-(C14:0)ketene-(C12:0)acid-H]- ion. This 
MS/MS studies supports the suggested structure assignment of the deprotonated molecule 
(LipA1), and indicates that the H2PO3 group is located at the O-4ʹ position of the non-
reducing end of the disaccharide backbone. It also confirms the presence of the two 
molecules of 3-hydroxyl myristic acids located at the positions O-3, and N-2 of the reducing 
end of the disaccharide backbone. 
 
 89 
 
 
 
 
 
 
 
Figure 3.1.2:  CID-MS/MS of the precursor deprotonated [M1-H]-  molecules at m/z 1716.30.⁕ 
 
 
 
 
 
 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other isobars 
isolated during the MS/MS analysis. 
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Whereas the branched (C14:0(3-O-C14:0)) and (C14:0(3-O-C12:0)) fatty acids were 
located on O-3ʹ and N-2ʹ positions of the non-reducing end of the β-D-GlcpN-(1→6)-α-D-
GlcpN disaccharide backbone of this lipid A1 (El-Aneed et al., 2006, Lukasiewicz et al., 
2010, John et al., 2014, and Brodbelt et al., 2014). 
  The product ion scan of the deprotonated mono-phosphorylated LipA2 molecules 
at m/z 1688.19 afforded the product ions at m/z 1488.10, m/z 1444.02, m/z 1305.82, m/z 
1243.79, m/z 1017.59, and m/z 871.46 (Figure 3.1.3, Table 3.1.3 and Scheme 3.1.3) (El-
Aneed et al., 2006, and Lukasiewicz et al., 2010). The product ion at m/z 1488.01 was 
assigned as the [M2-(C12:0)acid-H]
- ion, which was created by elimination of the lauric 
acid form the branched fatty (C14:0(3-O-C12:0)) acid located either the O-3ʹ or N-2ʹ 
position (-200 Da). The product ion at m/z 1444.02 was assigned as [M2-(C14:0(3-
OH))acid-H]- ion. It was created by the loss of a 3-hydroxyl myristic acid (-244 Da) which 
was located at O-3 position of the LipA2 precursor ion. The product ion at m/z 1305.82 was 
assigned as the [M2-(C12:0)acid-(C12:0)ketene-H]
- ion. It was generated by both 
eliminations of lauric acid (-200 Da) and lauryl ketene (-182 Da) from the precursor ion at 
m/z 1688.19; these two losses originated from both the branched (C14:0(3-O- C12:0)) and 
(C14:0(3-O-C12:0)) fatty acyl groups located respectively O-3ʹ and N-2ʹ of the non-
reducing of the disaccharide backbone of lipid A (Figure 3.1.1). Similarly, the product ion 
at m/z 1243.79 was assigned as [M2-(C14:0(3-O-C12:0))acid-H2O-H]
- ion, and it was 
formed by consecutive losses of the branched fatty (C14:0(3-O-C12:0)) acid (-426 Da) 
located on position O-3ʹ and a molecule of water from the precursor ion at m/z 1688.19. 
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Figure 3.1.3: CID-MS/MS of the precursor deprotonated [M2-H]-  molecules at m/z 1688.19.⁕ 
 
 
 
 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other isobars 
isolated during the MS/MS analysis. 
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The product ion at m/z 1017.59 was assigned as [M2-(C14:0(3-O-12:0))acid-(C14:0(3-
OH))acid-H]- ion. It was formed by successive elimination of the branched fatty (C14:0(3-
O-C12:0)) acid form the O-3ʹ position (-426 Da), and a 3-hydroxyl myristic acid (-244 Da), 
which is located at O-3 of the LipA2 precursor ion. As well, the product ion of at m/z 871.46, 
assigned as [M2-(C14:0(3-O-C12:0))ketene-(C12:0)ketene-(C14:0(3-OH))ketene-H]
- ion. 
It was formed by the consecutive losses of the branched fatty (C14:0(3-O-C12:0)) ketene 
(-408 Da) located at the O-3ʹ position, lauryl ketene molecule (-182 Da) from the branched 
fatty acids (C14:0(3-O-C12:0)) located on the N-2ʹ position. The concomitant loss of 3-
hydroxyl myristic ketene molecule (-226 Da) located at the O-3 position of the β-D-GlcpN-
(1→6)-α-D-GlcpN disaccharide backbone of this LipA2 precursor ion. The structure of this 
product ion confirms the presence of the branched (C14:0(3-O-C12:0)) fatty acid ester 
group on the N-2ʹ position (El-Aneed et al., 2006, and Lukasiewicz et al., 2010). 
 The product ion scan of the deprotonated LipA3 molecules at m/z 1506.10 gave the 
series of product ion at m/z 1488.01, m/z 1461.95, m/z 1415.98, m/z 1305.85, and m/z 
666.39 (Figure 3.1.4, Table 3.1.4 and Scheme 3.1.4). The product ion at m/z 1488.01 was 
obtained by the loss of a molecule of water from the precursor ion. The product ion at m/z 
1461.95 was formed by the elimination of a molecule of propane (-44 Da), which most 
probably arose from the fatty acid chain located on O-3ʹ. This product ion was assigned as 
[M3-C3H8-H]
-. Similarly, the product ion at m/z 1415.95 was assigned as the [M3-C5H12-
H2O-H]
- ion, which was produced by the loss of pentane (-72 Da), most probably from the 
fatty acid of LipA3 located at the N-2ʹ and a molecule of water from the precursor ion.  
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Figure 3.1.4: CID-MS/MS of the precursor deprotonated [M3-H]-  molecules at m/z 1506.10.⁕ 
 
 
 
 
 
 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other isobars 
isolated during the MS/MS analysis. 
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The product ion at m/z 1305.85 was assigned as the [M3-(C12:0)acid-H]
- ion and was 
formed by the loss a molecule of lauric acid (-200 Da) from the branched (C14:0(3-O-
C12:0)) fatty acyl group located at the N-2ʹ position of LipA3 (El-Aneed et al., 2006, and 
Lukasiewicz et al., 2010).The last product ion at m/z 666.39 was produced from the C-
fragmentation routes described by Domon and Costello which was formed by glycosidic 
cleavages of the β-D-(l→6)-GlcN disaccharide, followed by the loss of a 3-hydroxy-
myristic ketene molecule (-226 Da) from the O-3 position of the D-GlcN residue (Domon 
and Costello, 1988). This product ion was assigned as the [C-(C14:0(3-O-C14:0))ketene-
H]- ion (Figure 3.4, Table 3.4 and Scheme 3.4). Please note that the [C-(C14:0(3-O-
C14:0))ketene-H]- product ion contains a phosphate group located on O-4 (Domon and 
Costello., 1988, El-Aneed et al., 2006, Banoub et al., 2010, and Kilár et al., 2013). 
Accordingly, this finding strongly confirms that the suggested structures for lipA2 contains 
an H2PO3 group located at the non-reducing end of the LipA3 at O-4ʹ, and it also confirms 
the location of the branched lauric acid at N-2ʹ. 
 The product ion scan of the deprotonated mono-phosphorylated LipA4 molecules 
[M4-H]
- (base peak) at m/z 1279.73 gave a series of product ions at m/z 1261.79, m/z 
1035.60, and m/z 791.50 (Figure 3.1.5, Table 3.1.5 and Scheme 3.1.5). The product ion at 
m/z 1261.79 was formed by the loss of a molecule of water from the precursor ion (-18 Da). 
The product ion at m/z 1035.60 was assigned as the [M4-(C14:0(3-OH))acid-H]
- ion, which 
was created by the eliminating of 3-hydroxy-myristic acid (C14:0(3-OH)) (-244 Da) 
located at the position O-3 of the reducing GlcN end. The last product ion at m/z 791.50 
was assigned as the [M4-(C14:0(3-OH))ketene-(C12:0))ketene-HPO3-H]
- ion.  
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Figure 3.1.5: CID-MS/MS of the precursor deprotonate [M4-H]- molecules at m/z 1279.73.⁕ 
 
 
 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other isobars 
isolated during the MS/MS analysis. 
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Scheme 3.1.5: Proposed fragmentation pathways obtained by CID-QqQ-MS/MS and SORI-CID-
FTICR MS/MS of the precursor monophosphorylated LipA4 [M4–H]- ion at m/z 1279.73. 
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It was created by the consecutive losses of the lauryl ketene (-182 Da) from the branched 
fatty (C14:0(3-O-C12:0)) acid (-182 Da) located on N-2ʹ, followed by 3-hydroxy-myristyl  
ketene (-226 Da) located at the position O-3 and finally by elimination of the neutral HPO3 
(-80 Da) moiety.  
 These findings support that our suggested LipA4 structure contains a H2PO3 group at 
the O-4ʹ position of the non-reducing D-GlcN residue, and that the 3-hydroxy-non reducing 
end myristic ester groups are located on the N-2 and N-2ʹ of β-D-GlcpN-(1→6)-α-D-GlcpN 
disaccharide backbone of lipid A4 (El-Aneed et al., 2006, Lukasiewicz et al., 2010, John et 
al., 2014, and Brodbelt et al., 2014). 
 The product ion scan of LipA5 at m/z 1097.63 gave series of product ions at m/z 
853.48, m/z 691.49, and m/z 581.36 (Figure 3.1.6, Table 3.1.6 and Scheme 3.1.6). The 
product ion at m/z 853.48 was assigned as the [M5-(C14:0(3-OH))acid-H]
- ion. It was 
created by the elimination of 3-hydroxy-myristic acid (C14:0(3-OH)) (-244Da) located at 
the position O-3 of the reducing GlcN end of the lipidA5 disaccharide. The product ion at 
m/z 691.49 was assigned as the [M5-(C14:0(3-OH))acid-(C2H4)-H2PO4-2H2O-H]
- ion. It 
was created by the consecutive loss of the 3-hydroxy-myristic acid (C14:0(3-OH)) (-244 
Da) located at the position O-3, a molecule of C2H4 (-28 Da) as part of the fatty acid chain 
located at N-2ʹ and H3PO4 (-98 Da) released from the O-4ʹ position of the D-GlcN non-
reducing end of LipA5. The last product ion at m/z 581.36 was assigned as the [M5-
(C14:0(3-OH))acid-(C10H18)-H2PO4-H2O-H]
- ion. It was created by the consecutive 
eliminations of the 3-hydroxy-myristic acid (C14:0(3-OH)) (-244 Da) located at the 
position O-3, of nC10H18 (-138 Da) as part of the fatty acid chain located at N-2ʹ, and  
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Figure 3.1.6: CID-MS/MS of the precursor deprotonated [M5-H]- molecules at m/z 1097.63.⁕ 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other isobars 
isolated during the MS/MS analysis. 
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Scheme 3.1.6: Proposed fragmentation pathways obtained by CID-QqQ-MS/MS and SORI-CID- 
FTICR MS/MS of the precursor monophosphorylated LipA5 [M5–H]- ion at m/z 1097.63. 
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Figure 3.1.7: CID-MS/MS of the precursor deprotonated [C-(C14:0)ketene-H]- molecules at m/z 
892.56.⁕ 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other isobars 
isolated during the MS/MS analysis.  
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Table 3.1.7: Assignments of the product ions observed from the CID-MS/MS and SORI-
CID-MS/MS analysis of the precursor deprotonated [C-(C14:0)ketene-H]- molecules at m/z 
892.56. 
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H3PO4 (-98 Da) and two molecules of water (-36 Da). Lastly, we also investigated the nature 
of the two deprotonated molecules at m/z 892.56, and m/z 666.06 observed in the ESI-MS 
of this lipid An mixture. We have tentatively assigned these deprotonated molecules as 
being created by the [C-H]- ion series, whose presence are probably an indication of the 
incomplete biosynthesis of the lipid A1-5 series of the LPS A. liquefaciens SJ-19a (Please 
understand, that these deprotonated molecules were named Fragment ions, to respect only 
the Domon and Costello nomenclature) (Domono and Cosetello 1988).   
 For simplification, we have tied these deprotonated molecules to the [M-H1-5]
- 
molecules and adopted a similar nomenclature. Hence, the product ion scan of the 
deprotonated [C-(C14:0)ketene-H]- molecule at m/z 892.56 gave a series of product ions  
at m/z 874.55, m/z 790.46, m/z 648.36, m/z 550.40, m/z 474.29, m/z 456.26, and m/z 368.19 
(Figure 3.1.7, Scheme 3.1.7, and Table 3.1.7). The product ion at m/z 874.55 was created 
by the loss of a water molecule from the precursor ion. The product ion at m/z 790.46 was 
assigned as [C-(C14:0)ketene-C6H12-H2O-H]
- ion. It was generated by the consecutive 
eliminations of n-hexane as a part of the fatty acid (-84 Da) probably located at N-2 and a 
molecule of water. Similarly, the product ion at m/z 648.36 was assigned as the [C-
(C14:0)ketene-(C14:0(3-OH))acid-H]- ion. It was created by the loss 3-hydroxy-myristic 
acid (C14:0(3-OH)) (-244 Da) located at the position O-3. The product ions at m/z 550.40 
was assigned as [C-(C14:0)ketene-(C14:0(3-OH))acid-H2PO4-H]
- ion. It was generated by 
the loss of both the 3-hydroxy-myristic acid (-244 Da) at O-3 position, and H3PO4 (-98 Da) 
at the O-4ʹ position of the GlcN monosaccharide residue. The ion at m/z 474.29 was 
assigned as [C(C14:0(3-OH))ketene-(C8H16)-HPO3-H]
- ion. It was generated by the loss of 
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both the 3-hydroxy-myristic acid located at O-3 (-226 Da), and n-octane (C8H16) (-112 Da) 
as part of the fatty acid chain located at N-2, in addition to the loss of HPO3 (-80 Da) from 
the non-reducing D-GlcN residue. The product ion at m/z 456.26 was assigned as [C-
(C14:0(3-OH))ketene-(C8H16)-H2PO4-H]
- ion. It was generated by the consecutive losses 
of 3-hydroxyl-myristic acid (-226 Da) located at O-3, n-octane (-112 Da) as part of the fatty 
acid chain located at N-2, and H3PO4 (-98 Da) at the position O-4 ʹ of the GlcN 
monosaccharide residue (El-Aneed et al., 2006, Lukasiewicz et al., 2010, John et al., 2014, 
and Brodbelt et al., 2014). 
 This series of product ions indicates the presence of a fatty acid possessing different 
length, and highlight the elimination of H3PO4 from the O-4ʹ position of the GlcN 
monosaccharide residue. The last product ion at m/z 368.19 was assigned as [C-(C14:0(3-
OH)acid-(C12:0)ketene-H2PO4-H]
- ion. It was formed by the consecutive losses of the 3-
hydroxy-myristic acid (C14:0) (-244 Da) at O-3, a molecule of lauryl ketene (-182 Da) 
from the branched (C14:0(3-O-C12:0)) ester at the N-2 position, followed by loss of H3PO4 
(-98 Da) from O-4 position of the GlcN monosaccharide residue (Figure 3.1.7, Scheme 
3.1.7, and Table 3.1.7). 
Once more, we have again a strong support indicating that the lipid A1-5 structures 
contained a H2PO3 group at O-4ʹ of the D-GlcN non-reducing end residue of the β-D-
GlcpN-(1→6)-α-D-GlcpN disaccharide backbone. Also, the presence of primary myristic 
esters located at both the O-3ʹ and N-2ʹ positions of this lipid A1-5 mixture. It also means 
that the position of the branched lauric acid ester is located on the N-2 position of the 
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reducing GlcN residue present in the β-D-GlcpN-(1→6)-α-D-GlcpN disaccharide 
backbone. 
 Finally, the CID-MS/MS afforded the precursor deprotonated mono-phosphorylated 
[C-(C14:0(3-O-C14:0))ketene-H]- molecules at m/z 666.06 afforded the following series of 
product ions at m/z 648.40, m/z 630.36, m/z 560.29, m/z 550.30, and m/z 520.25 (Figure 
3.1.8, Table 3.1.8 and Scheme 3.1.8). The presence of this category of molecules in our 
lipid An mixture provides an indication of the incomplete biosynthesis of this bacterial lipid 
An component. The product ion at m/z 648.40 was formed by the loss of a water molecule 
from the precursor ion. The product ion at m/z 630.36 was formed by the loss of two 
molecules of water (-36 Da). It was assigned as [C-(C14:0(3-O-C14:0))ketene-2(H2O)-H]
- 
ion. The product ion at m/z 560.29 was assigned as [B1-(C14:0(3-O-C14:0))ketene-
(C5H10)-2H2O-H]
- ion. It was assigned by the sequential eliminations of two molecules of 
water and a molecule of n-pentane (-70 Da) molecules from the branched (C14:0(3-O-
C12:0)) fatty acid at N-2 position. The product ion at m/z 550.30 was assigned as [C-
(C14:0(3-O-C1:0))ketene-(H2PO4)-H2O-H]
- ion. It was formed by sequential the loss of 
H3PO4 (-98 Da) from the O-4 position and a molecule of water. The product ion at m/z 
520.25 was assigned as [C-(C14:0(3-O-C14:0))ketene-(C9H20)-H2O-H]
- ion. It was formed 
by the loss of both nC9H20 (-128 Da) from the branched (C14:0(3-O-C12:0)) fatty acid at 
N-2 position and a molecule of water as previously stated. The product ions formed from 
the precursor ion at m/z 666.06 confirm our suggested lipid A1-5 structures, contained in 
their respective positions: The H2PO3 group at O-4ʹ position, and two molecules of 3-
hydroxyl-myristic acid at O-3 and N-2 of their lipid A1-5. In addition, the branched fatty 
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acid substituents, namely (C14:0(3-O-C14:0)) and (C14:0(3-O-C12:0)) the O-3ʹ, and N-2ʹ 
positions of their lipid A1-5 backbones. 
It is interesting to note that the CID-MS/MS analysis of the deprotonated molecules 
[M1-5-H]
- at m/z 1716.30 (LipA1), m/z 1688.19 (LipA2), m/z 1506.10 (LipA3), m/z 1279.73 
(LipA4), and m/z 1097.63 (LipA5) afforded distinctive series of product ions. In addition, it 
is important to comprehend that there was no cross connectivity between the different 
precursor deprotonated molecules. This indicates that the genesis of each of these species 
of precursor ions was distinctive. Moreover, each of these precursor deprotonated 
molecules created specific product ions. Once more, this finding seems to confirm that the 
origins of the precursor ions were indeed caused by an incomplete biosynthesis of the LPS 
and not by chemical degradation of any kind (El-Aneed et al., 2006, and Lukasiewicz et 
al., 2010). 
In general, it is important to note that during the low-energy CID-MS/MS analyses 
conducted with the QqQ-tandem instrument on these series of deprotonated molecules, we 
were able to confirm that the formation of each deprotonated molecule recorded in single 
stage ESI-QqQ-MS instrument, were indeed single unique diagnostic molecules that were 
not produced by further fragmentation from contiguous higher masses deprotonated 
molecules. In addition, these product ion scans created series of product ions that excluded 
the possibility, that they could be related to each other.   
Finally, precursor ion scans of these deprotonated molecules formed during the ESI-
QqQ-MS showed that there were no connectivities and/or genesi relations between these 
different deprotonated molecules (see Appendix). 
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Figure 3.1.8: CID-MS/MS of the precursor deprotonated [C-(C14:0(3-O-C14:0))ketene-H]- 
molecules at m/z 666.06.⁕ 
 
 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other 
isobars isolated during the MS/MS analysis. 
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Table 3.1.8: Assignments of the product ions observed from CID-MS/MS and SORI-
CID-MS/MS of the precursor ion at m/z 666.06. 
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3.3. ESI-FTICR-MS analysis of heterogeneous lipid An mixture isolated 
from the LPS of A. liquefaciens SJ-19a 
 
The ESI-MS analysis of the mixture of lipid Anwas also conducted with an FTICR-
mass spectrometer in order to create a spectrum with high mass resolving power. Because 
FT-ICR-MS is based on a time measurement and because the trapped ion frequencies are 
independent of the kinetic energy, this technique provides the highest resolving power and 
mass accuracy currently available which allow to determine the elemental composition of 
the analyzed produced ions (Marshall, et al., 1998, Marshall, et al., 1999, Palumbo et al., 
2011, van Agthoven et al., 2015, and Almostafa et al., 2016). As expected, this ESI-MS (- 
ion mode) obtained for lipid A of A. liquefaciens SJ-19a displayed an incomplete 
biosynthesis as illustrated by the multiple deprotonated molecules.   
Similarly to the ESI-QqQ-MS, the ESI-FTICR-MS (- ion mode) showed the 
presence of inter-alia seven fragment ions, five of which were assigned to different [M-H]- 
deprotonated mono-phosphorylated anions LipA1 at m/z 1716.2491, LipA2 at m/z 
1688.22091, LipA3 at m/z 1506.0511, LipA4 at m/z 1279.8593, and LipA5 at m/z 1097.6930, 
whereas, the last deprotonated molecules at m/z 892.5975 and m/z 666.4396 were assigned 
as belonging the [C-H]- indicating the presence of a heterogeneous mixture of lipid An 
(Figure 3.2.1, Scheme 3.1.1 and Table 3.1.1). 
When comparing the ESI-spectra recorded with QqQ-mass and the FTICR-mass 
spectrometer instruments, we noticed that the deprotonated molecules of the LipA1-5 
mixture had different abundances. 
 120 
 
 
 
 
 
 
 
Figure 3.2.1: ESI-FTICR-MS (- ion mode) of the native lipid An mixture extracted from A. 
liquefaciens SJ-19a. 
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   In the ESI-FTICR-mass spectrum, we noticed that the deprotonated molecule 
assigned to the LipA3 at m/z 1506.0511 was the most abundant (El-Aneed et al., 2006, 
Lukasiewicz et al., 2010, John et al., 2014, and Brodbelt et al., 2014). 
 
3.3.1 Measurement of the FT-ICR-MS isotopic distributions of the 
deprotonated molecules of lipid An isolated from the LPS of A. 
liquefaciens SJ-19a 
 
 The influence of spectral accuracy of the deprotonated molecular ions on elemental 
composition calculations was investigated by high-resolution mass spectrometer. For that 
reason, high mass accuracy together with high isotopic abundance accuracy proved to be 
generally important to obtain only few molecular formula candidates from an accurate mass 
measurement. The automated correction of isotope pattern abundance errors using peak 
shaping and correction algorithms resulted in better identification rates of the molecular 
formulas. It should be mentioned that the determination of the molecular formula or 
elemental composition requires a clean mass spectrum with no interfering noise or co-
eluting compounds (Kind et al., 2010, and Jaitly et al., 2009).   
 The algorithm includes a decision making step for proton and alkali metal adducts, 
automated determination of charge states and overlapping peaks, and an isotopic pattern 
matching. The freely available software SIRIUS (Sum formula Identification by Ranking 
Isotope patterns using mass spectrometry) has a user-friendly graphical interface and can 
be used on LINUX, MAC, and Windows platforms.  
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 The isotopic distribution of this series of deprotonated lipid An (where n=1-5), 
namely: LipA1 at m/z 1716.2491, LipA2 at m/z 1688.22091, LipA3 at m/z 1506.0511, LipA4 
at m/z 1279.8593, and LipA5 at m/z 1097.6930, and in addition to the two deprotonated 
molecules at m/z 892.5975 and m/z 666.4396, is indicated in the (Figure 3.3.1 and Figure 
3.3.2) (Kind et al., 2010, and Jaitly et al., 2009). Therefore, the calculated elemental 
compositions of the deprotonated molecule [M1-H]
-, [M2-H]
-, [M3-H]
-, [M4-H]
-, and [M5-
H]-, matched their experimental isotopic abundances using the algorithm “Gaussian 09 
software package”, which allowed us to calculate the isotopic fine structures and allow the 
modeling of Gaussian peak shapes according to the selected resolving power of the 
instrument (Kind et al., 2010, and Jaitly et al., 2009). In order to examine the difference in 
CID-gas-phase fragmentations between the QqQ and the FTICR-instruments, we subjected 
this series of deprotonated molecules to SORI-CID-FTICR-MS/MS analysis in order to 
confirm their exact structures. 
 
3.3.2 SORI-CID-FTICR-MS/MS analysis of lipid A isolated from the LPS 
of A. liquefaciens SJ-19a   
 
           It is well known that MS/MS analysis of different lipid A have provided researchers 
with information about the number and location of phosphoryl groups and by defining the 
nature of the ion charges (singly and doubly charged ions). In addition, it provides 
information about the fatty acids on the lipid A backbone, which can be identified by the 
sequential release of primary and/or secondary fatty acids, and cross-ring and inter-ring 
fragments.   
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Figure 3.3.1: Theoretical isotope distribution overlapped on top of the observed pattern of 
the lipid An extract from the LPS of A. liquefaciens SJ-19a. 
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Figure 3.3.2: Theoretical isotope distribution overlapped on top of the observed pattern of 
the lipid An extract from the LPS of A. liquefaciens SJ-19. 
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Please note that there was a never encountered doubly charged ion. The use of the low-
energy collision induced dissociation mass spectrometry (SORI-CID-MS/MS) was with a 
Fourier transform ion cyclotron resonance mass spectrometer instrument to establish the 
MS/MS fragmentation routes. 
 The product ion scan of the deprotonated molecules of LipA1 at m/z 1716.2491 gave 
the product ions at m/z 1488.0469, m/z 1243.8399, and m/z 1035.6975. The product ion at 
m/z 1488.0469 was assigned as the [M1-(C14:0)acid-H]
- ion, which was created by the 
elimination of myristic acid form the branched fatty (C14:0(3-O-C14:0)) acid acyl group 
located at O-3ʹ (-228 Da). The product ion at m/z 1243.8399 was assigned as [M1-
(C14:0)acid-C14:0(3-OH)acid-H]- ion. It was formed by consecutive losses of myristic 
acid form the branched fatty (C14:0(3-O-C14:0)) acid acyl group located at O-3ʹ (-228 Da), 
and ketene 3-hydroxy-myristic acid (C14:0(3-OH)) (-244 Da) located at the position O-3 
of the reducing GlcN end. The product ion at m/z 1035.6599 was assigned as the [M1-
(C14:0(3-O-C12:0))ketene-(C14:0(3-OH))acid-H]- ion, which was created by the 
elimination of a molecule of the branched fatty (C14:0(3-O-C12:0)) (-436 Da) and ketene 
3-hydroxy-myristic acid (C14:0(3-OH)) (-244 Da) located at the position O-3 of the 
reducing GlcN end (Figure 3.3.3, Scheme 3.1.2 and Table 3.1.2).  
 The product ion scan of the deprotonated LipA2 molecules at m/z 1688.2209 gave the 
product ions at m/z 1488.0379, m/z 1243.8851 and m/z 1035.6599 (Figure 3.3.4, Table 3.1.3 
and Scheme 3.1.3).  
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Figure 3.3.3: SORI-CID-MS/MS of the precursor deprotonated [M1-H]- molecules at m/z 
1716.2491. 
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Figure 3.3.4: SORI-CID-MS/MS of the precursor ion [M2-H]-  at m/z 1688.2209. 
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The product ion at m/z 1488.0379 was assigned as the [M2-(C12:0)acid-H]
- ion, which was 
created by elimination of the lauric acid form the branched fatty acid (C14:0(3-O-C12:0)) 
located either the O-3ʹ or N-2ʹ position (-200 Da). The product ion at m/z 1243.8851 was 
assigned as [M2-(C14:0(3-O-C12:0))acid-H2O-H]
- ion, and it was formed by consecutive 
losses of the branched fatty (C14:0(3-O-C12:0)) acid (-426 Da) located on position O-3ʹ 
and a molecule of water from the precursor ion at m/z 1688.2209. The product ion at m/z 
1035.6599 was assigned as the [M2-(C14:0(3-O-C12:0))ketene-(C14:0(3-OH))acid-H]
- 
ion, which was created by elimination of a molecule of the branched fatty (C14:0(3-O-
C12:0)) (-408 Da) and ketene 3-hydroxy-myristic acid (C14:0(3-OH)) (-244 Da) located at 
the position O-3 of the reducing GlcN end (El-Aneed et al., 2006, Shaffer et al., 2007, 
Lukasiewicz et al., 2010, John et al., 2014, and Brodbelt et al., 2014). 
 The product ion scan of the precursor deprotonated molecules of LipA3 m/z 
1506.0511 gave the major product ion at m/z 1261.8349, which was formed by the 
elimination of 3-hydroxy-myristic acid (-244 Da) from the precursor ion and (Figure 3.3.5, 
Table 3.1.4, and Scheme 3.1.4). This product ion was assigned as [M3-(C14:0(3-OH))acid-
H]- ion. It should be noted that this elimination can be in fact occur from either at the O-3 
and O-3′ positions located respectively in the reducing end or non-reducing end of the lipid 
A disaccharide backbone (El-Aneed et al., 2006, Shaffer et al., 2007, Lukasiewicz et al., 
2010, John et al., 2014, and Brodbelt et al., 2014). 
 Additionally, the product ion scan of LipA4 at m/z 1279.8593 afforded the product 
ion at m/z 1035.6622 was assigned as the [M4-(C14:0(3-OH))acid-H]
- ion. It was created  
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                Figure 3.3.5: SORI-CID-MS/MS of the precursor ion [M3-H]- at m/z 1506.0511. 
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Figure 3.3.6: SORI-CID-MS/MS of the precursor ion [M4-H]- at m/z 1279.8593. 
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by the elimination of 3-hydroxy-myristic acid (C14:0(3-OH)) (-244 Da) located at the 
position O-3 of the reducing GlcN end (Figure 3.3.6, Table 3.1.5 and Scheme 3.1.5). 
 Similarly, the product ion scan of deprotonated molecules of LipA5 at m/z 
1097.6865 gave the product ion at m/z 853.4897 was assigned as the [M5-(C14:0(3-
OH))acid-H]- ion, which was created by the elimination of 3-hydroxy-myristic acid 
(C14:0(3-OH)) (-244Da) located at the position O-3 of the reducing GlcN end of the lipidA5 
disaccharide (Figure 3.3.7, Table 3.1.6 and Scheme 3.1.6) (El-Aneed et al., 2006, 
Lukasiewicz et al., 2010, John et al., 2014, and Brodbelt et al., 2014). 
The following diagnostic deprotonated molecules, which were previously 
encountered in the ESI-QqQ-MS measurement of the lipid An mixture, were also produced 
by measurement with the FTICR-mass spectrometer instrument. They were assigned as [C-
H]- at m/z 892.5975 and m/z 666.4396. Accordingly, in order to confirm their putative 
structures and to confirm the presence of the phosphate group position, we acquired their 
product ion scans.   
SORI-CID-MS/MS of the deprotonated molecules at m/z 892.5975, which were 
assigned previously as [C-(C14:0)ketene-H]-, gave the product ions at m/z 648.3931, m/z 
466.2275 and m/z 448.2165 (Figure 3.3.8, Table 3.1.7, and Scheme 3.1.7). The product ion 
at m/z 648.3931 was assigned as the [C-(C14:0)ketene-(C14:0(3-OH))acid-H]- ion. It was 
formed by the elimination of the 3-hydroxy-myristic acid (C14:0(3-OH)) (-244 Da) from 
the O-3 of the precursor ion. The product ions at m/z 466.2275 was attributed as the [C-
(C14:0)ketene-(C14:0(3-OH))acid-(C12:0)ketene-H]- ion. It was formed by consecutive 
elimination of the 3-hydroxy-myristic acid (C14:0(3-OH)) (-244 Da) from the O-3, and 
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Figure 3.3.7: SORI-CID-MS/MS of the precursor ion [M5-H]- at m/z 1097.6865. 
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Figure 3.3.8: SORI-CID-MS/MS of the precursor ion of [C-(C14:0)ketene-H]- at m/z 892.5975. 
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 of lauric ketene (-182 Da) form the branched fatty acids (C14(3-O-C12:0)) at the N-2 
position of the non–reducing GlcN residue obtained from the precursor ion at m/z 892.5975. 
Though, the product ion at m/z 448.2165 was assigned as [C-(C14:0(3-O-C14:0))acid-
(C12:0)acid-H]-. It was formed by consecutive eliminations of both 3-hydroxyl-myristic 
acid (C14:0) (-244 Da) at O-3 position and lauric acid molecule (-200 Da) from the 
branched (C14:0(3-O-C12:0)) at the N-2 position of lipid A. It is clearly evident that this 
product ion contains a PO4 group located at the non-reducing end O-4ʹ. 
 Similarly, the SORI-CID-MS/MS of the precursor deprotonated [C-(C14:0(3-O-
C14:0))ketene-H]- molecule at m/z 666.4396 gave the product ions at m/z 648.3235, m/z 
386.2526 and at m/z 326.2173, respectively (Figure 3.3.9, Table 3.1.8, and Scheme 3.1.8). 
The product ion m/z 648.3235 was formed by the elimination of a molecule of water, from 
the precursor ion. The product ion at m/z 386.2526 was assigned as [C-(C14:0(3-O-
C14:0))ketene-(C12:0)acid-HPO3-H]
- ion. It was formed by the consecutive eliminations 
of the lauric acid (-200 Da) from the branch (Cl4:0(3-O-C12:0)) fatty acids. It was attached 
to the N-2ʹ position, of HPO3 (-80 Da) located at O-4ʹ position of the lipid A disaccharide 
backbone. The product ion at m/z 324.2173 was assigned as [C-(C14:0(3-O-C14:0))ketene-
(C12:0)acid-H2PO4-C3H8-H]
- ion (-340 Da). It was formed by the consecutive eliminations 
of the lauric acid (-200 Da) from the branched (Cl4:0(3-O-C12:0)) fatty acid which was 
attached to the N-2ʹ position, by the loss of H3PO4 (-98 Da) at O-4 ʹ position, and by loss 
of n-propane (-44 Da) from the alkyl chain (C14:0) located at N-2ʹ. The SORI-CID-MS/MS 
of the precursor ion at m/z 666.4396 and its associated product ions strongly confirms that  
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Figure 3.3.9: SORI-CID-MS/MS of the precursor ion of [C-(C14:0(3-O-C14:0))ketene-H]- at m/z 
666.4396. 
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our suggested structures of the LipA1-5 are certainly correct, and specify that these 
structures contain a PO4 group located at the non- reducing end of the lipid A at O-4ʹ. 
Finally, it also defines the location of the branched lauric acid at N-2ʹ (El-Aneed et al., 
2006, Shaffer et al., 2007, Lukasiewicz et al., 2010, John et al., 2014, and Brodbelt et al., 
2014). 
 
3.3.3. Comparison between low-energy CID-QqQ-MS/MS and SORI-
CID-MS/MS of the deprotonated molecules obtained from the mixture of 
lipid An isolated from the LPS of A. liquefaciens SJ-19a 
 
  Comparing between the CID-MS/MS analysis with the QqQ-MS/MS and SORI-
MS/MS, we have noticed that the number of distinctive product ions decreased with SORI-
MS/MS analysis, when compared to CID-MS/MS analysis with the QqQ-mass 
spectrometer instrument. As all of the previous schemes (3.1.2 – 3.1.8) showed, we have 
noticed that all the of the product ions which obtained from SORI-CID-MS/MS were 
produced by the primary fatty acid fragmentation not the branched, most of the time the 
elemenation occure at O-3 and O-3ˊ posetion. Fore This was probably due to the trapping 
in the ultra-high-vacuum ICR cell of the formed precursor deprotonated molecules. 
Accordingly, there are many more collisions with much lower kinetic energy, than in the 
collision cell (q) of the QqQ-mass spectrometer. Also, SORI-CID-MS/MS is a soft tandem 
mass spectrometric technique, in which, only the precursor ion is accelerated, whereas in 
the quadrupole, the product ions are also accelerated.   
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In SORI-CID-MS/MS, the product ions formed from the precursor are not 
accelerated, as I the precursor deprotonated molecules alone are the only ones being 
excited. Once, they dissociate the product ions are not energized. Whereas with the CID-
QqQ-MS/MS in the collision cell q, the precursor ions and the formed product ions have 
time to collide, gain energy, and to further CID-fragment. All the produced product ions 
are then accelerated through the q (Wieboldt et al., 1997, Gauthier et al., 1991, and Stafford 
et al., 2002). 
 
3.4. High-energy MALDI-TOF-MS analysis of the extracted mixture of 
lipid An isolated from the LPS of A. liquefaciens SJ-19a 
  
The MALDI-TOF-MS (- ion mode) of the lipid A obtained from A. liquefaciens SJ-
19a was measured in the reflector mode with the TOF/TOF instrument and high laser 
power. Similarly, MALDI-TOF-MS showed similar spectra to the ones measured with the 
ESI-QqQ-MS and FTICR-MS instruments, indicating again that the biosynthesis of lipid 
A was incomplete. Accordingly, as previously discussed in section 3.2 and 3.4, we shall 
use the same nomenclature of all the analyzed deprotonated molecules.  
Hence, we have assigned that this lipid A mixture contained seven common 
structures corresponding to the different [M-H]- deprotonated mono-phosphorylated anions 
LipAs, respectively: at m/z 1716.24, LipA2 at m/z 1688.2145, LipA3 at m/z 1506.0574, 
LipA4 at m/z 1279.8541, and LipA5 at m/z 1097.6871, whereas, the last deprotonated 
molecule at m/z 920.6234 which was assigned as belonging to the [C-H]-.  
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Figure 3.4.1: MALDI-TOF-MS (- ion mode) of the native lipid An mixture extracted from A. 
liquefaciens SJ-19a. 
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The ion at m/z 920.6234 was assigned as [C-(C12:0)ketene-H]-  (Figure 3.4.1, Scheme 3.1.1 
and Table 3.1.1). In the MALDI-TOF-mass spectrum, we noticed that the ions assigned to 
the LipA3 at m/z 1506.0574 and LipA4 at m/z 1279.8541 were the most abundant in the 
mass spectrum. It is important to note that the ion at m/z 920.6234 was only observed in the 
MALDI-TOF-MS as a major peak, as illustrated in (Figure 3.4.1).  
 
3.4.1. High-energy MALDI-CID-TOF/TOF-MS/MS analysis of the 
extracted mixture of lipid An isolated from the LPS of A. liquefaciens SJ-
19a 
   
The lipid A isolated from A. liquefaciens SJ-19a was subjected to high-energy CID-
TOF/TOF-MS/MS. The structures of the detected product ions were deduced as previously 
described in the ESI-MS/MS studies of lipid A. High-energy CID-TOF/TOF-MS/MS of 
the anion at m/z 1716.2458 LipA1 is illustrated in (Figure 3.4.2, Tables 3.1.2, and Scheme 
3.1.2). Product ion scan of LipA1 formed the product ions at m/z 1688.2265, m/z 
1488.0512, and m/z 1243.8398. The product ion at m/z 1688.2265 was assigned as [M1-
(C2H4)-H]
- ion and it was created by the losses of a molecule of C2H4 (-28 Da) as part of 
the fatty acid chain located at O-3ʹ. The product ion at m/z 1488.0512 was assigned as the 
[M1-(C14:0)acid-H]
- ion. It was created by the elimination of myristic acid form the 
branched fatty (C14:0(3-O-C14:0) acid acyl group located at O-3ʹ (-228 Da). The last 
product ion at m/z 1243.6 was assigned as [M1-(C14:0) (3-O-C14:0))acid-H2OH]
- ion. It 
was formed by the consecutive losses of molecule of water and the branched fatty 
(C14:0(3-O-C14:0)) acid acyl group located at O-3ʹ (-454 Da).  
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Figure 3.4.2: High-energy CID-TOF/TOF-MS/MS of the precursor ion [M1-H]-  ion at m/z 
1716.2458. 
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Figure 3.4.3: High-energy CID-TOF/TOF-MS/MS of the precursor ion [M2-H]-  ion at m/z 
1688.2145. 
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High-energy CID-TOF/TOF-MS/MS of the anion at m/z 1688.2145 LipA2 is 
illustrated in (Figure 3.4.3, Tables 3.1.3, and Scheme 3.1.3). Product ion scan of LipA2 
created the product ions at m/z 1488.0324, m/z 1444.9743, and m/z 1243.8512. The product 
ion at m/z 1488.0324 was assigned as the [M2-(C12:0)acid-H]
- ion. It was created by the 
elimination formed by elimination of lauric acid from the branch (Cl4:0(3-O-C12:0)) fatty 
acids (-200 Da), which was attached to the N-2ʹ position of the lipid A disaccharide 
backbone. Which was created by loss of a 3-hydroxyl myristic acid (-244 Da), it was 
located at O-3 position. The last product ion at m/z 1243.8512 was assigned as [M2-
(C14:0(3-O-C12:0))acid-H2O-H]
- ion. It was formed by the consecutive losses of a 
molecule of water and the myristic acid form the branched fatty (C14:0(3-O-C12:0)) acid 
acyl group located at O-3ʹ (-426 Da). 
High-energy CID-TOF/TOF-MS/MS of the anion at m/z 1506.0574 LipA3 is 
illustrated in (Figure 3.4.4, Tables 3.1.4, and Scheme 3.1.4). Product ion scan of LipA3 
formed the product ions at m/z 1261.8510, m/z 1243.8398, and m/z 1035.6597. The product 
ion at m/z 1261.8510 was assigned as the [M2-(C14:0(3-OH))acid-H]
- ion, which was 
created by the elimination of a 3-hydroxyl myristic acid (-244 Da), It was located at O-3 or 
O-3ʹ position. The product ion at m/z 1243.8398 was assigned as the [M2-(C14:0(3-
OH))acid-H2O-H]
- ion. It was created by the elimination of a molecule of water and a 3-
hydroxyl myristic acid (-244 Da) molecule which was located at O-3 or O-3ʹ position. The 
product ion at m/z 1035.6597 was assigned as the [M2-(C14:0(3-OH))acid-(C14:0)(3-
OH))ketene-H]- ion. It was created by the elimination of a 3-hydroxyl myristic acid (-244 
Da) and a 3-hydroxyl myristic ketene (-226 Da) which is located at O-3 and O-3ʹ position. 
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Figure 3.4.4: High-energy CID-TOF/TOF-MS/MS of the precursor ion [M3-H]- ion at m/z 
1506.0574. 
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Figure 3.4.5: High-energy CID-TOF/TOF-MS/MS of the precursor ion [M4-H]-  ion at m/z 
1279.8541. 
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High-energy CID-TOF/TOF-MS/MS of the anion at m/z 1279.8541 LipA4 is illustrated in 
(Figure 3.4.5, Tables 3.1.5, and Scheme 3.1.5).  
 Product ion scan of LipA4 formed the product ions at m/z 1261.8511, m/z 
1079.6732, m/z 1035.6721, and m/z 1017.6343. The product ion at m/z 1261.8511 was 
created by the elimination of a molecule of water. The product ion at m/z 1079.6732 was 
assigned as the [M2-(C12:0)acid-H]
- ion; it was created by the elimination of lauric acid 
from the branch (Cl4:0(3-O-C12:0)) fatty acids (-200 Da) attached to the N-2ʹ position. 
The product ion at m/z 1035.6721 was assigned as the [M2-(C14:0(3-OH))acid-H]
- ion and 
was formed by elimination of a 3-hydroxyl myristic acid (-244 Da) located at O-3 position. 
The last secondary product ion at m/z 1017.6343 was obtained from the primary product 
ion at m/z 1035.7 by elimination of two molecules of water. 
The product ion scan of LipA5 at m/z 1097.6871 gave a series of product ions at m/z 
853.4843 and m/z 527.2514 (Figure 3.4.6, Table 3.1.6, and Scheme 3.1.6). The product ion 
at m/z 853.4843 was assigned as the [M5-(C14:0(3-OH))acid-H]
- ion, which was created by 
the elimination of 3-hydroxy-myristic acid (C14:0(3-OH)) (-244Da), located at the position 
O-3 of the reducing GlcN end of the lipidA5 disaccharide. The product ion at m/z 527.2514 
was assigned to be formed by the [0,4A-H]- cleavage of the reducing D-Glucosamine end as 
shown in (Figure 3.4.6). The primary ion at m/z 920.6234 assigned as [C-(C12:0)ketene-
H]- gave the secondary product ions at m/z 808.5012 and m/z 710.4240. The product ion at 
m/z 808.5012 was assigned as [C-(C12:0)ketene-C8H16-H]
- ion, which was created by the 
elimination of n-C8H16 from the fatty acid located at O-3ʹ (-112 Da).  
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Figure 3.4.6: High-energy CID-TOF/TOF-MS/MS of the precursor ion [M5-H]-  ion at m/z 
1097.6871. 
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Figure 3.4.7:  High-energy CID-TOF/TOF-MS/MS of the precursor ion [C-(C12:0)ketene-H]-  ion 
at m/z 920.6234. 
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The product ion at m/z 710.4240 was assigned as [C-(C12:0)ketene-(C14:0)ketene-H]- ion 
and was created by the elimination of a molecule of myristic ketene (-210 Da) from the 
branched (C14(3-O-C14:0)) ester at the O-3ʹ position (Figure 3.4.7). 
 
3.4.2. Comparison between low-energy CID-QqQ-MS/MS and high-
energy CID-TOF/TOF-MS/MS 
 
 A quick comparison between the MALDI-CID-TOF/TOF-MS/MS and the ESI-CID-
QqQ-MS/MS analysis indicate that the formation of distinctive product ions have decreased 
with MALDI-CID-TOF/TOF analysis. We have noticed that all the of the product ions which 
obtained from MALDI-CID-TOF/TOF just like SORI-CID-MS/MS were produced by the 
primary fatty acid fragmentation not the branched, most of the time the elimination occur at 
O-3 and O-3ˊ position (Schemes 3.1.2-3.1.8 and Tables 3.1.2 - 3.1.8). It is well known that 
high-energy CID-TOF/TOF-MS/MS experiments occur in the collision chamber having low 
gas pressure and subsequently leads to only single or few collisions. In addition, the high 
kinetic energy of the ions leads to shorter time scale for dissociation (few microseconds).  
However, in low-energy CID-QqQ-MS/MS analysis the target gas pressure selected allow 
multiple (tens to hundreds) collisions. Furthermore, when low-energy CID-QqQ-MS/MS 
analysis is used, the collisions occur in a longer time scale and the product ions have time to 
collide, gain energy, and to further fragment, before been accelerated through the q 
(McLuckey et al., 1997 and Sleno et al., 2004).   
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3.5. Summary. 
  The lipid A isolated from the LPS of A. Liquefactions SJ-19a which was grown in 
presence of phage and was assessed to be phage resistant. This lipid A, when analyzed by 
ESI- and MALDI-MS, afforded series of deprotonated molecules and fragment ions 
indicating that the lipid A analyte, was really a mixture of components composed of a series 
different lipid A1-5 molecules. The presence of this series of different lipid A1-5 molecules 
was attributed to the incomplete biosynthesis of the LPS due to the interaction with the 
phage during the growth of this Gram-negative bacterium. It should be stated that the ESI- 
and MALDI-MS (negative ion mode) afforded series of deprotonated molecules and 
fragment ions which were the identical when analyzed with different instruments such as 
ESI-QqQ-MS, ESI-FTICR-MS, and MALDI-TOF/TOF-MS (Please note that MALDI did 
not contain m/z 893 and m/z 666). In ESI-QqQ-MS, we have assigned these fragment ions 
as the series of [Mn-H]
- deprotonated mono-phosphorylated molecules, represented as the 
following individual lipid A of this series (mixture), namely: LipA1 at m/z 1716.30, LipA2 
at m/z 1688.19, LipA3 at m/z 1506.10, LipA4 at m/z 1279.73, LipA5 at m/z 1097.63, m/z 
892.56 and m/z 666.06. It is important to mention, that the structures of this series of 
incomplete biosynthesized lipid A obtained from LPS Aeromonas Liquefaciens SJ-19a 
(phage resistant), has not been characterized before this work. 
 In addition, the molecular structures of this heterogeneous mixture of lipid An were 
investigated by tandem mass spectrometry using low-energy collision SORI-CID-MS/MS 
(tandem in time) and CID-MS/MS (tandem in space) with the aforementioned instruments.  
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In this study, we have noticed that the SORI-MS/MS analysis of the various 
precursor deprotonated molecules were much simpler than those of the acquired CID-
MS/MS with the high-energy MALDI-CID-TOF/TOF-MS/MS and low-energy CID-QqQ-
MS/MS instruments.  
The combined MS/MS studies indicate that all the proposed structures of the lipid 
A1 to A5 contained one phosphate group at the position O-4ʹ. They were built by a 
(H3PO4→4-O-)-β-D-GlcpN-(1→6)-α-D-GlcpN disaccharide blueprint, substituted with 
(C14:0(3-OH)) at the N-2 and O-3 and contained different substitution permutations with 
(C14:0(3-O-12:0)) and (C14:0(3-O-14:0)) at the N-2´, and the O-3´ positions (Scheme 
3.1.1).  
In conclusion, the low-energy CID-QqQ-MS/MS, SORI-CID-FTICR-MS/MS and 
MALDI-CID-TOF/TOF-MS/MS, allowed to rationalize the different structures of the 
different lipid A1-5. These studies also allowed to elucidate the different structures of all 
diagnostic product ions and showed the presence of C-C heterolytic fragmentation of the 
fatty acid chains during these various gas-phase CID-fragmentations. 
The presence of this series mixture of lipid An in the MS spectrum is good indicator 
to incomplete biosynthesis of lipid A. Also, the presence of the monosaccharide backbone 
was reported in all of them, such as the deprotonated molecules at m/z 892.56, m/z 920.62, 
and m/z 666.43. 
As mentioned earlier in (Chapter 1, introduction section 1.1.1.3), lipid A structure 
plays a critical role in the bacteria infection. Bacteriophages interaction with the bacteria 
cell is complicated process which dose not always result in cell lysis. In this obtaiend series 
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of lipid An mixture, we have shown that the distribution of the various primary fatty acid 
chain length and the presence of phosphate groups were affected by this virus infection. 
 In conclusion, it is postulated that mutant LPS SJ-19a strain, obtained by 
bacteriophage infection of bacteria A. Liquefactions SJ-19a, afforded an LPS containing a 
lipid A, that has been due to the bacteriophages disruption in core biosynthesis process 
occurring at different stages.  
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                                                Chapter 4 
Mass Spectral analysis of the mixture of lipid An isolated from the 
LPS of A. hydrophilla SJ-55a 
 
Aeromonas Hydrophilla is a genus Gram-negative, heterotrophic, aerobic and 
anaerobic belonging to the Vibrionaceae families. This bacterium infects fish in both, warm-
water and cold-water fishes, and causes ulcers, tail rot, fin rot, and hemorrhagic septicemia 
(Michon et al., 1984, and Banoub et al., 1983).  
The LPS of SJ-55a was obtained from the rough mutant Gram-negative bacteria 
Aeromonas Hydrophilla grown in the presence of phage, and it was classified as phage 
resistant as previously described in Chapters 2 and 3. 
The following sections discuss the various mass spectrometric analyses that were 
used for the structural investigation of the complex lipidn mixture.  
 
4.1. Gas chromatography-mass spectrometry (GC-MS) of the fatty 
methyl ester released from the lipid An mixture isolated from the LPS of 
the A. hydrophilla SJ-55a 
 
The qualitative analysis of fatty acids was carried out by GC-MS to identify 
separately the amide and the ester-bound fatty acids. The (R)-3-hydroxytetradecanoic acid 
(C14:0(3-OH)) was identified as an amide-linked fatty acid, whereas the (R)-3-
hydroxydodecanoic acid (C12:0(3-OH)) was identified as amide-linked fatty acids (Perry 
et al., 1979, Rebeil et al., 2004, and Lukasieweicz et al., 2006). In addition to the methyl 
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ester derivative of 3-methoxytetradecanoic acid, the fatty acid methyl esters obtained by 
trans-esterification with sodium methoxide also showed the presence of the (C14:0(3-OH)) 
acid, which was substituted by the tetradecanoic acid (C14:0) (myristic acid) in the native 
lipid A. Similarly, the (C12:0(3-OH)) acid was also shown to be substituted by myristic 
acid. The absolute configuration of the GlcN residues in lipid A was determined as D on 
the deacylated, dephosphorylated lipid A fraction, using (R)-2-butanol. (M. Almostafa., et 
al 2016 and Lukasieweicz et al., 2006).  
 
4.2. ESI-QqQ-MS analysis of the extracted mixture of lipid An isolated 
from the LPS of A. hydrophilla SJ-55a  
 
           The extracted mixture of the lipid A constituting portion of A. hydrophilla SJ-55a 
bacteria is composed of a complex mixture of many structurally-related components, which 
we presume are produced by the incomplete biosynthesis of this lipid A.  
The ESI-QqQ-MS (- ion mode) of the lipid An (where n=1-8) mixture shows the 
presence of inter-alia eleven different fragment ions at m/z 1796.30, m/z 1716.15, m/z 
1688.26, m/z 1506.12, m/z 1359.75, m/z 1279.87, m/z 1097.64, m/z 1053.69, m/z 892.55, 
m/z 710.40 and m/z 666.37. This indicate the presence of a heterogeneous mixture of lipid 
An assigned by the [Mn-H]
- molecules (Scheme.4.1.1.).  
It is well known that structures of pure extract of lipid A contain two phosphate 
groups which are always located on the O-4ʹ and O-1 positions of the β-D-GlcpN-(1→6)-
α-D-GlcpN disaccharide backbone of lipid A (Lukasiewicz et al., 2006, Lukasiewicz et al., 
2010, John et al., 2014, Banoub et al., 2010, and Brodbelt et al., 2014).  
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Figure 4.1.1: ESI-QqQ-MS of the native lipid An extract from the LPS of A. hydrophilla SJ-55a. 
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For this reason, the three deprotonated molecules LipA1 at m/z 1796.30, LipA5 at m/z 
1359.75, and LipA7 at m/z 1097.64 were also assigned as containing both di-phosphorylated 
groups at the O-1 and O-4 respectively and as such were specifically diagnostic for this 
mixture of lipid An (where n=1-8), obtained from the LPS SJ-55a. However, the remaining 
deprotonated molecules at m/z 1716.15, m/z 1688.26, m/z 1506.12, m/z 1279.87, m/z 
1053.69, m/z 892.55, m/z 710.40 and m/z 666.37 are mono-phosphorylated molecules and 
were assigned as follows as following:  LipA2 at m/z 1716.15, LipA3 at m/z 1688.26, LipA4 
at m/z 1506.12, LipA6 at m/z 1279.87, and LipA8 at m/z 1053.69 (Figure 4.1.1, Scheme 
4.1.1, and Table 4.1.1). We also observed three deprotonated molecules at m/z 892.55, m/z 
710.40, and m/z 666.37. These latter deprotonated molecules were recognized as the C-
fragment ions at lower m/z values, which can be produced by the incomplete biosynthesis 
of the lipid A (Please understand, that these deprotonated molecules were named Fragment 
ions, to respect only the Domon and Costello nomenclature) (Domono and Cosetello 1988). 
  We have tentatively assigned that the putative structures of our lipid An mixtures 
contained 3-hydroxy-myristic acid (C14:0(3-OH)) fatty acid chains that acylate the various 
free positions of the β-D-GlcpN-(1→6)-α-D-GlcpN backbone of as the GlcN disaccharide. 
These 3-hydroxy-myristic acid (C14:0(3-OH)) fatty acid chains were attached to the O-3, 
O-3ʹ, and N-2 positions of this lipid A. In addition, we presumed that the 3-hydroxy-lauric 
acid (C12:0(3-OH)) fatty acid chains, acylated the last free positions of the β-D-GlcpN-
(1→6)-α-D-GlcpN backbone of the fully biosynthesized lipid An, which was definitely 
attached to the N-2ʹ positions of this lipid A. In this lipid An mixture, we have proposed 
that the one of the (C14:0(3-OH)) fatty acyl groups at O-3ˊcould be substituted with 
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myristic acid as branched fatty acid (C14:0(3-O-C14:0)) (Scheme 4.1.1). The primary 
(C12:0(3-OH)) fatty acyl groups could be substituted with myristic acid as branched fatty 
acid (C12:0(3-O-C14:0)) located at N-2ʹ positions of the non-reducing end group of the β-
D-GlcpN-(1→6)-α-D-GlcpN disaccharide backbone of this lipid An mixture (Scheme 4.1.1) 
(Lukasiewicz et al., 2006, Lukasiewicz et al., 2010, Banoub et al., 2010, Kilár et al., 2013, 
Brodbelt et al., 2014, and Almostafa et al., 2016). Based on these presumptions, we 
assigned the lipid An (where n=1-8) mixture as in the following: 
 The deprotonated molecule [M1-H]
- LipA1 at m/z 1796.30 was assigned as the di-
phosphorylated hexa-acylated completely biosynthetisized lipid A, which is composed of 
three primary 3-hydroxy-myristic acids (C14:0(3-OH)) fatty acids, one of which, can be 
substituted with myristic acid, forming the branched fatty acid (Cl4:0(3-O-C14:0)) located 
at the O-3ʹ position. In addition, we also presumed that the primary 3-hydroxy-lauric acid 
(C12:0(3-OH)) fatty acid chain, which was acylated with myristic acid, forming the 
branched fatty acid (Cl2:0(3-O-C14:0)) located at the N-2ʹ position of the non-reducing end 
group of the LipA1 disaccharide backbone (Scheme 4.1.1) (El-Aneed et al., 2006, 
Lukasiewicz et al., 2006, Lukasiewicz et al., 2010, John et al., 2014, and Brodbelt et al., 
2014).  
 Likewise, the deprotonated molecule [M2-H]
- LipA2 at m/z 1716.15 was tentatively 
assigned as the mono-phosphorylated hexa-acylated GlcN disaccharide containing three 
primary 3-hydroxy-myristic acids (C14:0(3-OH)) fatty acids, in which one of them was 
substituted by myristic acid forming the branched fatty acids (Cl4:0(3-O-C14:0)) 
presumably located at the O-3ʹ position. In addition, the primary 3-hydroxy-lauric acid 
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(C12:0(3-OH)) fatty acid chain was acylated by myristic acid, forming the branched fatty 
acid (Cl2:0(3-O-C14:0)) located at the N-2ʹ position of the non-reducing end group of the 
LipA2 disaccharide backbone (Scheme 4.1.1) (El-Aneed et al., 2006, Lukasiewicz et al., 
2006, John et al., 2014, and Brodbelt et al., 2014). 
 The structure of deprotonated molecule [M3-H]
- of LipA3 at m/z 1688.26 was 
tenatively assigned as been composed of a mono-phosphorylated hexaacylated GlcN 
disaccharide molecule. In that deprotonated molecule, we presume that the hexa-acylated 
was composed from three primary 3-hydroxy-myristic acids (C14:0(3-OH)) fatty acids, one 
of which, was substituted by lauric acid forming the branched fatty acid (Cl4:0(3-O-C12:0)) 
located on the O-3 position. We tentatively presumed that the primary 3-hydroxy-lauric 
acid (C12:0(3-OH)) fatty acid chain was substituted by myristic acid, forming the branched 
fatty acid (Cl2:0(3-O-C14:0)). This branched fatty acid substituent was located at the N-2ʹ 
position of the non-reducing end group of the LipA3 disaccharide backbone (Scheme 4.1.1) 
(El-Aneed et al., 2006, Lukasiewicz et al., 2006, John et al., 2014, and Brodbelt et al., 
2014). 
 The deprotonated molecules LipA4 at m/z 1506.12 was assigned as the mono-
phosphorylated pentaacylated form of the β-D-(1→6)-Glucosamine disaccharide carrying 
three primary 3-hydroxy-myristic acids (C14:0(3-OH)) fatty acids located at the O-3, N-2, 
O-3ʹ position. Whereas, the fourth primary 3-hydroxy-lauric acid (C12:0(3-OH)) fatty acid 
chains was substituted by myristic acid, forming the branched fatty acid (Cl2:0(3-O-
C14:0)) located at the N-2ʹ of the non-reducing end residue of β-D-GlcpN-(1→6)-α-D-
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GlcpN disaccharide of LipA4 (Scheme 4.1.1) (El-Aneed et al., 2006, Lukasiewicz et al., 
2006, John et al., 2014, and Brodbelt et al., 2014). 
 The deprotonated molecule of LipA5 [M5-H]
- at m/z 1359.75 was assigned as 
containing a di-phosphorylated tri-acylated form of the β-D-GlcpN-(1→6)-α-D-GlcpN 
disaccharide, carrying two primary 3-hydroxy-myristic acids (C14:0(3-OH)) fatty acid 
groups acylating the t O-3 and N-2 position of the reducing end of the disaccharide. The 
third primary 3-hydroxy-lauric acid (C12:0(3-OH)) fatty acid chain was substituted by 
myristic acid, forming the branched fatty acid (Cl2:0(3-O-C14:0)); and this branched fatty 
acid acyl group was located at the N-2ʹ of the non-reducing end residue of β-D-GlcpN-
(1→6)-α-D-GlcpN disaccharide of LipA5 (Scheme 4.1.1). 
 While, the deprotonated molecule of LipA6 [M6-H]
- at m/z 1279.87 was assigned as 
a mono-phosphorylated triacylated form of the β-D-GlcpN-(1→6)-α-D-GlcpN 
disaccharide, carrying two primary 3-hydroxy-myristic acid (C14:0(3-OH)) fatty acids 
located at O-3 and N-2 position of the reducing end of the disaccharide. It should be noted 
that a third primary fatty acid was identified as the 3-hydroxy-lauric acid (C12:0(3-OH)) 
fatty acid chain. This latter fatty acid was substituted by myristic acid, forming the branched 
fatty acid (Cl2:0(3-O-C14:0)) located at the N-2ʹ of the non-reducing end residue of β-D-
GlcpN-(1→6)-α-D-GlcpN disaccharide of LipA6 (El-Aneed et al., 2006, Lukasiewicz et 
al., 2006, John et al., 2014, and Brodbelt et al., 2014). 
  The deprotonated molecule of LipA7 [M7-H]
- at m/z 1097.63 was assigned as 
containing a mono-phosphorylated tri-acylated form of the β-D-GlcpN-(1→6)-α-D-GlcpN 
disaccharide, carrying three primary 3-hydroxy-myristic acid (C14:0(3-OH)) fatty acid 
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located at N-2, O-3 position of the reducing end, and at N-2ˊposition of the non-reducing 
end of the disaccharide β-D-GlcpN-(1→6)-α-D-GlcpN disaccharide. 
  The deprotonated molecule [M8-H]
- at m/z 1053.69 was assigned as LipA8 mono-
phosphorylated tri-acylated β-D-GlcpN-(1→6)-α-D-GlcpN disaccharide containing two 3-
hydroxy-myristic acid (C14:0(3-OH)) fatty acids, which can be tentatively distributed on 
the N-2 and O-3 positions of this lipid A. The third primary 3-hydroxy-lauric acid (C12:0(3-
OH)) fatty acid chain located at the N-2ʹ of the non-reducing end residue of β-D-GlcpN-
(1→6)-α-D-GlcpN disaccharide (Scheme 4.1.1) (El-Aneed et al., 2006, Lukasiewicz et al., 
2006, John et al., 2014, and Brodbelt et al., 2014). 
 In addition, we have also observed the deprotonated molecule at m/z 892.55 which 
was tentatively assigned as deprotonated [C-(C14:0)ketene-H]- molecule. This latter, 
contained a primary 3-hydroxy-myristic (C14:0(3-OH)) fatty acid, and another primary 3-
hydroxy-lauric acid (C12:0(3-OH)) fatty acid chain, which was substituted by myristic 
acid, forming the branched fatty acid (Cl2:0(3-O-C14:0)) located at the N-2 (Scheme 
4.1.1). 
Another deprotonated molecule at m/z 710.40 was assigned as [Y-H]-. This was 
recognized as the mono-phosphorylated D-GlcN species containing two 3-hydroxy-
myristic acids (C14:0(3-OH)) fatty acids, which would be tentatively distributed on the O-
3 and N-2. 
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The last deprotonated molecule at m/z 666.37 was assigned as [C-(C14:0(3-O-
C14:0))ketene-H]-. This molecule was recognized as the mono-phosphorylated D-GlcN 
species, containing one branched (Cl2:0(3-O-C14:0)) fatty acyl group on the N-2 position 
(Scheme 4.1.1).  
We presume that the formation of the C-fragment and Y-fragment ions at lower m/z 
values, are produced by the incomplete biosynthesis of the lipid A (El-Aneed et al., 2006, 
Lukasiewicz et al., 2006, John et al., 2014, and Brodbelt et al., 2014).  
At this point of this study, we have tentatively identified a series of complete and 
incomplete O-3, O-3ʹ, N-2 and N-2ʹ acylated the β-D-GlcpN-(1→6)-α-D-GlcpN 
disaccharide backbone of the lipid A1-8 structures sharing common properties.  
We have identified the presence of three primary hydroxytetradecanoic acids 
(C14:0(3-OH)) at N-2, O-3, and O-3ʹ position present on the β-D-GlcpN-(1→6)-α-D-GlcpN 
disaccharide backbone of this mixture of lipidA1-8. The primary 3-hydroxy-myristic acids 
(C14:0(3-OH)) fatty acids can be acylated with myristic acyl groupss, forming the branched 
fatty acids (Cl4:0(3-O-C14:0)) located at the O-3ʹ position. In addition, we have also 
proposed that the primary 3-hydroxy-lauric (C12:0(3-OH)) fatty acid chain was acyalted 
with myristic acid, forming the branched fatty acid (Cl2:0(3-O-C14:0)) located at the N-2ʹ. 
This series of lipid An was shown to contain either two and/or one phosphate groups.   
The use of the low-energy collision dissociation tandem mass spectrometry analysis 
confirms our tentative assignments, and the putative structures for the eight deprotonated 
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molecules LipA1 to LipA8 and other fragment ions (El-Aneed et al., 2006, Lukasiewicz et 
al., 2006, John et al., 2014, and Brodbelt et al., 2014). 
 As previously described in this thesis we have used the Domon and Costello 
carbohydrate nomenclature to define and characterize all the deprotonated molecules; it 
was produced by their gas-phase fragmentation in the ESI-MS and CID-MS/MS analysis. 
(Domon and Costello, 1988). 
 
4.2.1. Low-energy CID-MS/MS analysis of the extracted mixture of lipid 
An isolated from the LPS of A. hydrophilla SJ-55a using the QqQ-MS/MS 
instrument  
  The low-energy CID-MS/MS analysis were conducted using the triple quadrupole 
(QqQ) instrument (tandem-in-space) on the eight different precursor [M-H]- deprotonated 
molecules: at m/z 1796.30 (LipA1), m/z 1716.15 (LipA2), m/z 1688.26 (LipA3), m/z 1506.12 
(LipA4), m/z 1359.75 (LipA5), m/z 1279.87 (LipA6), m/z 1097.64 (LipA7), and m/z 1053.69 
(LipA8) (Figure 4.1.2). The product ion scans of these precursor molecules afforded series 
of distinct and diagnostic product ions, which were produced by competitive cleavages of 
the primary and/or secondary fatty esters located on β-D-GlcpN-(1→6)-α-D-GlcpN 
disaccharide backbone of lipid A.  
 As mentioned previously in section (3.1.2), it is well known that the ester-linked 
fatty groups at O-3 and O-3ʹ are more readily hydrolysable than the fatty acyl amide groups 
at N-2 and N-2ʹ; in addition, the cleavages arising from the glycosidic bond are followed 
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by inter-ring bond cleavages (Lukasiewicz et al., 2006, Kilár et al., 2013, and Brodbelt et 
al., 2014).  
 The product ion scan of the deprotonated di-phosphorylated LipA1 molecules at m/z 
1796.30 allowed us to investigate the fatty acyl group distributions detected in ESI-QqQ-
MS analysis of LipA1, as shown in (Figure 4.1.2).  
           The CID-MS/MS of the deprotonated molecules at m/z 1796.30 produced the 
following series of product ions at m/z 1732.17, m/z 1532.96, m/z 1279.90, m/z 1097.65, 
and m/z 804.47 (Figure 4.1.2, Scheme 4.1.2 and Table 4.1.2). The product ions at m/z 
1732.17 was assigned as the [M1-2(H2O)-(C2H6)-H]
- ion and was formed by the 
consecutive losses of two molecules of water and a molecule of  ethane (C2H6,-30 Da) as 
part of the fatty acid chain properly located at O-3ʹ of LipA1. Likewise, the product ion at 
m/z 1532.96 was assigned as the [M1-2(H2O)-(C14:0)acid-H]
- ion, which was created by 
the elimination of two molecules of water, and myristic acid forming  the branched fatty 
(C14:0(3-O-C14:0) acid acyl group located at O-3ʹ (-228 Da). The product ion at m/z 
1279.90 was formed form the precursor ion by consecutive loss of the branched fatty 
(C14:0(3-O-C14:0)) located at O-3ʹ position (-436 Da) and by the elimination of the neutral 
HPO3 (-80 Da) moiety located at O-3ˊ. This product ion was assigned as [M1-(C14:0(3-O-
C14:0))ketene-HPO3-H]
- ion. The product ion at m/z 1097.65 was formed form the 
precursor ion by elimination of a molecule of the branched fatty (C14:0(3-O-C14:0)) acid 
(-454 Da) from the O-3ʹ position, and followed by the elimination of the 3-hydroxyl 
myristic acid (-244 Da) from the O-3 position. This product ion was assigned as [M1-
(C14:0(3-O-C14:0))acid-(C14:0(3-OH))acid-H]- ion.  
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Figure 4.1.2:  CID-MS/MS of the precursor deprotonated [M1-H]-  molecules at m/z 1796.30.⁕ 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other isobars 
isolated during the MS/MS analysis. 
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Table 4.1.2: Assignments of the product ions observed from CID-MS/MS of the precursor 
deprotonated [M1-H]- molecules at m/z 1796.30. 
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Scheme 4.1.2: Proposed fragmentation pathways obtained by CID-QqQ-MS/MS and SORI-CID-
FTICR-MS/MS of the precursor deprotonated [M1–H]- molecules at m/z 1796.30. 
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Finally, the product ion at m/z 804.47 was formed by the glycosidic cleavages of the β-D-
GlcpN-(1→6)-α-D-GlcpN disaccharide backbone of the precursor deprotonated molecule 
to afford the reducing D-GlcN-OH species obtained, following consecutive losses of 
myristic (-228 Da) located at O-3 position and a molecule of C5H7 (-70 Da) as part of the 
fatty acid chain properly located at N-2. This products ion was assigned as [C-(C14:0)acid-
(C5H7)-H]
- ion. These results are indicating the presence of three molecules of 3-hydroxyl 
myristic acids at the positions O-3, O-3ʹ and N-2 of the disaccharide backbone, and a 3-
hydroxy-lauric (C12:0(3-OH)) fatty acid chains located at the N-2ʹ, whereas the branched 
(C14:0(3-O-C14:0)) fatty acids were located on O-3ʹ and N-2ʹ positions of the non-reducing 
end of the β-D-GlcpN-(1→6)-α-D-GlcpN disaccharide backbone of this lipid A1.  
 The product ion scan of the deprotonated mono-phosphorylated LipA2 molecules at 
m/z 1716.15 afforded the product ions m/z 1462.65, m/z1279.80, m/z 1035.68, and m/z 
710.37 (Figure 4.1.3, Scheme 4.1.3, and Table 4.1.3). The product ions at m/z 1462.65 was 
assigned as the [M2-(C14:0)ketene-C3H8-H]
- ion. It was formed by the elimination of 
myristic acid from the branch (Cl4:0(3-O-C14:0)) fatty acids (-210 Da), which was attached 
to the O-3ʹ position, and the concomitant loss of molecule of C3H8 (-44 Da) as part of the 
fatty acid chain, properly located at O-3ʹ position of the β-D-GlcpN-(1→6)-α-D-GlcpN 
disaccharide backbone of the lipid A. The product ion at m/z 1279.80 was assigned as the 
[M2-(C14:0(3-O-C14:0))ketene-H]
- ion, which was formed by the elimination of myristic 
acid and the branched fatty (C14:0(3-O-14:0)) acid acyl group located at O-3ʹ (-436 Da).  
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Figure 4.1.3:  CID-MS/MS of the precursor deprotonated [M2-H]-  molecules at m/z 1716.15.⁕ 
 
 
 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other isobars 
isolated during the MS/MS analysis.
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The product ion at m/z 1035.68 was formed by the elimination of a molecule of the 
branched fatty (C14:0(3-O-C14:0)) ketene (-436 Da) from the O-3ʹ position and by the loss 
of a 3-hydroxyl myristic acid (-244 Da) from O-3. This product ion was assigned as [M2-
(C14:0(3-O-C14:0))ketene-(C14:0(3-OH))acid-H]- ion, as shown in (Figure 4.1.3, Table 
4.1.3, and Scheme 4.1.3). The product ion at m/z 710.37 was assigned as [Y-H]-, and it was 
recognized as the mono-phosphorylated D-GlcN species containing two 3-hydroxy-
myristic acid (C14:0(3-OH)) fatty acids, which would be tentatively distributed on the O-
3 and N-2 (El-Aneed et al., 2006, Lukasiewicz et al., 2010, Kilár et al., 2013, and Brodbelt 
et al., 2014). 
It is important to note that the obtained product ion scan of the deprotonated mono-
phosphorylated LipA2 molecules at m/z 1716.15 is completely different from the one 
obtained for the deprotonated molecule of LipA1 isolated from the lipid An SJ-19a (Chapter 
3). This indicated that both deprotonated molecules for m/z 1716 are indeed isobaric and 
have completely different structures. 
This MS/MS studies supports our suggested structure assignment of the 
deprotonated molecule (LipA2), and indicates that the H2PO3 group is located at the O-4ʹ 
position of the non-reducing end of the disaccharide backbone. It also confirms the position 
of the presence of two molecules of 3-hydroxyl myristic acids at the positions O-3, and N-
2 of the reducing end of the GlcN disaccharide backbone, and a 3-hydroxy-lauric (C12:0(3-
OH)) fatty acid acyl chain which was substituted by myristic acid, forming the branched 
fatty acids (Cl2:0(3-O-C14:0)) located at the N-2ʹ. Whereas the branched (C14:0(3-O-
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C14:0)) fatty acid appeared to be located on O-3ʹ positions of the non-reducing end of the 
β-D-GlcpN-(1→6)-α-D-GlcpN disaccharide backbone of this lipid A (El-Aneed et al., 
2006, Lukasiewicz et al., 2006, John et al., 2014, and Brodbelt et al., 2014).  
The product ion scan of the deprotonated mono-phosphorylated LipA3 molecules at 
m/z 1688.26 afforded the product ions at m/z 1331.79, m/z 1243.80, and m/z 548.23 (Figure 
4.1.4, Table 4.1.4 and Scheme 4.1.4). The product ion at m/z 1331.79 was assigned as the 
[M3-(C12:0)acid-(C11H24)-H]
- ion, and it was generated by the eliminations of lauric acid 
(-200 Da) located at O-3, and the concomitant loss of molecule of C11H24 (-156 Da) as part 
of the fatty acid chain, properly located at N-2ˊ position of the β-D-GlcpN-(1→6)-α-D-
GlcpN disaccharide backbone of the lipid A. (Figure 4.1.4).he product ion at m/z 1243.80 
was assigned as [M3-(C14:0(3-O-12:0)))acid-H2O-H]
- ion, and it was formed by 
consecutive losses of the branched fatty (C14:0(3-O-C12:0)) acid (-426 Da) located on 
position O-3ʹ and a molecule of water from the precursor ion at m/z 1688.26. The product 
ion of at m/z 548.23, assigned as [C-(C12:0)acid-(C14:0)acid-(H 3PO4)-H]
- ion; was formed 
by the consecutive losses of the branched fatty (C14:0(3-O-C12:0)) acid (-200 Da) located 
at the O-3ʹ position, myristic acid (-228 Da) from the branched fatty acids (C12:0(3-O-
C14:0)) located on the N-2ʹ position, and the elimination of the neutral H3PO4 (-98 Da) 
moiety (Figure 4.1.4, Table 4.1.4, and Scheme 4.1.4). The structure of this product ion 
confirms the presence of the branched (C14:0(3-O-C12:0)) fatty acid ester group on the O-
3ʹ position, and the presence of the branched (C12:0(3-O-C14:0)) fatty acid ester group on 
the N-2ʹ position (El-Aneed et al., 2006, Lukasiewicz et al., 2010, John et al., 2014, and 
Brodbelt et al., 2014). 
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Figure 4.1.4: CID-MS/MS of the precursor deprotonated [M3-H]-  molecules at m/z 1688.26.⁕ 
 
 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other isobars 
isolated during the MS/MS analysis. 
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It is important to note that the obtained product ion scan of the deprotonated mono-
phosphorylated LipA3 molecules at m/z 1688.26 is completely different from the one 
obtained for the deprotonated molecule of LipA2 isolated from the lipid An SJ-19a (Chapter 
3). This indicated that both deprotonated molecules for m/z 1688 are indeed isobaric and 
have completely different structures. 
 The product ion scan of the deprotonated LipA4 molecules at m/z 1506.12 gave the 
series of product ion at m/z 1261.81, m/z 1053.63, and m/z 690.36 (Figure 4.1.5, Table 
4.1.5, and Scheme 4.1.5). The product ion at m/z 1261.81 was assigned as the [M4-
(C14:0(3-OH))acid-H]- ion, and was formed by the elimination of 3-hydroxy-myristic acid 
(C14:0(3-OH)) (-244 Da) located at the position O-3ʹ. The product ion m/z 1053.63 was 
assigned as the [M4-2(C14:0(3-OH))ketene-H]
-, and it was formed by the elimination of 
two of the 3-hydroxy-myristic ketene (C14:0(3-OH)) (-226 Da) located at the position O-3 
and O-3ʹ. The last product ion at m/z 690.36 was assigned as [0,4A-(C14:0(3-OH))acid-H]- 
produced by cleavage of the non-reducing mono-phosphorylated D-Glucose residue, and it 
was formed by the loss of a 3-hydroxy-myristic ketene molecule (-244 Da) from the O-3 
position. This latter product ion was indeed produced from the C-fragmentation routes 
described by Domon and Costello. It is initiated by glycosidic cleavages of the β-D-(l→6)-
GlcN disaccharide (Domon and Costello, 1988).  
It is important to note that the obtained product ion scan of the deprotonated mono-
phosphorylated LipA4 molecules at m/z 1506.12 is completely different from the one 
obtained for the deprotonated molecule of LipA3 isolated from the lipid An SJ-19a (Chapter 
3).  
 178 
 
 
 
 
Figure 4.1.5: CID-MS/MS of the precursor deprotonated [M4-H]-  molecules at m/z 1506.12.⁕ 
 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other isobars 
isolated during the MS/MS analysis.  
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This indicated that both deprotonated molecules for m/z 1506 are indeed isobaric and have 
completely different structures.  
 The product ion scan of the deprotonated di-phosphorylated LipA5 molecules [M5-
H]- at m/z 1359.75 gave a series of product ions at m/z 1209.75, m/z 1085.53, m/z 1000.55, 
m/z 953.50, and m/z 554.24 (Figure 4.1.6, Table 4.1.6 and Scheme 4.1.6). The product ion 
at m/z 1209.75 was assigned as [M5-HPO3-(C5H10)-H]
- ion. It was formed by the 
elimination of the neutral HPO3 (-80 Da) moiety and a molecule of C5H10 (-116 Da) as part 
of the fatty acid chain properly located at N-2ʹ position. The product ion at m/z 1085.53 
was assigned as [M5-(C10H20)-HPO4-2H2O-H]
- ion. It was formed by consecutive 
elimination of two molecules of water (-36 Da), a molecule of C10H20 (-140 Da) FROM the 
fatty acid chain located at O-3 position, and the elimination of the neutral H3PO4 (-98 Da) 
moiety. The product ion at m/z 1000.55 was assigned as [M5-HPO3-(C14:0)ketene-(C5H10)-
H]- ion. It was formed by the consecutive elimination of the neutral HPO3 (-80 Da) moiety, 
the alkane (C5H10) (-70 Da) as part of the fatty acid chain located at O-3 position, and the 
myristic ketene (-208 Da) from the branched fatty (C12:0(3-O-14:0)) acid located on N-2ʹ. 
The product ion at m/z 953.50 was assigned as [M5-HPO3-(C12:0)acid-(C7H16)-H]
- ion, and 
it was formed by consecutive elimination of the neutral HPO3 (-80 Da) moiety, (C7H16) (-
116 Da) as part of the fatty acid chain properly located at O-3 position, and the myristic 
acid (-226 Da) from the branched fatty (C12:0(3-O-14:0)) acid located on N-2ʹ. The last 
product ion at m/z 554.24 was assigned as the [C-(C8H16)-H]
- ion, and it was formed by the 
elimination of the (C8H16) (-112 Da) as part of the fatty acid chain located at N-2 position.  
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Figure 4.1.6: CID-MS/MS of the precursor deprotonated [M5-H]-  molecules at m/z 1359.75.⁕ 
 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other 
isobars isolated during the MS/MS analysis 
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These findings support that our suggested LipA5 structure contains two H2PO3 groups at 
the O-4ʹ and O-1 position of lipid A5 (El-Aneed et al., 2006, Lukasiewicz et al., 2010, John 
et al., 2014, and Brodbelt et al., 2014). 
 The product ion scan of the deprotonated mono-phosphorylated LipA6 molecules 
[M6-H]
- at m/z 1279.87 gave a series of product ions at m/z 1147.50 and m/z 1035.64. The 
product ion at m/z 1147.5 which was assigned as the [M6-C8H17-H2O-H]
- ion. It was created 
by the elimination of the (C8H17) (-113 Da) as part of the fatty acid chain properly located 
at N-2ˊ position, and a molecule of water (Figure 4.1.7, Table 4.1.7 and Scheme 4.1.7). The 
product ion at m/z 1035.64 which was assigned as the [M6-(C14:0(3-OH))acid-H]
- ion. It 
was created by the elimination of 3-hydroxy-myristic acid (C14:0(3-OH)) (-244 Da) 
located at the position O-3 of the reducing GlcN end (Figure 4.1.7, Table 4.1.7 and Scheme 
4.1.7) (El-Aneed et al., 2006, Lukasiewicz et al., 2010, John et al., 2014, and Brodbelt et 
al., 2014). 
It is important to note that the obtained product ion scan of the deprotonated mono-
phosphorylated LipA6 molecules at m/z 1279.87 is completely different from the one 
obtained for the deprotonated molecule of LipA4 isolated from the lipid An SJ-19a (Chapter 
3). This indicated that both deprotonated molecules for m/z 1279 are indeed isobaric and 
have completely different structures. 
The product ion scan of LipA7 at m/z 1097.64 gave a series of product ions at m/z 
1079.65, m/z 1023.59, m/z 961.34, and m/z 852.47 (Figure 4.1.8, Table 4.1.8, and Scheme 
4.1.8). The product ion at m/z 1079.65 was created by the loss of a molecule of water. The 
product ion m/z 1023.59 was assigned as the [M7-(C4H18)-H2O-H]
- ion.  
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Figure 4.1.7: CID-MS/MS of the precursor deprotonate [M6-H]- molecules at m/z 1279.87.⁕ 
 
 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other 
isobars isolated during the MS/MS analysis. 
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 Scheme 4.1.7: Proposed fragmentation pathways obtained by CID-QqQ-MS/MS and SORI-CID-
FTICR-MS/MS of the precursor deprotonated [M6-H]- molecules at m/z 1279.87. 
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It was created by the eliminations of nC4H8 (-56 Da) as part of the fatty acid chain located 
at O-3, and a molecule of water (-18 Da). The product ion m/z 961.34 was assigned as the 
[M7-(C7H16)-2H2O-H]
- ion. It was created by the eliminations of a molecule of nC7H16 (-
100 Da) as part of the fatty acid chain located at O-3, and two molecules of water (-36 Da). 
The product ion at m/z 852.48 was assigned as the [M7-(C14:0(3-OH)) acid-H]
- ion, which 
was created by the elimination of a myristic acid (C14:0(3-OH)) (-244 Da) located at the 
position O-3 of the reducing GlcN end of the LipA7 disaccharide (El-Aneed et al., 2006, 
Lukasiewicz et al., 2010, and Brodbelt et al., 2014).  
It is important to note that the obtained product ion scan of the deprotonated di-
phosphorylated LipA7 molecules at m/z 1097.64 is completely different from the one 
obtained for the deprotonated molecule of LipA5 isolated from the lipid An SJ-19a (Chapter 
3). This indicated that both deprotonated molecules for m/z 1097 are indeed isobaric and 
have completely different structures. 
The product ion scan of LipA8 at m/z 1053.69 gave a series of product ions at m/z 
843.45, m/z 763.48, and m/z 648.36 (Figure 4.1.9, Table 4.1.9, and Scheme 4.1.9). The 
product ion at m/z 843.45 was assigned as the [M8-(C14:0))ketene-H]
- ion. It was formed 
by the elimination of the myristic ketene (-210 Da) from the branch (Cl2:0(3-O-C14:0)) 
fatty acids which was attached to the N-2ʹ position. The product ion at m/z 763.48 was 
assigned as the [M8-(C14:0)keten-HPO3-H]
- ion, and it was created by the consecutive 
losses of myristic ketene molecule (-210 Da) from the branched (C12:0(3-O-C14:0)) fatty 
acid at the N-2ˊ position, and HPO3 (-80 Da) released from the O-4ʹ position of the D-GlcN 
non-reducing end of LipA8.  
 190 
 
 
 
 
Figure 4.1.8: CID-MS/MS of the precursor deprotonated [M7-H]- molecules at m/z 1097.64.⁕ 
 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other isobars 
isolated during the MS/MS analysis. 
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Scheme 4.1.8: Proposed fragmentation pathways obtained by CID-QqQ-MS/MS and SORI-CID-
FTICR-MS/MS of the precursor deprotonated [M7-H]- molecules at m/z 1097.64.⁕ 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other isobars 
isolated during the MS/MS analysis. 
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Table 4.1.9: Assignments of the product ions observed from CID-MS/MS of the precursor 
deprotonated [M8-H]- molecules at m/z m/z 1053.69. 
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Figure 4.1.9: CID-MS/MS of the precursor deprotonated [M8-H]- molecules at m/z 1053.69.⁕ 
 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other isobars 
isolated during the MS/MS analysis. 
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Scheme 4.1.9: Proposed fragmentation pathways obtained by CID-QqQ-MS/MS and SORI-CID-
FTICR-MS/MS of the precursor deprotonated [M8-H]- molecules at m/z 1035.69. 
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The last product ion at m/z 648.36 was assigned to be formed by the [B-H]- cleavage of the 
reducing D-Glucosamine end (Domon and Costello, 1988). 
  Lastly, we also investigated the nature of the deprotonated molecules at m/z 892.55, 
m/z 710.40 and m/z 666.37 observed in the ESI-MS of this lipid An mixture. We have 
previously assigned these deprotonated molecules as being created by the [C-H]-  and [Y-
H]- ion series whose presence are probably an indication of the incomplete biosynthesis of 
the lipid A1-8 series of the LPS A. hydrophilla SJ-55a.
   
        The product ion scan of the deprotonated [C-(C14:0)ketene-H]- molecule at m/z 
892.56 gave a series of product ions at m/z 791.45, m/z 682.38, and m/z 648.40 (Figure 
4.1.10, Scheme 4.1.10, and Table 4.1.10). The product ion at m/z 791.45 was assigned as 
[C-(C14:0)ketene-C6H11-H2O-H]
- ion, and it was generated by the consecutive eliminations 
of n-hexane as a part of the fatty acid (-83 Da) probably located at N-2 or O-3, and a 
molecule of water. It is important to note that the obtained product ion scan of the 
deprotonated mono-phosphorylated molecules at m/z 892.56 is completely different from 
the one obtained for the deprotonated molecule that was isolated from the lipid An SJ-19a 
and was assigned as [C-(C14:0)ketene-H]- (Chapter 3). This indicated that both 
deprotonated molecules for m/z 892 are indeed isobaric and have completely different 
structures. 
Similarly, the product ion at m/z 682.39 was assigned as the [C-2(C14:0)ketene-H]- 
ion, and it was created by losses of the myristic ketene molecule (-210 Da) from the 
branched fatty acids (C14:0(3-O-C12:0)) at the N-2 position.  
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Figure 4.1.10: CID-MS/MS of the precursor deprotonated [C-(C14:0)ketene-H]- molecules 
at m/z 892.55.⁕ 
 
 
 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other isobars 
isolated during the MS/MS analysis. 
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Table 4.1.10: Assignments of the product ions observed from the SORI-MS/MS and 
CID-MS/MS analysis of the precursor deprotonated [C-(C14:0)ketene-H]- molecules 
at m/z 892.55. 
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Scheme 4.1.10: Proposed fragmentation pathways obtained by CID-QqQ-MS/MS and SORI-
CID- FTICR MS/MS analysis of the precursor deprotonated [C-(C14:0)ketene-H]-  molecules.at  
m/z 892.55. 
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The product ions at m/z 648.40 was assigned as [C-(C14:0)ketene-(C14:0(3-OH))acid-H]- 
ion and it was formed by the loss of the 3-hydroxy-myristic acid (-244 Da) at O-3 position.  
Once more, we have again a strong support indicating that the lipid A1, lipid A5, 
and lipid A7 only knows, and lipid a have structures containing two H2PO3 group at O-4ʹ 
of the D-GlcN non-reducing end, and at O-1 at the reducing end of the D-GlcN. These 
deprotonated molecules also contain a primary myristic ester located at N-2, O-3, and O-3ʹ 
position, and a primary lauric esters located at the N-2ʹ position of this lipid GlcN 
disaccaride backbone. It also means that the myristic acid ester is located on the branched 
fatty acids (C14:0(3-O-C12:0)) acyl group located at N-2ˊ. Whereas the branched fatty ester 
(C14:0(3-O-C14:0)) is located at O-3ˊ position of the reducing GlcN residue present in the 
β-D-GlcpN-(1→6)-α-D-GlcpN disaccharide backbone. Whereas the structures of the 
deprotonated molecules Lip A2, Lip A3, Lip A4, Lip A6, and Lip A8 are identical to that of 
the di-phosphorylated Lip A1, Lip A5, and Lip A7 with the absence of one phosphate group 
located on O-1.  
The product ion scan of the deprotonated [Y-H]- molecule at m/z 710.40 gave a 
series of product ions at m/z 664.36, and m/z 466.20 (Figure 4.1.11, Table 4.1.11 and 
Scheme 4.1.11). The product ion at m/z 664.36 was assigned as [Y-C2H4-H2O-H]
- ion and 
it was generated by consecutive eliminations of n-C2H4 as a part of the fatty acid (-28 Da) 
probably located at O-3 and a molecule of water. Similarly, the product ion at m/z 466.20 
was assigned as the [Y-(C14:0(3-OH))acid-H]- ion and it was created by loss the 3-
hydroxy-myristic acid (C14:0(3-OH)) (-244 Da) located at the position O-3. 
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Table 4.1.11: Assignments of the product ions observed from CID-MS/MS and SORI-
MS/MS of the precursor ion at m/z 710.40. 
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Figure 4.1.11: CID-MS/MS of the precursor deprotonated [Y-H]- molecules a m/z 710.40.⁕ 
 
 
 
 
 
 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other isobars 
isolated during the MS/MS analysis. 
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Scheme 4.1.11: Proposed fragmentation pathways obtained by CID-QqQ-MS/MS and SORI-CID-
FTICR-MS/MS of the precursor mono-phosphorylated ion [Y-H]- m/z 710.40. 
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Finally, the CID-MS/MS affords the precursor deprotonated mono-phosphorylated 
molecules at m/z 666.37 assigned as [C-(C14:0(3-O-C14:0))ketene-H]- gave the following 
series of product ions at m/z 648.30, m/z 563.29, m/z 520.25, and m/z 438.20 (Figure 4.1.12, 
Table 4.1.12, and Scheme 4.1.12). The product ion at m/z 648.30 was formed by the loss 
of a molecule of water. The product ion at m/z 563.29 was assigned as [C-(C14:0(3-O-
C14:0))acid-(C6H14)-H2O-H]
- ion, and it was formed by the consecutive eliminations of n-
C6H14 as a part of the fatty acid (-86 Da) located at N-2, and a molecule of water. The 
product ion at m/z 520.25 was assigned as [C-(C14:0(3-O-C14:0))ketene-(C9H20)-H2O-H]
- 
ion, and it was formed by the consecutive eliminations of n-C9H20 as a part of the fatty acid 
(-128 Da) probably located at N-2, and a molecule of water. The product ion at m/z 438.20 
was assigned as [C-(C14:0(3-O-C14:0))ketene-(C14:0)acid-H]- ion, and it was formed by 
the elimination of a molecule of myristic acid (-228 Da) from the branched (C12:0(3-O-
C14:0)) ester at the N-2 position. It is important to note that the obtained product ion scan 
of the deprotonated mono-phosphorylated molecules at m/z 666.37 is completely different 
from the one obtained for the deprotonated molecule that was isolated from the lipid An SJ-
19a, which was assigned as [C-(C14:0(3-O-C14:0))ketene-H]- (Chapter 3). This indicated 
that both deprotonated molecules for m/z 666 are indeed isobaric and have completely 
different structures. 
It should be noticed that the CID-MS/MS analysis of the deprotonated molecules 
[M1-8-H]
- at m/z 1796.30 (LipA1), m/z 1716.15 (LipA2), m/z 1688.26 (LipA3), m/z 1506.12 
(LipA4), m/z 1359.75 (LipA5), m/z 1279.87 (LipA6), m/z 1097.64 (LipA7), and m/z 1053.69 
(LipA8) afford distinctive series of product ions. Additionally, it is important to  
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Figure 4.1.12: CID-MS/MS of the precursor deprotonated [C-(C14:0(3-O-C14:0))ketene-H]-
molecules at m/z 666.37.⁕ 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other isobars 
isolated during the MS/MS analysis.  
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Table 4.1.12: Assignments of the product ions observed from CID-MS/MS and SORI-
MS/MS of the precursor ion at m/z 666.37. 
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Scheme 4.1.12: Proposed fragmentation pathways obtained by CID-QqQ-MS/MS and SORI-
CID-FTICR MS/MS of the precursor mono-phosphorylated ion [C-(C14:0(3-O-C14:0))ketene-
H]- m/z 666.37. 
 
 
 
 
 
 
reference that there was no cross connectivity between the different precursor deprotonated 
molecules. These findings indicate that each one of these species was individual and created 
specific product ions.  
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In conclusion, the MS/MS finding described herewith confirm that the origins and 
presence of this series of precursor ions was caused by an incomplete biosynthesis of the 
LPS. Also, it is important to note that during the low-energy CID-MS/MS analyses 
conducted with the QqQ-tandem instrument on these series of deprotonated molecules, we 
were able to confirm that the formation of each deprotonated molecule recorded in single 
stage ESI-QqQ-MS instrument, were indeed single unique diagnostic molecules that were 
not produced by further fragmentation from contiguous higher masses deprotonated 
molecules. In addition, these product ion scans created series of product ions, that excluded 
the possibility, that they could be related to each other.   
Finally, precursor ion scans of these deprotonated molecules formed during the ESI-
QqQ-MS showed that there were no connectivities and/or genesi relations between these 
different deprotonated molecules (see Appendix). 
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4.3. ESI-FTICR-MS analysis of heterogeneous lipid An mixture isolated 
from the LPS of A. hydrophilla SJ-55a  
 
The ESI-FTICR-mass spectrometer analysis was also applied to the mixture of lipid 
An (where n=1-8), in order to produce spectrum as a time depending technique with its high 
resolving power and mass accuracy currently available, which allows to determine the 
elemental conformation of the analyzed produced ions (Marshall, et al., 1998, Marshall, et 
al., 1999, Palumbo et al., 2011, and van Agthoven et al., 2015). 
 Unsurprisingly, this ESI-MS (- ion mode) obtained for lipid A of A. hydrophilla 
SJ-55a displayed an incomplete biosynthesis as demonstrated by the multiple deprotonated 
molecules. 
Similarly, to the ESI-QqQ-MS, the ESI-FTICR-MS (- ion mode) showed the 
presence of inter-alia eight fragment ions, three of which were assigned to different [M-
H]- deprotonated di-phosphorylated molecules LipA1 at m/z 1796.2228, LipA5 at m/z 
1359.8180, and LipA7 at m/z 1097.6930, and five deprotonated mono-phosphorylated 
molecules LipA2 at m/z 1716.2610, LipA3 at m/z 1688.2253, LipA4 at m/z 1506.0530, LipA6 
at m/z 1279.8489, and LipA8 m/z 1053.6583. Also, the last deprotonated molecules at m/z 
892.5979, m/z 710.4258, and m/z 666.4013 were assigned as belonging to the [Y-H]- and 
[C-H]-, indicating the presence of a heterogeneous mixture of lipid An (Figure 4.2.1, 
Scheme 4.1,1 and Table 4.1.1).  
           It should be noted that the ESI-FTICR-mass spectrum gives the same deprotonated 
molecules of the LipA1-8 mixture as ESI-QqQ-MS with different abundances. In the ESI- 
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Figure 4.2.1: ESI-FTICR-MS (- ion mode) of the native lipid An mixture extracted from A. 
hydrophilla SJ-55a. 
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FTICR-mass spectrum, we noticed that the deprotonated molecule assigned to the LipA6 at 
m/z 1279.8489 was the most abundant. 
 
4.3.1. Measurement of the FT-ICR-MS isotopic distributions of the 
deprotonated molecules of lipid An isolated from the LPS of A. hydrophilla 
SJ-55a  
 
 The influence of spectral accuracy of the deprotonated molecular ions on elemental 
composition calculations was investigated by high-resolution mass spectrometer. The 
isotopic distribution of this series of deprotonated lipid An (where n=1-8), namely: LipA1 
at m/z 1796.2228, LipA2 at m/z 1716.2610, LipA3 at m/z 1688.2253, LipA4 at m/z 
1506.0530, LipA5 at m/z 1359.8180, LipA6 at m/z 1279.8489, LipA7 at m/z 1097.6930, m/z 
1053.6583, and LipA8 at m/z 1053.69, and in addition to the two deprotonated molecules 
at m/z 892.5979, m/z 710.4258, and m/z 666.4013, is indicated in (Figure 4.2.2, Figure 
4.2.3, and Figure 4.2.4) (Kind et al., 2010, and Jaitly et al., 2009). Therefore, the calculated 
elemental compositions of the deprotonated molecule [M1-H]
-, [M2-H]
-, [M3-H]
-, [M4-H]
-, 
[M5-H]
-, [M6-H]
-, [M7-H]
-, and [M8-H]
-, matched their experimental isotopic abundances 
using the algorithm “Gaussian 09 software package”, which allowed us to calculate the 
isotopic fine structures and allow the modeling of Gaussian peak shapes according to the 
selected resolving power of the instrument (Kind et al., 2010, and Jaitly et al., 2009).  
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Figure 4.2.2: Theoretical isotope distribution overlapped on top of the observed pattern of the 
lipid An extract from the LPS of A. hydrophilla SJ-55a. 
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Figure 4.2.3: Theoretical isotope distribution overlapped on top of the observed 
pattern of the lipid An extract from the LPS of A. hydrophilla SJ-55a. 
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Figure 4.2.4: Theoretical isotope distribution overlapped on top of the observed pattern of the lipid 
An extract from the LPS of A. hydrophilla SJ-55a. 
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4.3.2. SORI-CID-FTICR-MS/MS analysis of lipid An mixture isolated 
from the LPS of A. hydrophilla SJ-55a 
  
In this study, like in chapter 3, we have used SORI-CID-FTICR-MS/MS 
experiments for the CID-analysis of these series of deprotonated molecules, in order to 
further confirm their exact structures.   
 It is important to note that the SORI product ion scan of the precursor deprotonated 
molecules of LipA1 at m/z 1796.2228 was not successful, as regrettably this was due to the 
low count abundance of species which deceptively refused to MS/MS fragment. The 
product ion scan of the deprotonated LipA2 molecules at m/z 1716.2610 gave the product 
ions at m/z 1488.0460, m/z 1243.8380, and m/z 1035.6578. The product ion at m/z 1488.08 
was assigned as the [M2-(C14:0)acid-H]
- ion, which was created by elimination of myristic 
acid form the branched fatty (C14:0(3-O-C14:0)) acid acyl group located at O-3ʹ (-228 Da). 
The product ion at m/z 1243.8380 was assigned as the [M2-(C14:0(3-O-C14:0))acid-H2O-
H]- ion, which was created by elimination of the branched fatty (C14:0(3-O-C14:0)) acid 
acyl group located at O-3ʹ (-454 Da) and a molecule of water. The product ion at m/z 
1035.6578 was assigned as the [M2-(C14:0(3-O-C14:0))ketene-(C14:0)(3-OH)acid-H]
- 
ion, which was created by the elimination of the branched fatty (C14:0(3-O-C14:0)) acid 
acyl group located at O-3ʹ (-436 Da) and 3-hydroxy-myristic acid (C14:0(3-OH)) (-244 Da) 
located at the position O-3 (Figure 4.2.5, Scheme 4.1.3 and Table 4.1.3) (El-Aneed et al., 
2006, Shaffer et al., 2007, Lukasiewicz et al., 2010, John et al., 2014, and Brodbelt et al., 
2014). 
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Figure 4.2.5: SORI-CID-MS/MS of the precursor deprotonated [M2-H]-  molecules at m/z 
1716.2610. 
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Figure 4.2.6: SORI-CID-MS/MS of the precursor deprotonated [M3-H]-  molecules at m/z 
1688.2253. 
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The product ion scan of the deprotonated LipA3 molecules at m/z 1688.2253 gave 
the product ions at m/z 1488.0382, m/z 1243.8451 and m/z 1035.6577 (Figure 4.2.6, Table 
4.1.4, and Scheme 4.1.4). The product ion at m/z 1488.0382 was assigned as the [M3-
(C12:0)acid-H]- ion, which was created by the elimination of the lauryl acid (-200 Da) from 
the branched fatty (C14:0(3-O-C12:0)) acid located on N-2ʹ. The product ion at m/z 
1243.8451 was assigned as the [M3-(C14:0(3-O-C12:0)acid)acid-H2O-H]
- ion, which was 
created by the elimination of the branched fatty (C14:0(3-O-C12:0)) acid acyl group 
located at O-3ʹ (-426 Da) and a molecule of water. The product ion at m/z 1035.6577 was 
assigned as the [M3-(C14:0(3-O-C12:0))ketene-(C14:0)(3-OH)acid-H]
- ion, which was 
created by elimination the branched fatty (C14:0(3-O-C12:0)) acyl group located at O-3ʹ (-
408 Da) and 3-hydroxy-myristic acid (C14:0(3-OH)) (-244 Da) located at the position O-
3.  
The product ion scan of the precursor deprotonated molecules of LipA4 m/z 
1506.0530 gave the major product ion at m/z 1261.8399.  This product ion was assigned as 
[M4-(C14:0(3-OH)acid-H]
- ion, which was formed by the elimination of 3-hydroxy-
myristic acid (-244 Da) from the precursor ion located either at the O-3 and O-3′ positions 
located respectively in the reducing end or non-reducing end of the lipid A (Figure 4.2.7, 
Table 4.1.5 and Scheme 4.1.5) (El-Aneed et al., 2006, Shaffer et al., 2007, Lukasiewicz et 
al., 2010, John et al., 2014, and Brodbelt et al., 2014). 
 The product ion scan of the deprotonated LipA5 molecules at m/z 1359.8180 gave 
the product ions at m/z 1261.8420, m/z 1115.6120, m/z 1035.6676, and m/z 1017.6390 
(Figure 4.2.8, Table 4.1.6, and Scheme 4.1.6).  
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Figure 4.2.7: SORI-CID-MS/MS of the precursor deprotonated [M4-H]- molecules at m/z 
1506.0530.  
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Figure 4.2.8: SORI-CID-MS/MS of the precursor deprotonated [M5-H]- molecules at m/z 
1359.8180. 
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The product ions at m/z 1261.8349 was assigned as [M5-H2PO4-H]
- ion, and it was formed 
by the elimination of the neutral H3PO4 (-98 Da) moiety. The product ion at m/z 1115.6120 
was assigned as [M5-(C14:0)(3-OH)acid-H]
- ion, and it was formed by the elimination of 
3-hydroxy-myristic acid (-244 Da) from the precursor ion located either at the O-3. The 
product ion m/z 1035.6676 was assigned as [M5-(C14:0)(3-OH)acid-HPO3-H]
- ion. It was 
formed by the elimination of 3-hydroxy-myristic acid (-244 Da) from the precursor ion 
located either at the O-3, and the neutral HPO3 (-80 Da) moiety. The product ion at m/z 
1017.6390 created by the loss of a molecule of water from the product ion at m/z 1035.6676 
(El-Aneed et al., 2006, Shaffer et al., 2007, Lukasiewicz et al., 2010, John et al., 2014, and 
Brodbelt et al., 2014). 
 Additionally, the product ion scan of LipA6 at m/z 1279.8489 afforded the product 
ion at m/z 1035.6678. The product ion at m/z 1035.6678 was assigned as [M6-(C14:0)(3-
OH)acid-H]- ion. It was formed by the elimination of 3-hydroxy-myristic acid (-244 Da) 
from the precursor ion located either at the O-3 (Figure 4.2.9, Table 4.1.7 and Scheme 
4.1.7) (El-Aneed et al., 2006, Shaffer et al., 2007, Lukasiewicz et al., 2006, John et al., 
2014, and Brodbelt et al., 2014). 
 The product ion scan of deprotonated molecules of LipA7 at m/z 1097.6930 gave 
the product ion at m/z 853.4835 which was assigned as the [M7-(C14:0)acid-H]
- ion. It was 
created by the elimination of 3-hydroxy-myristic acid (C14:0(3-OH)) (-244Da) located at 
the position O-3 of the reducing GlcN end of the lipidA7 disaccharide (Figure 4.2.10, Table 
4.1.8 and Scheme 4.1.8). 
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Figure 4.2.9: SORI-CID-MS/MS of the precursor deprotonated [M6-H]- molecules at m/z 
1279.8489. 
 
 
 
 
 223 
 
 
 
 
Figure 4.2.10: SORI-CID-MS/MS of the precursor deprotonated [M7-H]- molecules at 
m/z 1097.6930. 
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Similarly, the product ion scan of deprotonated molecules of LipA8 at m/z 
1053.6583 gave the product ion at m/z 843.4829 which was assigned as [M8-(C14:0)keten-
H]- ion. It was formed by the elimination of the myristic acid (-210 Da) from the branch 
(Cl2:0(3-O-C14:0)) fatty acids which was attached to the N-2ʹ position (Figure 4.2.11, 
Table 4.1.9 and Scheme 4.1.9) (El-Aneed et al., 2006, Shaffer et al., 2007, Lukasiewicz et 
al., 2010, John et al., 2014, and Brodbelt et al., 2014). 
SORI-CID-MS/MS of the deprotonated molecules at m/z 892.5979, which was 
assigned previously as [C-(C14:0)ketene-H]-, gave the product ion at m/z 648.3949 (Figure 
4.2.12, Table 4.1.10, Scheme 4.10). The product ion at m/z 648.3949 was assigned as the 
[C-(C14:0)ketene-(C14:0(3-OH))acid-H]- ion and it was formed by the elimination of the 
3-hydroxy-myristic acid (C14:0(3-OH)) (-244 Da) from the O-3 of the precursor ion.  
 The deprotonated molecules at m/z 710.4259, which were assigned previously as 
[Y-H]-, gave the product ion at m/z 466.2219 which was assigned as [Y-(C14:0(3-
OH))acid-H]- ion, and it was formed by the elimination of the 3-hydroxy-myristic acid 
(C14:0(3-OH)) (-244 Da) from the O-3 position of the precursor ion (Figure 4.2.13, Table 
4.1.11 and Scheme 4.1.11) (El-Aneed et al., 2006, Shaffer et al., 2007, Lukasiewicz et al., 
2010, John et al., 2014, and Brodbelt et al., 2014).  
 The SORI-CID-MS/MS of the precursor deprotonated [C-(C14:0(3-O-
C14:0))ketene-H]- molecule at m/z 666.4013 gave the product ions at m/z 648.3239 and m/z 
438.2216 (Figure 4.2.11, Table 4.1.12 and Scheme 4.1.12). The product ions m/z 648.3239 
was described previously as just a loss of a molecule of water.  
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Figure 4.2.11: SORI-CID-MS/MS of the precursor deprotonated [M8-H]- molecules at 
m/z 1053.6583. 
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Figure 4.2.12: SORI-CID-MS/MS of the precursor deprotonated [C-(C14:0)ketene-H]- molecules 
at m/z 892.5979. 
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Figure 4.2.13: SORI-CID-MS/MS of the precursor deprotonated [C-(C14:0)ketene-
(C12:0)Ketene-H]- molecules at m/z 710.4259. 
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Figure 4.2.14: SORI-CID-MS/MS of the precursor deprotonated [C-(C14:0(3-O-
C14:0))ketene-H]- molecules at m/z 666.4013. 
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The product ion at m/z 438.2216 was assigned as [C-(C14:0(3-O-C14:0))ketene-
(C14:0)acid-H]- ion. It was formed by the elimination of a myristic acid (-228 Da), which 
was located at N-2 position of the precursor ion. 
  The SORI-MS/MS of the precursor ion at m/z 666.4013 and its associated product 
ions strongly confirm our suggested structures of the LipA1-8 (El-Aneed et al., 2006, 
Shaffer et al., 2007, Lukasiewicz et al., 2010, John et al., 2014, and Brodbelt et al., 2014). 
 
4.3.3. Comparison between low-energy CID-QqQ-MS/MS and SORI-
CID-MS/MS of the deprotonated molecules obtained from the mixture 
of lipid An isolated from the LPS of A. hydrophilla SJ-55a  
 
 
As discussed in the chapter 3 sections 3.3.3, we have made a comparison between 
the CID-MS/MS analyses with the QqQ-MS/MS and SORI-MS/MS. We have noticed that 
the number of distinctive product ions decreased with SORI-MS/MS analyses, when 
compared to CID-MS/MS analyses with the QqQ-mass spectrometer instrument. As in all 
of the previous schemes (4.1.2 – 4.1.8), we have noticed that all of the product ions obtained 
from SORI-CID-MS/MS were produced by the primary fatty acid fragmentation only. 
There were no CID-fragmentation from the branched fatty acyl groups and it was noted 
that most eliminations occurred from the O-3 and O-3ˊ positions. The reasons for the 
obtained differences in product ions formation are the same as these presented in section 
3.3.3. 
 230 
 
4.4. High-energy MALDI-TOF-MS analysis of the extracted mixture of 
lipid An isolated from the LPS of A. hydrophilla SJ-55a  
 
 
The MALDI-TOF-MS (- ion mode) of the lipid A obtained from A. Hydrophilla SJ-
55a was measured in the reflector mode with the TOF/TOF instrument and high laser 
power. Similarly, MALDI-MS shows similar spectra to the ones measured with the ESI-
QqQ-MS and FTICR-MS instruments. Accordingly, we have assigned for this lipid A 
mixture, the original seven common structures of the lipid A as suggested previously in 
sections: 4.2 and 4.3. They were assigned to different [M-H]- deprotonated di-
phosphorylated molecules LipA1 at m/z 1796.2088 and LipA5 at m/z 1359.8615, and mono-
phosphorylated molecules LipA2 at m/z 1716.2569, LipA3 at m/z 1688.2145, LipA4 at m/z 
1506.0499, LipA6 at m/z 1279.8615, and LipA7 at m/z 1097.6426 (Figure 4.3.1, Scheme 
4.1.1 and Table 4.1.1) (Kussak et al., 2002, El-Aneed et al., 2006, Shaffer et al., 2007, 
Lukasiewicz et al., 2010, and Brodbelt et al., 2014). 
In MALDI-TOF-mass spectrum, we noticed that the deprotonated molecules 
assigned to the LipA6 at m/z 1279.8432 were the most abundant in the mass spectrum. It is 
important to note that there was no observation of the deprotonated molecules as being 
created by the[C-H]- or [Y-H]- ion in the MALDI-TOF-MS, as illustrated in (Figure 4.3.1). 
In order to examine the difference in CID-gas-phase fragmentations between the low-
energy-CID-QqQ-MS/MS and the SORI-CID-FTICR-MS/MS analysis, we subjected this 
series of deprotonated molecules to a detailed analysis of the high energy CID-TOF/TOF-
MS/MS analysis.  
 231 
 
 
 
 
F
ig
u
re
 4
.3
.1
: 
M
A
L
D
I-
T
O
F
-M
S
 (
- 
io
n
 m
o
d
e)
 o
f 
th
e 
n
at
iv
e 
li
p
id
 A
n
 m
ix
tu
re
 e
x
tr
ac
te
d
 f
ro
m
 
A
. 
h
yd
ro
p
h
il
la
 S
J-
5
5
a.
 
 
 232 
 
4.4.1. High-energy MALDI-CID-TOF/TOF-MS/MS analysis of the 
extracted mixture of lipid An isolated from the LPS of A. hydrophilla SJ-
55a 
 
These series of deprotonated molecules were subjected to high-energy CID-
TOF/TOF-MS/MS, and the structures of the obtained product ions were deduced as 
previously described in the low-energy CID-QqQ-MS/MS and SORI-CID-FTICR-MS/MS 
described in section 4.2 and 4.3.  
High-energy CID-TOF/TOF-MS/MS of the deprotonated molecules LipA1 at m/z 
1796.2088 is illustrated in (Figure 4.3.2, Tables 4.1.2, and Scheme 4.1.2). This product ion 
scan of LipA1 produced the product ions at m/z 1506.0529, m/z 1488.0465, and m/z 
1279.8498. The product ion at m/z 1506.0529 was assigned as [M1-(C14:0)ketene-HPO3-
H]- ion. It was created by the loss of a myristic ketene (-210 Da) from the branched fatty 
(C14:0(3-O-C14:0)) located at O-3ʹ positions and neutral HPO3 (-80 Da) located at O-1. 
The product ion at m/z 1488.0465 was created by extra losses of a molecule of water from 
the product ion at m/z 1506.0529. The last product ion at m/z 1279.8498 was assigned as 
[M1-(C14:0(3-O-C14:0))ketene-HPO3-H]
-. It was formed by the elimination of the 
consecutive losses of the branched fatty (C14:0(3-O-C14:0)) located on position O-3ʹ (-436 
Da) and by the elimination of the neutral HPO3 (-80 Da) moiety located at O-1 (Kussak et 
al., 2002, El-Aneed et al., 2006, Shaffer et al., 2007, Lukasiewicz et al., 2010, and Brodbelt 
et al., 2014). 
 High-energy CID-TOF/TOF-MS/MS of the deprotonated molecules LipA2 at m/z 
1716.2569 is illustrated in (Figure 4.3.3, Tables 4.1.3, and Scheme 4.1.3).  
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Figure 4.3.2: High-energy CID-TOF/TOF-MS/MS of the precursor ion [M1-H]-  ion at m/z 
1796.2088. 
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Figure 4.3.3: High-energy CID-TOF/TOF-MS/MS of the precursor ion [M2-H]-  ion at m/z 
1716.2569. 
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 The product ion scan of the deprotonated LipA2 molecules gave the product ions at 
m/z 1488.0234, m/z 1444.9687, and m/z 1243.8512. The product ion at m/z 1488.0234 was 
assigned as the [M2-(C14:0)acid-H]
- ion, which was created by the elimination of myristic 
acid form the branched fatty (C14:0(3-O-14:0)) acid acyl group located at O-3ʹ (-228 Da). 
The product ions at m/z 1444.9687 is created by extra losses of n-propane (-44 Da) from 
the alkyl chain (C14:0) located at N-2ʹ.The product ion at m/z 1243.8512 was assigned as 
was assigned as [M2-(C14:0)acid-(C14:0(3-OH))acid-H]
- ion. It was formed by 
consecutive losses of a 3-hydroxyl myristic acid (-244 Da), which was located at O-3 
position, and a myristic acid form the branched fatty (C14:0(3-O-C14:0)) acid acyl group 
located at O-3ʹ (-228 Da) from the precursor ion at m/z 1716.2569 (Kussak et al., 2002, El-
Aneed et al., 2006, Shaffer et al., 2007, Lukasiewicz et al., 2010, and Brodbelt et al., 2014). 
 High-energy CID-TOF/TOF-MS/MS of the deprotonated molecules LipA3 at m/z 
1688.2145 is illustrated in (Figure 4.3.4, Tables 4.1.4, and Scheme 4.1.4). The production 
scan of the deprotonated LipA3 molecules gave the product ions at m/z 1488.0403 m/z 
1444.9765, and m/z 1243.8520. The product ion at m/z 1488.0403 was assigned as the [M2-
(C12:0)acid-H]- ion, which was created by the elimination of the lauryl acid (-200 Da) from 
the branched fatty (C14:0(3-O-12:0)) acid located on N-2ʹ.The product ions at m/z 
1444.9765 was assigned as [M3-(C14:0(3-OH)acid-H]
- ion. It was created by the loss of a 
3-hydroxyl myristic acid (-244 Da), which was located at O-3 position of the LipA3.  
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Figure 4.3.4:  High-energy CID-TOF/TOF-MS/MS of the precursor ion [M3-H]-  ion at m/z 
1688.2145. 
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The product ion at m/z 1243.8520 was assigned as [M3-(C14:0(3-O-12:0))acid-H2O-H]
- 
ion, and it was formed by the consecutive losses of the branched fatty (C14:0(3-O-C12:0)) 
acid (-426 Da) located on position O-3ʹ and a molecule of water from the precursor ion at 
m/z 1688.2145 (Kussak et al., 2002, El-Aneed et al., 2006, Shaffer et al., 2007, 
Lukasiewicz et al., 2010, and Brodbelt et al., 2014). 
 High-energy CID-TOF/TOF-MS/MS of the deprotonated molecules LipA4 at m/z 
1506.0499 is illustrated in (Figure 4.3.5, Tables 4.1.5, and Scheme 4.1.5). The product ion 
scan of the deprotonated LipA4 molecules gave the product ions at m/z 1488.0420, m/z 
1261.8501, m/z 1243.8511, and m/z 1035.6614. The product ion at m/z 1488.0420 was 
obtained by the loss of a molecule of water from the precursor ion. The product ions at m/z 
1261.8501 was assigned as [M4-(C14:0(3-OH)acid-H]
- ion. It was formed by the 
elimination of 3-hydroxy-myristic acid (-244 Da) from the precursor ion. This elimination 
could in fact occur from either at the O-3 and O-3′ positions; located respectively in the 
reducing end or non-reducing end of the lipid A disaccharide backbone. The product ion at 
m/z 1243.8511 was assigned as [M4-(C14:0(3-OH))acid-H2O-H]
- ion, and it was formed by 
the consecutive losses of a molecule of water and 3-hydroxy-myristic acid (-244 Da). It can 
in fact occur from either at the O-3 and O-3′ positions located respectively in the reducing 
end or non-reducing end of the lipid A disaccharide backbone (Kussak et al., 2002, El-
Aneed et al., 2006, Shaffer et al., 2007, Lukasiewicz et al., 2010, and Brodbelt et al., 2014). 
The product ion at m/z 1035.6614 was assigned as [M4-(C14:0(3-OH))acid-(C14:0(3-
OH))ketene-H]- ion.  
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Figure 4.3.5: High-energy CID-TOF/TOF-MS/MS of the precursor ion [M4-H]-  ion at m/z 
1506.0499. 
 
 
 
 
 239 
 
It was formed by the consecutive losses of the 3-hydroxy-myristic acid (-244 Da) and the 
3-hydroxy-myristic ketene (-226 Da), which can in fact occur from either at the O-3 and 
O-3′ positions; located respectively in the reducing end or non-reducing end of the lipid A 
disaccharide backbone (Kussak et al., 2002, El-Aneed et al., 2006, Shaffer et al., 2007, 
Lukasiewicz et al., 2010, and Brodbelt et al., 2014). 
High-energy CID-TOF/TOF-MS/MS of the deprotonated molecule LipA5 at m/z 
1359.8615 is illustrated in (Figure 4.3.6, Tables 4.1.6, and Scheme 4.1.6). The product ion 
scan of the deprotonated LipA5 molecules gave the product ions at m/z 1262.8510, m/z 
1115.6097 and m/z 1085.5630. The product ion at m/z 1261.8510 was assigned as [M5-
H2PO4-H]
-, which was created by the loss of H3PO4 (-98 Da). The product ion at m/z 
1115.6097 was assigned as [M5-(C14:0)(3-OH)acid-H]
- ion, and it was formed by the 
elimination of 3-hydroxy-myristic acid (-244 Da) from the precursor ion located at O-3. 
The product ion at m/z 1085.5630 was assigned as [M5-(C12:0)acid-(C4H8)-H2O-H]
- ion. It 
was formed by the consequent elimination of a water molecule, (C4H8) (-56 Da) as part of 
the fatty acid chain properly located at O-3 position, and the lauryl acid (-200 Da) from the 
branched fatty (C14:0(3-O-12:0)) acid located on N-2ʹ (Kussak et al., 2002, El-Aneed et 
al., 2006, Shaffer et al., 2007, Lukasiewicz et al., 2010, and Brodbelt et al., 2014). 
High-energy CID-TOF/TOF-MS/MS of the deprotonated molecules LipA6 anion at 
m/z 1279.8432 is illustrated in (Figure 4.3.7, Tables 4.1.7, and Scheme 4.1.7). The product 
ion scan of the deprotonated LipA6 molecules gave the product ions at m/z 1035.6598, m/z 
913.4996, m/z 817.4598 and m/z 666.3897 (Kussak et al., 2002, El-Aneed et al., 2006, 
Shaffer et al., 2007, Lukasiewicz et al., 2010, and Brodbelt et al., 2014).  
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Figure 4.3.6: High-energy CID-TOF/TOF-MS/MS of the precursor ion [M5-H]-  ion at m/z 
1359.8615. 
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Figure 4.3.7: High-energy CID-TOF/TOF-MS/MS of the precursor ion [M6-H]-  ion at 
m/z 1279.8432. 
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The product ion at m/z 1035.6598 was assigned as the [M6-(C14:0(3-OH))acid-H]
- ion, 
which was created by the elimination of 3-hydroxy-myristic acid (C14:0(3-OH)) (-244 Da) 
located at the position O-3 of the reducing GlcN end. The product ion at m/z 913.4996 was 
assigned as [M6-(C14:0(3-OH))ketene-(C10H20)-H]- ion, which was created by the 
elimination of 3-hydroxy-myristic ketene (C14:0(3-OH)) (-226 Da) located at the position 
O-3, and n-(C10H20) as a part of the fatty acid located in N-2ʹ(-140 Da). The last product 
ion at m/z 666.3897 was assigned as [C-H]- as the mono-phosphorylated D-GlcN species 
containing one branched (Cl4:0(3-O-C12:0)) fatty acyl group on the N-2 position (Scheme 
4.1.1) (Kussak et al., 2002, El-Aneed et al., 2006, Shaffer et al., 2007, Lukasiewicz et al., 
2010, and Brodbelt et al., 2014). 
High-energy CID-TOF/TOF-MS/MS of the deprotonated molecules LipA7 at m/z 
1097.6426 is illustrated in (Figure 4.3.8, Tables 4.1.8, and Scheme 4.1.8). The product ion 
scan of the deprotonated LipA7 molecules gave the product ions at m/z 852.4797 and m/z 
527.2520. The product ion at m/z 852.4797 was assigned as the [M7-(C14:0) acid-H2O-H]
- 
ion, which was created by the elimination of a myristic acid (C12:0(3-O-C14:0)) (-244 Da) 
located at the position N-2ˊ of the non-reducing GlcN end of the LipA7 disaccharide, and a 
molecule of water. The product ion m/z 693.4959 was assigned as the [M7-(C14:0)ketene-
2H2PO4-H]
- ion. It was created by the elimination of a myristic ketene (C12:0(3-O-C14:0)) 
(-208 Da) located at the position N-2ˊ of the non-reducing GlcN end of the LipA7 
disaccharide, and a two neutral H3PO4 (-196 Da) moiety (as shown in Figure 4.3.8) (Kussak 
et al., 2002, El-Aneed et al., 2006, Shaffer et al., 2007, Lukasiewicz et al., 2010, and 
Brodbelt et al., 2014). 
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Figure 4.3.8: High-energy CID-TOF/TOF-MS/MS of the precursor ion [M7-H]- ion at 
m/z 1097.6426. 
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4.4.2. Comparison between low-energy CID-QqQ-MS/MS and high-
energy CID-TOF-TOF-MS/MS  
 
 
 Similarly, to Chapter 3 in section 3.4.2, when we compared between the MALDI-
CID-TOF/TOF-MS/MS analysis and the ESI-CID-QqQ-MS/MS, we have noticed that the 
number of distinctive product ions decreased with MALDI-CID-TOF/TOF analysis which 
was probably due the number of collisions. We have noticed that all the of the product ions 
which obtained from MALDI-CID-TOF/TOF just like SORI-CID-MS/MS were produced 
by the primary fatty acid fragmentation not the branched, most of the time the elimination 
occur at O-3 and O-3ˊ position (Schemes 4.1.2 - 4.1.8 and Tables 4.1.2 - 4.1.8). Once more, 
we have attributed this anomaly to the high-energy CID that leads to few collisions of the 
precursors. Also, the high kinetic energy of the ions leads to shorter time scale for 
dissociation (few microseconds).  
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4.5. Summary 
The deprotonated molecules obtained from this heterogeneous mixture of lipid An 
were investigated by tandem mass spectrometry using low-energy collision SORI-CID-
MS/MS (tandem in time) and CID-MS/MS (tandem in space) instruments. Likewise, The 
MALDI-CID-TOF/TOF-MS/MS, CID-QqQ, and SORI-FTICR-MS/MS fragmentation 
studies of the different lipid A1-6 have shown the presence of diagnostic and unique C-C 
heterolytic fragmentation of the fatty acid chains. 
We have noticed that the SORI-MS/MS spectra of the various precursor 
deprotonated molecules were much simpler than those of the acquired CID-MS/MS with 
the MALDI-TOF/TOF and QqQ-instrument.  
The combined MS/MS studies indicate that all the proposed structures of the lipid 
A1 to A8 contain two phosphate groups at the position O-1 and O-4ʹ. They were built by a 
β-D-GlcpN-(1→6)-α-D-GlcpN disaccharide blueprint. the lipid A backbone disaccharide 
was substituted with (C14:0(3-OH)) at the O-3, O-3ˊ and N-2 positions, and (C12:0(3-OH)) 
at N-2ˊposition, which contain different substitution permutations with (C12:0(3-O-
C14:0)) at the N-2´ position, and (C14:0(3-O-C14:0)) at the O-3´ position (Scheme 4.1.1).  
The presence of this mixture series of lipid An isolated from SJ-55a in the ESI- and 
MALDI-MS spectra is good indicator to incomplete biosynthesis of lipid A. Also, the 
presence of the monosaccharide backbone was reported in all of them, such as the 
deprotonated molecules at m/z 892, m/z 710,40 and m/z 666.55. 
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 In conclusion, the interaction between the bacteria and the bacteriophages lead to 
some mutation which leads to incomplete lipid A biosynthesis, due to the disruption in core 
biosynthesis process occurring at different stages. Such structural aberrations could affect 
bacteriophage adsorption which could increases the resistance of the bacteria to the 
bacteriophages. 
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Chapter 5 
Mass Spectral analysis of the mixture of Lipid An isolated from the LPS 
of A. salmonicida SJ-113 
Aeromonas Salmonicida is a genus of Gram-negative, anaerobic homogeneous in 
cultural and biochemical characteristics. Aeromonas Salmonicida is considered as one of 
the oldest described fish pathogens, and causes the disease known as furunculosis (ex. 
ulcers and tail rot in fish) in cultured pond-fish and salmonids (Brisson et al., 2004). First, 
its genus was belonged to the Gram-negative of the family Pseudomonadaceae. Then, it 
was transferred to the family of Vibrionaceae. Then consequently to its own family which 
is Aeromonadaceae (Austin 2011, and Chart et al., 1984). The LPS of SJ-113a was 
obtained from the rough mutant Gram-negative bacteria A. salmonicida grown in the 
presence of phage and it was classified as phage resistant.  
 
5.1. Gas chromatography-mass spectrometry (GC-MS) of the fatty 
methyl ester released from the lipid An mixture isolated from the LPS of 
the A. salmonicida SJ-113 
 
The qualitative analysis of fatty acids was carried out by GC-MS to identify 
separately the amide and the ester-bound fatty acids. The (R)-3-hydroxytetradecanoic acid 
(C14:0(3-OH)) was identified as an amide-linked fatty acid, whereas the (R)-3-
hydroxytetradecanoic acid (C14:0(3-OH)) (3-hydroxymyristic acid) and dodecanoic acid 
(C12:0) (lauric acid) were identified as amide-linked fatty acids (Perry et al., 1979, Rebeil 
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et al., 2004, and Almostafa et al., 2016). In addition to the methyl ester derivative of 3-
methoxytetradecanoic acid, the fatty acid methyl esters obtained by trans-esterification with 
sodium methoxide also showed the presence of the (C14:0(3-OH)) acid, which was 
substituted by dodecanoic acid (lauric acid) (C12:0) in the native lipid A. The absolute 
configuration of the GlcN residues in lipid A was determined as D on the deacylated, 
dephosphorylated lipid A fraction, using (R)-2-butanol (M. Almostafa., et al 2016).  
 
5.2. ESI-QqQ-MS analysis of the extracted mixture of lipid An isolated 
from the LPS of A. salmonicida SJ-113a  
 
   The A. salmonicida SJ-113a bacteria dissolved in chloroform and methanol was 
electrosprayed in the negative ion mode. The ESI-QqQ-ToF-MS is shown in (Figure 5.1.1). 
The lipid An component of the A. salmonicida SJ-113a bacteria is not merely composed of 
a single lipid A entity. In reality, it is a complex mixture of many structurally-related 
components produced by the incomplete biosynthesis of this lipid A. 
 The ESI-QqQ-MS (- ion mode) of the lipid An (where n=1-6). mixture showed the 
presence of inter-alia seven different fragment ions at m/z 1768.20, m/z 1688.17, m/z 
1586.12, m/z 1506.09, m/z 1359.79, m/z 1279.89, and m/z 892.55. This indicates the 
presence of a heterogeneous mixture of lipid An assigned by the [Mn-H]
- molecules 
(Scheme.5.1.1).  
 We have assigned these fragment ions as the series of [Mn-H]
- deprotonated mono-
phosphorylated molecules, and assigned as deprotonated di-phosphorylated molecules. The 
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deprotonated di-phosphorylated molecules are m/z 1768.20, m/z 1586.12 and m/z 1359.79. 
The rest are assigned as deprotonated mono-phosphorylated molecules m/z 1688.17, m/z 
1506.09, m/z 1279.89, and m/z 892.50 represented as the following: LipA1 at m/z 1768.20, 
LipA2 m/z 1688.17, LipA3 at m/z 1586.12, LipA4 at m/z 1506.09, LipA5 at m/z 1359.79, and 
LipA6 at m/z 1279.89 (Figure 5.1.1, Scheme 5.1.1, and Table 5.1.1). For simplification, we 
have tied this series of analyzed deprotonated [C-H]- ion molecules to previously 
nomenclature adopted in sections 3.2. and 4.2. It is important to note that our tentative 
structural assignments of this series of deprotonated molecules have relied on comparison 
with well know Lipid A structures by a manual and expert-driven process. This was done 
without help of any software such as LipidView™ Software produced by Sciex.  
           Based on well-known literature, the structures of the heterogeneous lipid An mixture 
may contain phosphate groups, which can be located on the O-4ʹ and O-1 positions of the 
β-D-GlcpN-(1→6)-α-D-GlcpN disaccharide backbone of lipid A. Also, the 3-hydroxy-
myristic acid (C14:0(3-OH)) fatty acid chains that acylate the various free positions of the 
β-D-GlcpN-(1→6)-α-D-GlcpN backbone of the fully biosynthesized lipid An. These fatty 
acid chains were certainly attached to the O-3, O-3ʹ, N-2 and N-2ʹ positions of this lipid A. 
Also, it is proposed that the two of these (C14:0(3-OH)) fatty acyl groups are substituted 
with a lauric acid (Cl4:0(3-O-C12:0)) fatty acyl groups, which are probably located on the 
O-3 position at the reducing end, and N-2ʹ positions of the non-reducing end group of the 
β-D-GlcpN-(1→6)-α-D-GlcpN disaccharide backbone of this lipid An mixture (Scheme 
5.1.1) (Lukasiewicz et al., 2010, Banoub et al., 2010, Kilár et al., 2013, Brodbelt et al., 
2014, and Almostafa et al., 2016). 
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 The deprotonated molecule [M1-H]
- LipA1 at m/z 1768.20 was assigned as the di-
phosphorylated hexa-acylated forms carrying four primary 3-hydroxy-myristic acid 
(C14:0(3-OH)) fatty acids, in which two of them were substituted by lauric acids forming 
the branched fatty acids (Cl4:0(3-O-C12:0)). This series of fatty acyl groups can be 
distributed on the O-3, O-3ʹ, N-2, and N-2ʹ position, not necessarily in that order (Scheme 
5.1.1).  
         The deprotonated molecule [M2-H]
- of LipA2 at m/z 1688.17 was attributed to the 
mono-phosphorylated hexa-acylated molecules. Accordingly, we presume that this 
molecule was formed by four (C14:0(3-OH)) 3-hydroxy-myristic acids in which two of 
these fatty acids were esterified with two separate molecules of lauric acid (C12:0) at the 
3-hydroxyl position of (C14:0(3-OH)) myristic acids. Once more, by comparing with other 
known structures of lipid A these two branched (Cl4:0(3-O-C12:0)) fatty acids are probably 
located on the O-3 position of the reducing end, and N-2ʹ positions of the non-reducing end 
group of the LipA2 disaccharide backbone (Scheme 5.1.1). 
 The deprotonated molecules LipA3 at m/z 1586.12 was assigned as the di-
phosphorylated penta-acylated form of the β-D-(1→6)-Glucosamine disaccharide carrying 
four primary 3-hydroxy-myristic acid (C14:0(3-OH)) fatty acids, in which one of them was 
substituted by lauric acids forming the branched fatty acids (Cl4:0(3-O-C12:0)), which we 
tentatively assigned to be located at N-2ʹ of the non-reducing end residue of β-D-GlcpN-
(1→6)-α-D-GlcpN disaccharide of LipA3. 
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Figure 5.1.1: ESI-QqQ-MS of the native lipid An extract from the LPS of A. salmonicida SJ-
113a. 
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 The deprotonated molecules LipA4 at m/z 1506.09 was assigned as the mono-
phosphorylated penta-acylated form of the β-D-(1→6)-Glucosamine disaccharide carrying 
four primary 3-hydroxy-myristic acid (C14:0(3-OH)) fatty acids, in which one of them was 
substituted by lauric acids forming the branched fatty acids (Cl4:0(3-O-C12:0)), which we 
tentatively assigned to be located at N-2ʹ of the non-reducing end residue of β-D-GlcpN-
(1→6)-α-D-GlcpN disaccharide of LipA4. 
 The deprotonated molecule of LipA5 [M5-H]
- at m/z 1359.79 was assigned as 
containing a di-phosphorylated tri-acylated form of the β-D-GlcpN-(1→6)-α-D-GlcpN 
disaccharide carrying three primary 3-hydroxy-myristic acid (C14:0(3-OH)) fatty acids, in 
which one of them was substituted by lauric acids forming the branched fatty acids 
(Cl4:0(3-O-C12:0)), probably located at the N-2ʹ position of this lipid A.  
           The deprotonated molecule of LipA6 [M6-H]
- at m/z 1279.89 was assigned as 
containing a mono-phosphorylated tri-acylated form of the β-D-GlcpN-(1→6)-α-D-GlcpN 
disaccharide carrying three primary 3-hydroxy-myristic acid (C14:0(3-OH)) fatty acids, 
and the other one was substituted by lauric acids forming the branched fatty acids (Cl4:0(3-
O-C12:0)), probably located at the N-2ʹ position of this lipid A. 
 In addition, we have also observed the deprotonated molecule at m/z 892.55 which 
was tentatively assigned as [C-(C14:0)ketene-H]-. This latter deprotonated molecule was 
attributed to the deprotonated molecule mono-phosphorylated D-GlcN species containing 
a 3-hydroxy-myristic (C14:0(3-OH)) fatty and a branched (Cl4:0(3-O-C12:0)) fatty acid 
group located on N-2 (Scheme 5.1.1).  
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At this stage, we have tentatively identified a series of complete and incomplete O-
3, O-3ʹ, N-2 and N-2ʹ acylated the β-D-GlcpN-(1→6)-α-D-GlcpN disaccharide backbone of 
the lipid A1-8 structures sharing common properties. We have identified the presence of two 
primary hydroxytetradecanoic acids (14:0(3-OH)) at N-2 and O-3 positions present on the 
β-D-GlcpN-(1→6)-α-D-GlcpN disaccharide backbone of this mixture of lipidA1-8. In 
addition, we have also proposed the presence of branched fatty acid (Cl4:0(3-O-C12:0)) at 
the positions O-3 and N-2ʹ.   
   The use of the low-energy collision dissociation tandem mass spectrometry analysis 
confirms our tentative assignments and the putative structures for the six deprotonated 
molecules LipA1 to LipA6 and the other various fragment ions. Domon and Costello 
carbohydrate nomenclature was used to define and characterize all the deprotonated 
molecules, which were produced by their gas-phase fragmentation in the ESI-MS and CID-
MS/MS analysis (Domon and Costello, 1988). 
   The glycosidic cleavage provides useful structural information and defends the 
sugar sequencing of the lipid A backbone (Domon and Costello., 1988, Banoub et al., 2010, 
Kilár et al., 2013, and Almostafa et al., 2016). 
 
5.2.1. Low-energy CID-MS/MS analysis of the extracted mixture of lipid 
An isolated from the LPS OF A. salmonicida SJ-113a using the QqQ-
MS/MS instrument 
 
The triple quadrupole (QqQ) instrument was used in this investigation using the 
low-energy CID-MS/MS (tandem-in-space) analysis, which conducted on the eight 
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different precursor [M-H]- deprotonated molecules at m/z 1768.20 (LipA1), m/z 1688.17 
(LipA2), m/z 1586.12 (LipA3), m/z 1506.09 (LipA4), m/z 1359.79 (LipA5), and m/z 1279.89 
(LipA6) (Figure 5.1.1). These precursor molecules afforded series of distinct and diagnostic 
product ions which produced by competitive hydrolysis of the primary and/or secondary 
fatty esters located on β-D-GlcpN-(1→6)-α-D-GlcpN disaccharide backbone of lipid A. It 
is well known that the ester-linked fatty groups at O-3 and O-3ʹ are more readily 
hydrolysable than the fatty acyl amide groups at N-2 and N-2ʹ (Banoub et al., 2010, Kilár 
et al., 2013). Also, the cleavages arising from the glycosidic bond followed by inter-ring 
bond cleavages (Domon and Costello., 1988).  
 The product ion scan of the deprotonated di-phosphorylated LipA1 molecules at m/z 
1768.20 allowed us to investigate the fatty acyl group distributions detected in ESI-QqQ-
MS analysis of LipA1 as shown in (Figure 5.1.2). The CID-MS/MS of the deprotonated 
molecules at m/z 1768.20 produced the following series of product ions at m/z 1532.95, m/z 
1279.81, m/z 1097.63, and m/z 803.49 (Figure 5.1.2, Scheme 5.1.2 and Table 5.1.2) 
(Lukasiewicz et al., 2010).  The product ion at m/z 1532.95 was assigned as the [M1-
2(H2O)-(C14:0)acid-H]
- ion, and it was created by the elimination of two molecules of 
water and myristic acid form the branched fatty (C14:0(3-O-C14:0) acid acyl group located 
at O-3 (-228 Da).  
 The product ion at m/z 1279.81 was formed by the consecutive losses of the 
branched fatty (C14:0(3-O-C12:0)) located on position O-3 (-408 Da), and by the 
elimination of the neutral HPO3 (-80 Da) moiety located at O-1 position. This product ion 
was assigned as [M1-(C14:0(3-O-C12:0))ketene-HPO3-H]
- ion (-488 Da).  
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 The product ion at m/z 1097.63 was formed by the elimination of a molecule of the 
branched fatty (C14:0(3-O-C12:0)) ketene (-408 Da) from the O-3 position, lauryl ketene 
molecule (-182 Da) from the branched fatty acids (C14:0(3-O-C12:0)) located on the N-2ʹ 
position, and by the elimination of the neutral HPO3 (-80 Da) located at O-1 position. This 
product ion was assigned as [M1-(C14:0(3-O-C12:0))ketene-(C12:0)ketene-HPO3-H]
- ion 
(as shown in Figure 5.1.2, Table 5.1.2, and Scheme 5.1.2). 
  The product ion at m/z 804.49 was formed by the glycosidic cleavages of the β-D-
GlcpN-(1→6)-α-D-GlcpN disaccharide backbone to afford the reducing D-GlcN-OH 
species. It was obtained by the consecutive losses of myristic (-228 Da) located at O-3 
position and a molecule of C5H10 (-70 Da), as part of the fatty acid chain properly located 
at N-2. This product ion was assigned as [C-(C14:0)acid-(C5H10)-H]
- ion.  
 This MS/MS studies supports our suggested structural assignments of the 
deprotonated molecule (LipA1), and indicates that the two H2PO3 groups are located at the 
O-1 and O-4ʹ position of the disaccharide backbone. It also confirms the presence of the 
two molecules of 3-hydroxyl myristic acids at the positions O-3, and N-2 of the reducing 
end of the disaccharide backbone, whereas the branched (C14:0(3-O-C12:0) fatty acids 
were located on O-3 positions of the reducing end, and N-2ʹ positions of the non-reducing 
end of the β-D-GlcpN-(1→6)-α-D-GlcpN disaccharide backbone of this lipid A1 (El-Aneed 
et al., 2006, Lukasiewicz et al., 2010, John et al., 2014, and Brodbelt et al., 2014).  
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Figure 5.1.2:  CID-MS/MS of the precursor deprotonated [M1-H]-  molecules at m/z 1768.20.⁕ 
 
 
 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other isobars 
isolated during the MS/MS analysis. 
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The product ion scan of the deprotonated mono-phosphorylated LipA2 molecules at m/z 
1688.17 afforded the product ions at m/z 1305.83, m/z 1243.79, m/z 1035.62 and m/z 710.43 
(Figure 5.1.3, Table 5.1.3 and Scheme 5.1.3). The product ion at m/z 1305.83 was assigned 
as the [M2-(C12:0)acid-(C12:0)ketene-H]
- ion, and it was generated by both eliminations 
of lauric acid (-200 Da) and lauryl ketene (-182 Da) from the precursor ion at m/z 1688.17. 
These two losses originated from both the branched fatty acids (C14:0(3-O-C12:0)) and 
(C14:0(3-O-C12:0)) fatty acyl groups located respectively O-3 positions of the reducing 
end, and N-2ʹ of the non-reducing of the disaccharide backbone of lipid A (Figure 5.1.3). 
Similarly, the product ion at m/z 1243.79 was assigned as [M2-(C14:0(3-O-12:0)))acid-
H2O-H]
- ion, and it was formed by the consecutive losses of the branched fatty (C14:0(3-
O-C12:0)) acid (-426 Da) located on position O-3 and a molecule of water from the 
precursor ion at m/z 1688.17.  
   The product ion of at m/z 1035.62 was assigned as [M2-(C14:0(3-O-12:0)))acid-
(C14:0(3-OH))ketene-H]- ion, and it was formed by the consecutive losses of the branched 
fatty (C14:0(3-O-C12:0)) acid (-426 Da) located at the O-3 position, and the 3-hydroxy-
myristic ketene (C14:0(3-OH)) (-226 Da) located at the position O-3ʹ.  
 The last product ion at m/z 710.43 was assigned as the [C-(C12:0)ketene-H]- ion, 
which was created by the elimination of a molecule of a lauryl ketene (-182 Da) from the 
branched fatty acids (C14:0(3-O-C12:0) which is located at N-2 (Figure 5.1.3, Table 5.1.3 
and Scheme 5.1.3). The structure of this product ion confirms the presence of the branched 
(C14:0(3-O-C12:0)) fatty acid ester group on the N-2ʹ position (El-Aneed et al., 2006, 
Lukasiewicz et al., 2010, John et al., 2014, and Brodbelt et al., 2014). 
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Figure 5.1.3: CID-MS/MS of the precursor deprotonated [M2-H]-  molecules at m/z 1688.17.⁕ 
 
 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other isobars 
isolated during the MS/MS analysis. 
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It is important to note that the obtained product ion scan of the deprotonated mono-
phosphorylated LipA2 molecules at m/z 1688.17 is completely different from the one 
obtained for the deprotonated molecule of LipA2 and LipA3 that were isolated from the lipid 
An SJ-19a (Chapter 3) and SJ-55a (Chapter 4). This indicated that the deprotonated 
molecules for m/z 1688 are indeed isobaric and have completely different structures.  
  The product ion scan of the deprotonated LipA3 molecules at m/z 1586.12 gave the 
series of product ions at m/z 1341.85, m/z 1261.81, m/z 1053.62, m/z 690.35 and m/z 630.49 
(Figure 5.1.4, Table 5.1.4, and Scheme 5.1.4). The product ion at m/z 1341.85 was assigned 
as the [M3-(C14:0(3-OH))acid-H]
-, and it was formed by the elimination of the 3-hydroxy-
myristic acid (C14:0(3-OH)) (-244 Da) located either at the position O-3 or O-3ʹ. The 
product ion at m/z 1261.81 was assigned as the [M3-(C14:0(3-OH))acid-HPO3-H]
- ion and 
was formed by elimination of the neutral HPO3 (-80 Da) moiety located at O-1 position, 
and the 3-hydroxy-myristic acid (C14:0(3-OH)) (-244 Da) located either at the position O-
3 or O-3ʹ. 
   The product ion m/z 1053.62 was assigned as the [M3-2(C14:0(3-OH))ketene-
HPO3-H]
- . It was formed by the elimination of the neutral HPO3 (-80 Da) moiety located 
at O-1 position, and two of the 3-hydroxy-myristic ketene (C14:0(3-OH)) (-226 Da) located 
at the position O-3 and O-3ʹ. The product ion at m/z 690.35 was assigned as [0,4A-(C14:0(3-
OH))acid-H]- produced by the cleavage of the non-reducing mono-phosphorylated D-
Glucose residue, and it was formed by the loss of a 3-hydroxy-myristic ketene molecule (-
244 Da) from the O-3 position. The product ion at m/z 630.49 was formed by the by 
consecutive elimination of neutral HPO3 (-80 Da) moiety located at O-4 position,  
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Figure 5.1.4: CID-MS/MS of the precursor deprotonated [M3-H]- molecules at m/z 1586.12. ⁕ 
 
 
 
 
 
 
 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other isobars 
isolated during the MS/MS analysis. 
 
 267 
 
 
 
P
ro
d
u
ct
 i
o
n
s 
o
f 
th
e 
d
ep
ro
to
n
a
te
d
 m
o
le
cu
le
s 
[M
3
-H
]-
  
a
t 
 m
/z
 1
5
8
6
.1
2
 
M
A
L
D
I-
T
O
F
/T
O
F
-M
S
/M
S
 
δ
 p
p
m
 
 
-2
.8
 
-4
.3
 
- 
5
.2
 
- - - 
m
/z
 
O
b
se
rv
ed
; 
C
a
lc
u
la
te
d
 
(%
) 
 
1
4
8
8
.0
4
6
5
; 
1
4
8
8
.0
4
2
3
 
(4
1
) 
1
3
4
1
.8
0
9
9
; 
1
3
4
1
.8
0
4
1
 
(1
0
0
) 
- 
1
2
4
3
.8
4
3
0
; 
1
2
4
3
.8
4
9
5
 
(3
9
) 
- - - 
E
S
I-
F
T
IC
R
-M
S
/M
S
 
 
δ
 p
p
m
 
 
2
.2
 
-1
.1
 - 
-0
.4
 
- - - 
m
/z
 
O
b
se
rv
ed
; 
C
a
lc
u
la
te
d
 
(%
) 
 
1
4
8
8
.0
4
6
5
; 
1
4
8
8
.0
4
9
9
 
(6
6
) 
1
3
4
1
.8
0
9
9
; 
1
3
4
1
.8
0
8
3
 
(2
1
) 
- 
1
2
4
3
.8
4
3
0
; 
1
2
4
3
.8
4
2
5
 
(3
0
) 
- - - 
E
S
I-
Q
q
Q
-M
S
/M
S
 
δ
 p
p
m
 
 -
 
3
7
.2
 
-2
3
.7
 
- 
-2
8
.6
 
5
6
 
6
3
 
m
/z
 
O
b
se
rv
ed
; 
C
a
lc
u
la
te
d
 
(%
) 
 
- 
1
3
4
1
.8
0
; 
1
3
4
1
.8
5
 
(4
1
) 
1
2
6
1
.8
4
; 
1
2
6
1
.8
1
 
(1
9
) 
- 
1
0
5
3
.6
6
.;
 1
0
5
3
.6
3
 
(3
5
) 
6
9
0
.3
9
; 
6
9
0
.3
5
 (
2
2
) 
6
3
0
.4
5
; 
6
3
0
.4
9
 (
2
0
) 
  
E
m
p
ir
ic
a
l 
F
o
rm
u
la
 
 
C
8
6
H
1
4
8
N
2
O
2
0
P
 
C
6
6
H
1
2
3
N
2
O
2
1
P
2
 
C
6
6
H
1
2
2
N
2
O
1
8
P
 
C
6
6
H
1
2
0
N
2
O
1
7
P
 
C
5
2
H
9
9
N
2
O
1
7
P
 
C
3
4
H
6
2
N
O
1
1
P
 
C
3
4
H
6
4
N
O
9
 
 
  
T
a
b
le
 5
.1
.4
: 
A
ss
ig
n
m
en
ts
 o
f 
th
e 
p
ro
d
u
ct
 i
o
n
s 
o
b
se
rv
ed
 f
ro
m
 C
ID
-M
S
/M
S
 o
f 
th
e 
p
re
cu
rs
o
r 
d
ep
ro
to
n
at
ed
 
[M
3
-H
]-
 m
o
le
cu
le
s 
at
 m
/z
 1
5
8
6
.1
2
. 
 
 268 
 
 
 
S
ch
em
e 
5
.1
.4
: 
P
ro
p
o
se
d
 f
ra
g
m
en
ta
ti
o
n
 p
at
h
w
ay
s 
o
b
ta
in
ed
 b
y
 C
ID
-Q
q
Q
-M
S
/M
S
 a
n
d
 S
O
R
I-
C
ID
-F
T
IC
R
-M
S
/M
S
 o
f 
th
e 
p
re
cu
rs
o
r 
d
ep
ro
to
n
at
ed
 [
M
3
-H
]-
 m
o
le
cu
le
s 
at
 m
/z
 1
5
8
6
.1
2
. 
 
 269 
 
and a lauryl ketene (-182 Da) from the branched fatty acids (C14:0(3-O-C12:0)) located on 
the N-2ʹ position. It was assigned as[C-(C12:0)ketene-HPO3-H]- ion (El-Aneed et al., 2006, 
Lukasiewicz et al., 2010, John et al., 2014, and Brodbelt et al., 2014).  
 These latter product ions were indeed produced from the C-fragmentation routes 
described by Domon and Costello. It is initiated by the glycosidic cleavages of the β-D-
(l→6)-GlcN disaccharide (Domon and Costello., 1988).  
  The product ion scan of the deprotonated LipA4 molecules at m/z 1506.09 gave the 
series of product ion at m/z 1261.82, m/z 1035.62, m/z 690.36, and m/z 630.41 (Figure 5.1.5, 
Table 5.1.5, and Scheme 5.1.5). The product ion at m/z 1261.82 was assigned as the [M4-
(C14:0(3-OH))acid-H]- ion, and it was created by the elimination of 3-hydroxy-myristic 
acid (C14:0(3-OH)) (-244 Da) located either at the position O-3 or O-3ʹ. The product ion 
m/z 1035.62 was assigned as the [M4-(C14:0(3-OH))ketene-(C14:0(3-OH))acid-H]
-. It was 
formed by the elimination of the 3-hydroxy-myristic ketene (C14:0(3-OH)) (-226 Da) and 
3-hydroxy-myristic acid (C14:0(3-OH)) (-244 Da) located at the position O-3 and O-3ʹ. 
The product ion at m/z 690.36 was assigned as [0,4A-(C14:0(3-OH))acid-H]-. It was 
produced by the cleavage of the non-reducing mono-phosphorylated D-Glucose residue, 
and it was formed by the losses of a 3-hydroxy-myristic ketene molecule (-244 Da) from 
the O-3 position. The product ion at m/z 630.41 was by the consecutive elimination of 
neutral HPO3 (-80 Da) moiety and a lauryl ketene (-182 Da) from the branched fatty acids 
(C14:0(3-O-C12:0)) located on the N-2ʹ position. 
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Figure 5.1.5: CID-MS/MS of the precursor deprotonated [M4-H]-  molecules at m/z 1506.09.⁕ 
 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other 
isobars isolated during the MS/MS analysis. 
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It was assigned as [C-(C12:0)ketene-HPO3-H]
- ion (El-Aneed et al., 2006, Lukasiewicz et 
al., 2010, John et al., 2014, and Brodbelt et al., 2014).  
 These latter product ions were indeed, produced from the C-fragmentation routes 
described by Domon and Costello. It is initiated by the glycosidic cleavages of the β-D-
(l→6)-GlcN disaccharide (Domon and Costello, 1988). 
It is important to note that the obtained product ion scan of the deprotonated mono-
phosphorylated LipA4 molecules at m/z 1506.09 is completely different from the one 
obtained for the deprotonated molecule of LipA1 and LipA4 isolated from the lipid An SJ-
19a (Chapter 3) and SJ-55a (Chapter 4). This indicated that the deprotonated molecules for 
m/z 1506 are indeed isobaric and have completely different structures. 
The product ion scan of the deprotonated di-phosphorylated LipA5 molecules [M5-
H]- at m/z 1359.79 gave a series of product ions at m/z 1279.90, m/z 1209.74, m/z 1035.64, 
and m/z 690.36 (Figure 5.1.6, Table 5.1.6 and Scheme 5.1.6). The product ion at m/z 
1279.90 was assigned as [M5-HPO3-H]
- ion, and it was formed by the elimination of the 
neutral HPO3 (-80 Da) moiety properly located at O-1 position. The product ion at m/z 
1209.74 was assigned as [M5-HPO3-(C5H10)-H]
- ion. It was formed by the elimination of 
the neutral HPO3 (-80 Da) moiety located at O-1 position, and a molecule of C5H10 (-70 Da) 
as part of the fatty acid chain properly located at N-2ʹ position. The product ion at m/z 
1035.64 was assigned as [M5-HPO3-(C14:0)(3-OH))acid-H]
- ion, and it was formed by the 
consequent elimination of the neutral HPO3 (-80 Da) moiety located at O-1 position, and 
the 3-hydroxy-myristic acid (C14:0(3-OH)) (-244 Da) located at the position O-3. The 
product ion at m/z 690.36 was assigned as [0,4A-H]-.  
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Figure 5.1.6: CID-MS/MS of the precursor deprotonated [M5-H]-  molecules at m/z 1359.79.⁕  
 
 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other isobars 
isolated during the MS/MS analysis.  
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It is produced by the cleavage of the non-reducing mono-phosphorylated D-Glucose residue 
(Scheme 5.1.6) (El-Aneed et al., 2006, Lukasiewicz et al., 2010, John et al., 2014, and 
Brodbelt et al., 2014). 
It is important to note that the obtained product ion scan of the deprotonated mono-
phosphorylated LipA5 molecules at m/z 1359.79 is completely different from the one 
obtained for the deprotonated molecule of LipA5 isolated from the lipid An SJ-55a (Chapter 
4). This indicated that both deprotonated molecules for m/z 1359 are indeed isobaric and 
have completely different structures. 
The product ion scan of the deprotonated mono-phosphorylated LipA6 molecules 
[M6-H]
- at m/z 1279.89 gave a series of product ion at m/z 1035., m/z 853.46, and m/z 
648.40 (Figure 5.1.7, Table 5.1.7 and Scheme 5.1.7). The ion at m/z 1035.68 was assigned 
as the [M6-(C14:0(3-OH))acid-H]
- ion, which was created by the elimination of 3-hydroxy-
myristic acid (C14:0(3-OH)) (-244 Da) located at the position O-3 of the reducing GlcN 
end. The product ion at m/z 853.46 which was assigned as the [M6-(C12:0)ketene-(C14:0(3-
OH))acid-H]- ion, which was created by the elimination of a lauryl ketene molecule (-182 
Da) from the branched fatty acids (C14:0(3-O-C12:0)), located on the N-2ʹ position, and 3-
hydroxy-myristic acid (C14:0(3-OH)) (-244 Da) located at the position O-3 of the reducing 
GlcN end. The product ion at m/z 648.40 was assigned as [B-H]-, and it is produced by the 
cleavage of the non-reducing mono-phosphorylated D-Glucose residue (as shown in 
Scheme 5.1.7) (El-Aneed et al., 2006, Lukasiewicz et al., 2010, John et al., 2014, and 
Brodbelt et al., 2014). 
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Figure 5.1.7: CID-MS/MS of the precursor deprotonate [M6-H]- molecules at m/z 1279.89.⁕ 
 
 
 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other 
isobars isolated during the MS/MS analysis 
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   Scheme 5.1.7: Proposed fragmentation pathways obtained by CID-QqQ-MS/MS and SORI-CID-
FTICR-MS/MS of the precursor deprotonated [M6-H]- molecules at m/z 1279.89. 
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Figure 5.1.8: CID-MS/MS of the precursor deprotonated [C-H]- molecules at m/z 892.55. ⁕ 
 
 
 
 
 
⁕ Please note, that some product ions were not assigned as these were produced by other isobars 
isolated during the MS/MS analysis.  
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It is important to note that the obtained product ion scan of the deprotonated mono-
phosphorylated LipA6 molecules at m/z 1279.89 is completely different from the one 
obtained for the deprotonated molecule of LipA4 and LipA6 isolated from the lipid An SJ-
19a (Chapter 3) and SJ-55a (Chapter 4). This indicated that the deprotonated molecules for 
m/z 1279 are indeed isobaric and have completely different structures.  
 Lastly, we also investigated the nature of the deprotonated molecules at m/z 892.55 
observed in the ESI-MS of this lipid An mixture. The deprotonated molecule was assigned 
as being created by the [C-H]- ion series; whose presence are probably an indication of the 
incomplete biosynthesis of the lipid A1-6 series of the LPS A. Hydrophilla SJ-55a.
  
 For simplification, we have tied these deprotonated molecules to the [M-H1-6]
- 
molecules and adopted a similar nomenclature. Hence, the product ion scan of the 
deprotonated [C-H]- molecule at m/z 892.55 gave a series of product ions at m/z 874.56, m/z 
692.43, m/z 666.41, m/z 648.40, and m/z 562.24 (Figure 5.1.8, Scheme 5.1.8, and Table 
5.1.8). The product ion at m/z 874.56 was created by the loss of water molecule from the 
precursor ion at m/z 892.55. The product ion at m/z 692.43 which was assigned as [C-
(C12:0)acid-H]- ion, and it was generated by the loss of the lauric acid molecule (-200 Da) 
from the branched fatty acids (C14:0(3-O-C12:0)) at the N-2 position. The product ions at 
m/z 648.36 was assigned as [C-(C14:0(3-OH))acid-H]- ion, and it was generated by the loss 
the 3-hydroxy-myristic acid (-244 Da) at O-3 position. The product ion at m/z 666.41 was 
assigned as [C-(C14:0(3-OH))ketene-H]- ion, and it was generated by the loss the 3-
hydroxy-myristic ketene (-226 Da) at O-3 position. The last product ion at m/z 562.24 was 
assigned as [C-(C12:0)acid-(C8H16)-H2O-H]
- ion, and it was created by the consecutive 
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elimination of a molecule of water, a (C8H16) (-112 Da) as part of the fatty acid chain 
properly located at O-3 position, and the lauryl acid (-200 Da) from the branched fatty 
(C14:0(3-O-12:0)) acid located on N-2ʹ. 
These product ions strongly support that the lipid A1-6 structures contain two H2PO3 
group at O-4ʹ of the D-GlcN at the non-reducing end, and the other H2PO3 group is located 
at O-1 of the reducing end residue of the β-D-GlcpN-(1→6)-α-D-GlcpN disaccharide 
backbone.  
It is important to note that the obtained product ion scan of the deprotonated mono-
phosphorylated molecules at m/z 892.55 is completely different from the one obtained for 
the deprotonated molecule that were isolated from the lipid An SJ-19a (Chapter 3) and SJ-
55a (Chapter 4). This indicated that the deprotonated molecules for m/z 892.55 are indeed 
isobaric and have completely different structures. 
Also, it indicates the presence of primary myristic esters located at both the O-3ʹ 
and N-2ʹ positions of this lipid A1-6 mixture. It also means that the position of the branched 
lauric acids ester are located on the O-3 and N-2ʹ position of the reducing GlcN residue 
present in the β-D-GlcpN-(1→6)-α-D-GlcpN disaccharide backbone (El-Aneed et al., 
2006, Lukasiewicz et al., 2006, John et al., 2014, and Brodbelt et al., 2014). 
It should be noticed that the CID-MS/MS analysis of the deprotonated molecules 
[M1-6-H]
- at m/z 1768.20 (LipA1), m/z 1688.17 (LipA2), m/z 1586.12 (LipA3), m/z 1506.09 
(LipA4), m/z 1359.76 (LipA5), and m/z 1279.89 (LipA6) afforded distinctive series of 
product ions.  
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Furthermore, it is important to mention that there was no cross connectivity between 
the different precursor deprotonated molecules. This indicates that the genesis of each of 
these species of precursor ions was individual, and creates its specific product ions. This 
confirms that the origins of the precursor ions were indeed caused by an incomplete 
biosynthesis of the LPS (El-Aneed et al., 2006, and Lukasiewicz et al., 2010). 
In general, it is important to note that during the low-energy MS/MS analyses 
conducted with the QqQ-tandem instrument on these series of deprotonated molecules, we 
were able to confirm that the formation of each deprotonated molecule recorded in single 
stage ESI-QqQ-MS instrument, were indeed single unique diagnostic molecules that were 
not produced by further fragmentation from contiguous higher masses deprotonated 
molecules. In addition, these product ion scans created series of product ions that excluded 
the possibility, that they could be related to each other.   
Finally, precursor ion scans of these deprotonated molecules formed during the ESI-
QqQ-MS showed that there were no connectivities and/or genesi relations between these 
different deprotonated molecules (see Appendix). 
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5.3. ESI-FTICR-MS analysis of heterogeneous lipid An mixture isolated 
from the LPS of A. salmonicida SJ-113a   
  
               The ESI-FTICR-mass spectrometer analysis was also applied to the mixture of 
lipid An (where n=1-8), in order to produce spectrum as a time depending technique with 
its high resolving power and mass accuracy currently available, which allowed us to 
determine the elemental conformation of the analyzed produced ions (Marshall et al., 1998, 
Marshall et al., 1999, Palumbo et al., 2011, van Agthoven et al., 2015, and Almostafa et 
al., 2016). The ESI-MS (- ion mode) obtained for lipid A of A. salmonicida SJ-113a 
displayed an incomplete biosynthesis as demonstrated by the multiple deprotonated 
molecules. Likewise, to the ESI-QqQ-MS, the ESI-FTICR-MS (- ion mode) showed the 
presence of inter-alia six fragment ions, which were assigned to different [M-H]- 
deprotonated di-phosphorylated molecules LipA1 at m/z 1768.1817, LipA3 at m/z 
1586.0210, and LipA5 at m/z 1359.8166, and deprotonated mono-phosphorylated 
molecules LipA2 at m/z 1688.2115, LipA4 at m/z 1506.0580, and LipA6 at m/z 1279.8496. 
Also, the last deprotonated molecule at m/z 892.5979, which was assigned as it belongs to 
the [C-H]- indicating the presence of a heterogeneous mixture of lipid As (Figure 5.2.1, 
Scheme 5.1.1 and Table 5.1.1). ESI-FTICR-MS spectrum gives the same deprotonated 
molecules of the LipA1-6 mixture as ESI-QqQ-MS with different abundances. In the ESI-
FTICR-mass spectrum, we noticed that the deprotonated molecule assigned to the LipA4 at 
m/z 1506.0580 was the most abundant ion (as shown in Figure 5.2.1) (John et al., 2014, 
and Brodbelt et al., 2014). 
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Figure 5.2.1: ESI-FTICR-MS (- ion mode) of the native lipid An mixture extracted from A. 
salmonicida SJ-113a. 
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5.3.1. Measurement of the FT-ICR-MS isotopic distributions of the 
deprotonated molecules of lipid An isolated from the LPS of A. 
salmonicida SJ-113a. 
      
 As discussed before in chapter 3 section 3.3.1 and chapter 4 section 4.3.1 we 
investigated the obtained FTICR-MS spectral accuracy of the deprotonated molecular ions 
measured by high-resolution FT-ICR-MS. For that reason, we determined the high isotopic 
abundance accuracy. This latter, allowed us to calculate the excat molecular formula 
candidates from these accurate mass measurements. The isotopic distribution of this series 
of deprotonated lipid An, (where n=1-6) namely: LipA1 at m/z 1768.1817, LipA3 at m/z 
1586.0210, and LipA5 at m/z 1359.8166, and at m/z 892.5979, is indicated in the 
(Figure5.2.2 and Figure 5.2.3) (Kind et al., 2010, and Jaitly et al., 2009).   
 Therefore, the calculated elemental compositions of the deprotonated molecule 
[M1-H]
-, [M2-H]
-, [M3-H]
-, [M4-H]
-, [M5-H]
-, and [M6-H]
-, matched their experimental 
isotopic abundances using the algorithm “Gaussian 09 software package”, which allowed 
us to calculate the isotopic fine structures and allow the modeling of Gaussian peak shapes 
according to the selected resolving power of the instrument (Kind et al., 2010, and Jaitly et 
al., 2009). In order to examine the difference in CID-gas-phase fragmentations between the 
QqQ and the FTICR-instruments, we subjected this series of deprotonated molecules to 
SORI-CID-FTICR-MS/MS analysis in order to confirm their exact structures. 
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Figure 5.2.2: Theoretical isotope distribution overlapped on top of the observed pattern of the 
lipid An extract from the LPS of A. salmonicida SJ-113a. 
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Figure 5.2.3: Theoretical isotope distribution overlapped on top of the observed pattern of the 
lipid An extract from the LPS of A. salmonicida SJ-113a. 
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5.3.2. SORI-CID-FTICR-MS/MS analysis of lipid A isolated from the 
LPS OF A. salmonicida SJ-113a 
 
The MS/MS analysis have provided researchers with information about Lipid A 
structures including the number and location of phosphoryl groups. The fatty acids on the 
lipid A backbone (lengths and location), and by defining the nature of the ion charges 
(singly and doubly charged ions). 
           The low-energy collision induced dissociation mass spectrometry (SORI-CID-
MS/MS) with a Fourier transform ion cyclotron resonance mass spectrometer instrument 
was used to establish the MS/MS fragmentation routes.  
 Unfortunately, the SORI product ion scan of the deprotonated molecules of LipA1 at 
m/z 1768.1817 gave the product ions at m/z 1243.8450, m/z 1035.6578, m/z 1017.6378, and 
m/z 648.3945 (Figure 5.2.4, Scheme 5.1.2, and Table 5.1.2). The product ion at m/z 
1243.8450 was assigned as the [M1-(C14:0(3-O-C12:0))acid-H2PO4-H]
- ion. It was created 
by the elimination of the branched fatty (C14:0(3-O-C12:0)) acids located at O-3 (-426 
Da), and the neutral H3PO4 (-98 Da) moiety which located at O-1 position. The product ion 
at m/z 1035.6578 was assigned as [M1-(C14:0(3-O-C12:0))acid-(C14:0(3-OH))ketene-
HPO3-H]
- ion, and it was created by the elimination of the branched fatty (C14:0(3-O-
C12:0)) acids located at O-3 (-426 Da), the 3-hydroxy-myristic ketene (-226 Da) located at 
O-3ʹ, and the neutral HPO3 (-80 Da) moiety which located at O-1 position. The product ion 
at m/z 1017.6378 was created by the loss of a molecule of water from the product ion at 
m/z 1035.6578. The product ion at m/z 648.3945 was assigned as the [C-(C14:0(3-
 293 
 
OH))acid-H]- ion, and it was formed by the elimination of the 3-hydroxy-myristic acid 
(C14:0(3-OH)) (-244 Da) from the O-3 of the precursor deprotonated molecule at m/z 
1768.1817 (Shaffer et al., 2007, John et al., 2014, and Brodbelt et al., 2014).  
The product ion scan of the deprotonated LipA2 molecules at m/z 1688.2115 gave 
the product ions at m/z 1488.0382, m/z 1444.9820, m/z 1243.8446, m/z 1035.6591 and m/z 
1017.6381 (Figure 5.2.5, Table 5.1.3, and Scheme 5.1.3). The product ion at m/z 1488.0382 
was assigned as the [M2-(C12:0)acid-H]
- ion, which was created by the elimination of the 
lauryl acid (-200 Da) from the branched fatty (C14:0(3-O-12:0)) acid located either on N-
2ʹor O-3. The product ion at m/z 1444.9820 was assigned as the [M2-(C14:0(3-OH))acid- 
H]- ion, which was created by the elimination of the 3-hydroxy-myristic acid (C14:0(3-
OH)) (-244 Da) from the O-3ʹ. The product ion at m/z 1243.8446 was assigned as the [M2-
(C14:0(3-O-C12:0)acid)acid-H2O-H]
- ion, which was created by the elimination of the 
branched fatty (C14:0(3-O-C12:0)) acid acyl group located at O-3ʹ (-426 Da) and a 
molecule of water. The product ion at m/z 1035.6591 was assigned as the [M2-(C14:0(3-
O-C12:0))acid-(C14:0)(3-OH)ketene-H]- ion, which was created by the elimination of the 
branched fatty (C14:0(3-O-C12:0)) acyl group located at O-3ʹ (-426 Da) and 3-hydroxy-
myristic ketene (C14:0(3-OH)) (-226 Da) located at the position O-3ʹ. The product ion at 
m/z 1017.6381 was created by the loss of a molecule of water from the product ion at m/z 
1035.6591 (Shaffer et al., 2007, Lukasiewicz et al., 2010). 
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Figure 5.2.4: SORI-CID-MS/MS of the precursor deprotonated [M1-H]-  molecules at m/z 
1768.1817. 
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Figure 5.2.5: SORI-CID-MS/MS of the precursor deprotonated [M2-H]-  molecules at m/z 
1688.2115.  
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The product ion scan of the deprotonated LipA3 molecules at m/z 1586.0254 gave 
the product ions at m/z 1488.0499, m/z 1341.8083 and m/z 1243.8425 (Figure 5.2.6, Table 
5.1.4, and Scheme 5.1.4). The product ion at m/z1488.0499 was assigned as the [M3-H2PO4-
H]- ion, which was created by the elimination of the H3PO4 (-98 Da) located at O-1. The 
product ion at m/z 1341.8083 was assigned as [M3-(C14:0(3-OH))acid-H]
- ion, which was 
created by the elimination of the 3-hydroxy-myristic acid (C14:0(3-OH)) (-244 Da) located 
either at the position O-3 or O-3ʹ. The product ion at m/z 1243.8425 [M3-(C14:0(3-
OH))acid-HPO3-H]
- ion, which was created by the elimination of the H3PO4 (-98 Da) 
located at O-1, and the 3-hydroxy-myristic acid (C14:0(3-OH)) (-244 Da) located either at 
the position O-3 or O-3ʹ (El-Aneed et al., 2006, Shaffer et al., 2007, Lukasiewicz et al., 
2006, John et al., 2014, and Brodbelt et al., 2014). 
The product ion scan of the precursor deprotonated molecules of LipA4 m/z 
1506.0580 gave the major product ion at m/z 1305.8680, m/z 1261.8399, and m/z 
1035.6692. The product ion at m/z 1305.8680 was assigned as the [M4-(C12:0)acid-H]
- ion, 
and it was formed by the loss of a molecule of lauric acid (-200 Da) from the branched 
(C14:0(3-O-C12:0)) fatty acyl group located at the N-2ʹ position of LipA4. The product ion 
at m/z 1261.8399 was assigned as [M4-(C14:0(3-OH))acid-H]
- ion, which was created by 
the elimination of the 3-hydroxy-myristic acid (C14:0(3-OH)) (-244 Da) located either at 
the position O-3 or O-3ʹ. The product ion at m/z 1035.6692 was assigned as [M4-(C14:0(3-
OH))acid-(C14:0(3-OH))ketene-H]- ion, which was formed by the  elimination of 3-
hydroxy-myristic acid (-244 Da) and of 3-hydroxy-myristic ketene (-226 Da) from the 
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Figure 5.2.6: SORI-CID-MS/MS of the precursor deprotonated [M3-H]- molecules at m/z 
1586.0210. 
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Figure 5.2.7: SORI-CID-MS/MS of the precursor deprotonated [M4-H]- molecules at m/z 
1506.0580. 
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precursor ion located either at the O-3 and O-3′ positions (Figure 5.2.7, Table 5.1.5 and 
Scheme 5.1.5) (Shaffer et al., 2007, John et al., 2014, and Brodbelt et al., 2014). 
 The product ion scan of the deprotonated LipA5 molecules at m/z 1359.8180 gave 
the product ions at m/z 1261.8379, m/z 1115.6120, m/z 1035.6669, and m/z 1017.6377 
(Figure 5.2.8, Table 5.1.6, and Scheme 5.1.6). The product ions at m/z 1261.8379 was 
assigned as [M5-H2PO4-H]
- ion, and it was formed by the elimination of the neutral H3PO4 
(-98 Da) moiety. The product ion at m/z 1115.6125 was assigned as [M5-(C14:0)(3-
OH)acid-H]- ion, and it was formed by the elimination of 3-hydroxy-myristic acid (-244 
Da) from the precursor ion located at the O-3.The product ion m/z 1035.6669 was assigned 
as [M5-(C14:0)(3-OH)acid-HPO3-H]
- ion, and it was formed by the elimination of 3-
hydroxy-myristic acid (-244 Da) from the precursor ion located at the O-3, and the neutral 
HPO3 (-80 Da) moiety. The product ion at m/z 1017.6377 created by the loss of a molecule 
of water from the product ion at m/z 1035.6669 (El-Aneed et al., 2006, Shaffer et al., 2007, 
Lukasiewicz et al., 2010, John et al., 2014, and Brodbelt et al., 2014).  
Additionally, the product ion scan of LipA6 at m/z 1279.8496 afforded the product 
ion at m/z 1079.6750 m/z 1035.6678, and m/z 835.4846. The product ion at m/z 1079.6750 
was assigned as [M6-(C12:0)acid-H]
- ion, and it was formed by the elimination of the lauric 
acid (-200 Da) from the branch (Cl4:0(3-O-12:0)) fatty acids, which was attached to the N-
2ʹ position. The product ion at m/z 1035.6667 was assigned as [M6-(C14:0)(3-OH)acid-H]- 
ion, and it was formed by the elimination of 3-hydroxy-myristic acid(-244 Da) from the  
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Figure 5.2.8: SORI-CID-MS/MS of the precursor deprotonated [M5-H]- molecules at m/z 
1359.8180. 
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 precursor ion located either at the O-3.The last product ion at m/z 835.4846 was assigned 
as the [M6-(C12:0)ketene-(C14:0(3-OH))acid-H]
- ion, which was created by elimination of 
the lauryl ketene molecule (-182 Da) from the branched fatty acids (C14:0(3-O-C12:0)) 
located on the N-2ʹ position, and the 3-hydroxy-myristic acid (C14:0(3-OH)) (-244Da) 
located at the position O-3 of the reducing GlcN end of the lipidA6 disaccharide (Figure 
5.2.9, Table 5.1.7 and Scheme 5.1.7)  (El-Aneed et al., 2006, Shaffer et al., 2007, 
Lukasiewicz et al., 2010, John et al., 2014, and Brodbelt et al., 2014). 
In the same way to the MS/MS experiments described with the QqQ-MS 
spectrometer, the lower diagnostic deprotonated molecules were also selected, and 
subjected to SORI-CID-MS/MS measurements with the FTICR-mass spectrometer 
instrument. This was achieved to confirm the putative structures of these precursors’ 
deprotonated molecules, and also to confirm the location of the phosphate group.  
Consequently, the SORI-CID-MS/MS of the deprotonated molecules at m/z 892.5979, 
previously assigned as [C-H]- gave the product ions at m/z 648.3961 and m/z 466.2117 
(Figure 5.2.10, Table 5.1.8, Scheme 5.1.8). The product ion at m/z 648.3949 was assigned 
as the [C-(C14:0(3-OH))acid-H]- ion, and it was formed by the elimination of the 3-
hydroxy-myristic acid (C14:0(3-OH)) (-244 Da) from the O-3 of the precursor 
deprotonated molecule. The product ions at m/z 466.2117 was attributed as the [C-
(C14:0(3-OH))acid-(C12:0)ketene-H]-, which was formed by the consecutive elimination 
of the 3-hydroxy-myristic acid (C14:0(3-OH)) (-244 Da), from the O-3 position, and the 
lauric acid (-200 Da) from the branch (Cl4:0(3-O-12:0)) fatty acids, which was attached to 
the N-2 position of the non-reducing GlcN residue of the precursor ion at m/z 892.5979. 
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Figure 5.2.9: SORI-CID-MS/MS of the precursor deprotonated [M6-H]- molecules at m/z 
1279.8489. 
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Figure 5.2.10: SORI-CID-MS/MS of the precursor deprotonated [C-H]- molecules at m/z 
892.5979. 
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5.3.3. Comparison between low-energy CID-QqQ-MS/MS and SORI-
CID-MS/MS of the deprotonated molecules obtained from the mixture of 
lipid As isolated from the LPS of the A. salmonicida SJ-113a 
 
As discussed in the chapter 3 and 4 sections 3.3.3 and 4.3.3 we have made a 
comparison between the CID-MS/MS analyses with the QqQ-MS/MS and SORI-MS/MS. 
We have noticed that the number of distinctive product ions decreased with SORI-MS/MS 
analyses, when compared to CID-MS/MS analyses with the QqQ-mass spectrometer 
instrument. As in all of the previous schemes (5.1.2 – 5.1.8), we have noticed that all of the 
product ions obtained from SORI-CID-MS/MS were produced by the primary fatty acid 
fragmentation only. There were no CID-fragmenttaion from the branched fatty acyl groups 
and it was noted that most eliminations occurred from the O-3 and O-3ˊ positions. The 
reasons for the obtained differences in product ions formation are the same as these 
presented in section 3.3.3. 
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5.4. High-energy MALDI-TOF-MS analysis of the extracted mixture of 
lipid As isolated from the LPS of A. salmonicida SJ-113a 
 
 
The MALDI-TOF-MS (-ion mode) of the lipid A obtained from A. salmonicida SJ-
113a was measured in the reflector mode with the TOF/TOF instrument and high laser 
power. Similarly, the MALDI-MS showed comparable spectra to the ones measured with 
the ESI-QqQ-MS and FTICR-MS instruments. 
 Again, the MALDI-TOF-MS indicated that the biosynthesis of lipid A was 
incomplete. Accordingly, we have assigned for this lipid A mixture, the original seven 
common structures of the lipid A as suggested previously in sections: 5.2 and 5.3. They 
were assigned to different [M-H]- deprotonated di-phosphorylated molecules LipA1 at m/z 
1768.1798, LipA3 at m/z 1586.0210, LipA5 at m/z 1359.8259, and mono-phosphorylated 
molecules LipA2 at m/z 1688.2123, LipA4 at m/z 1506.0466, and LipA6 at m/z 1279.8510 
(Figure 5.3.1, Scheme 5.1.1 and Table 5.1.1). In the MALDI-TOF-mass spectrum, we 
noticed that the deprotonated molecules assigned to the LipA6 at m/z 1279.8510 was the 
most abundant in the mass spectrum. Also, the last deprotonated molecule at m/z 892.5961, 
which was assigned as belonging to the [C-H]- indicating the presence of a heterogeneous 
mixture of lipid An (as shown in Figure 5.3.1). 
In order to examine the difference in high-energy collision MS/MS dissociation 
with that of the low-energy collision MS/MS recorded with the QqQ and the FTICR-
instruments, we measured this series of product ion scans of these deprotonated molecules 
with the high energy CID-TOF/TOF-MS/MS instrument. 
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Figure 5.3.1: High-energy MALDI-TOF-MS (- ion mode) of the native lipid An mixture 
extracted from A. salmonicida SJ-113a. 
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5.4.1 High-energy MALDI-CID-TOF/TOF-MS/MS analysis of the 
extracted mixture of lipid As isolated from the LPS of A. salmonicida SJ-
113a 
 
The lipid A1-6 mixture isolated from A. salmonicida SJ-113a was subjected to high-
energy CID-TOF/TOF-MS/MS. The structures of the detected product ions were deduced 
as previously described in the ESI-CID-MS/MS studies of this lipid An mixture. 
 High-energy CID-TOF/TOF-MS/MS of the deprotonated molecules LipA1 at m/z 
1768.1798 is illustrated in (Figure 5.3.2, Tables 5.1.2, and Scheme 5.1.2). LipA1 produced 
the product ions at m/z 1488.0412, m/z 1243.8512, and m/z 1017.6320. The product ion at 
m/z 1488.0412 was assigned as [M1-(C12:0)acid-HPO3-H]
- ion, and it was created by the 
loss of the lauryl acid (-200 Da) from the branched (C14:0(3-O-C12:0)) located at N-2ʹ 
positions and neutral HPO3 (-80 Da) located at O-1. The product ion at m/z 1243.8512 was 
assigned as the [M1-(C14:0(3-O-C12:0))acid-H2PO4-H]
- ion, which was created by the 
elimination of the branched fatty (C14:0(3-O-C12:0)) acids located at O-3 (-426 Da), and 
the neutral H3PO4 (-98 Da) moiety which is located at O-1 position. 
 The product ion at m/z 1017.6320 was assigned as [M1-(C14:0(3-O-C12:0))acid-
(C14:0(3-OH))acid-HPO3-H]
- ion, which was created by the elimination of the branched 
fatty (C14:0(3-O-C12:0)) acids located at O-3 (-426 Da), the 3-hydroxy-myristic ketene (-
226 Da) located at O-3ʹ, and the neutral HPO3 (-80 Da) moiety which located at O-1 
position (Kussak et al., 2002, Shaffer et al., 2007, Lukasiewicz et al., 2010, and Brodbelt 
et al., 2014). 
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Figure 5.3.2:  High-energy CID-TOF/TOF-MS/MS of the precursor ion [M1-H]-  ion at m/z 
1768.1798. 
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High-energy CID-TOF/TOF-MS/MS of the anion at m/z 1688.2123 LipA2 is 
illustrated in (Figure 5.3.3, Tables 5.1.3, and Scheme 5.1.3). A product ion scan of the 
deprotonated LipA2 molecules gave the product ions at m/z 1488.0315, m/z 1261.8497, and 
m/z 1035.6520. The product ion at m/z 1488.0315 was assigned as the [M2-(C12:0)acid-H]
- 
ion, which was created by the elimination of the lauryl acid (-200 Da) from the branched 
(C14:0(3-O-C12:0)) located at N-2ʹ positions. The product ions at m/z 1261.8497 was 
assigned as [M2-(C14:0(3-O-12:0))acid-H]
- ion, and it was formed by the consecutive loss 
of the branched fatty (C14:0(3-O-C12:0)) acid (-426 Da) located on position O-3. The 
product ion at m/z 1035.6520 which was assigned as [M1-(C14:0(3-O-C12:0))acid-
(C14:0(3-OH))ketene-H]- ion, which was created by the elimination of the branched fatty 
(C14:0(3-O-C12:0)) acids located at O-3 (-426 Da), the 3-hydroxy-myristic ketene (-226 
Da) located at O-3ʹ.   
 High-energy CID-TOF/TOF-MS/MS of the anion at m/z 1586.0210 LipA3 is 
illustrated in (Figure 5.3.4, Tables 5.1.4, and Scheme 5.1.4). The product ion scan of the 
deprotonated LipA3 molecules gave the product ions at m/z 1488.0423, m/z 1341.8041, and 
m/z 1243.8495. The product ion at m/z 1488.0423 was obtained by the loss of a H3PO4 (-98 
Da) released from the O-1 position of the D-GlcN non-reducing end of LipA3. The product 
ion at m/z 1341.85 was assigned as the [M3-(C14:0(3-OH))acid-H]
- , and it was formed by 
the elimination of the 3-hydroxy-myristic acid (C14:0(3-OH)) (-244 Da) located either at 
the position O-3 or O-3ʹ. The product ion at m/z 1243.8495 was assigned as the [M3-
(C14:0(3-OH))acid-HPO3-H]
- ion, and it was formed by the elimination of the neutral 
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Figure 5.3.3: High-energy CID-TOF/TOF-MS/MS of the precursor ion [M2-H]-  ion at m/z 
1688.2126. 
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Figure 5.3.4: High-energy CID-TOF/TOF-MS/MS of the precursor ion [M3-H]-  ion at m/z 
1586.0210. 
 
 
 
 
 312 
 
H3PO4 (-98 Da) moiety located at O-1 position, and the 3-hydroxy-myristic acid (C14:0(3-
OH)) (-244 Da) located either at the position O-3 or O-3ʹ (Kussak et al., 2002, El-Aneed et 
al., 2006, Shaffer et al., 2007, Lukasiewicz et al., 2010, and Brodbelt et al., 2014). 
 High-energy CID-TOF/TOF-MS/MS of the anion at m/z 1506.0466 LipA4 is 
illustrated in (Figure 5.3.5, Tables 5.1.5, and Scheme 5.1.5). The product ion scan of the 
deprotonated LipA4 molecules gave the product ions at m/z 1261.8485 and m/z 1035.6621. 
The product ions at m/z 1261.8485 was formed by the elimination of 3-hydroxy-myristic 
acid (-244 Da) located either at O-3 or O-3ʹ from the precursor ion. This product ion was 
assigned as [M4-(C14:0(3-OH)acid-H]
- ion. The product ion at m/z 1035.6621 was assigned 
as [M4-(C14:0(3-OH))acid-(C14:0(3-OH))ketene-H]
- ion, and it was formed by the 
consecutive losses of the 3-hydroxy-myristic acid (-244 Da) and the 3-hydroxy-myristic 
ketene (-226 Da) which can be in fact occur from either at the O-3 and O-3′ positions 
located respectively in the reducing end or non-reducing end of the lipid A disaccharide 
backbone (Kussak et al., 2002, El-Aneed et al., 2006, Shaffer et al., 2007, Lukasiewicz et 
al., 2010, and Brodbelt et al., 2014). 
High-energy CID-TOF/TOF-MS/MS of the anion at m/z 1359.8259 LipA5 is 
illustrated in (Figure 5.3.6, Tables 5.1.6, and Scheme 5.1.6). The product ion scan of the 
deprotonated LipA5 molecules gave the product ions at m/z 1261.8476 and m/z 1115.6120. 
The product ion at m/z 1261.8476 was obtained by the loss of a H3PO4 (-98 Da) released 
from the O-1 position of the D-GlcN non-reducing end of LipA5.The product ion at m/z 
1115.6120 was assigned as [M5-(C14:0)(3-OH)acid-H]
- ion, and it was formed by the 
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Figure 5.3.5: High-energy CID-TOF/TOF-MS/MS of the precursor ion [M4-H]-  ion at m/z 
1506.1466. 
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Figure 5.3.6: High-energy CID-TOF/TOF-MS/MS of the precursor ion [M5-H]- ion at m/z 
1359.8259. 
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elimination of 3-hydroxy-myristic acid (-244 Da) from the precursor ion located either at 
the O-3ʹ. High-energy CID-TOF/TOF-MS/MS of the anion at m/z 1279.8510 LipA6 is 
illustrated in (Figure 5.3.7, Tables 5.1.7, and Scheme 5.1.7). The product ion scan of the 
deprotonated LipA6 molecules gave the product ions at m/z 1079.6711, m/z 1035.6619, and 
m/z 994.6175. The product ion at m/z 1079.6711 was assigned as [M6-(C12:0)acid-H]
- ion, 
which was formed by the elimination of the lauric acid (-200 Da) form the branched fatty 
acids (C14(3-O-C12:0)) at the N-2ʹ position of the non–reducing GlcN residue obtained 
from the precursor ion. The product ion at m/z 1035.6619 was assigned as the [M6-
(C14:0(3-OH))acid-H]- ion, which was created by the elimination of 3-hydroxy-myristics 
acid (C14:0(3-OH)) (-244 Da) located at the position O-3 of the reducing GlcN end. The 
product ion at m/z 994.6175 was assigned as [M6-(C14:0(3-OH))acid-(C3H6)-H]
- ion, which 
was created by the elimination of 3-hydroxy-myristic acid (C14:0(3-OH)) (-244 Da) 
located at the position O-3, and n-(C3H6) as a part of the fatty acid located in N-2ʹ(-41 Da). 
High-energy CID-TOF/TOF-MS/MS of the anion at m/z 892.5961, which was assigned 
previously as [C-H]-, gave the product ions at m/z 666.3922 and m/z 648.3897. The product 
ion at m/z 666.3922 was assigned as the [C-(C14:0(3-OH))ketene-H]- ion, and it was 
formed by the elimination of the 3-hydroxy-myristic ketene (C14:0(3-OH)) (-226 Da) from 
the O-3 of the precursor ion. The product ion at m/z 648.3931 was assigned as the [C-
(C14:0(3-OH))acid-H]- ion , and it was formed by the elimination of the 3-hydroxy-
myristic acid (C14:0(3-OH)) (-244 Da) from the O-3 of the precursor ion (Kussak et al., 
2002, El-Aneed et al., 2006, Shaffer et al., 2007, Lukasiewicz et al., 2010, and Brodbelt et 
al., 2014). 
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Figure 5.3.7: High-energy CID-TOF/TOF-MS/MS of the precursor ion [M6-H]- ion at m/z 
1279.8510. 
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Figure 5.3.8: High-energy CID-TOF/TOF-MS/MS of the precursor ion [C-H]-  ion at m/z 
892.5961.  
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5.4.2. Comparison between low-energy CID-QqQ-MS/MS and high-
energy CID-TOF/TOF-MS/MS 
 
 The comparison between the MALDI-CID-TOF/TOF-MS/MS analysis and the ESI-
CID-QqQ-MS/MS, indicated that the number of distinctive product ions obatined with 
MALDI-CID-TOF/TOF analysis decreased. This was attributed to the same reasons given 
in chapeter 3 and 4 (section 3.4.2 and 4.4.2). We have noticed that all the of the product ions 
which obtained from MALDI-CID-TOF/TOF just like SORI-CID-MS/MS were produced 
by the primary fatty acid fragmentation not the branched, most of the time the elimination 
occur at O-3 and O-3ˊ position (Schemes 5.1.2-5.1.8 and Tables 5.1.2 - 5.1.8). 
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5.5. Summary 
 The LPS extracted from the Gram-negative bacteria A. salmonicida SJ-113a 
exhibited a series of incomplete biosynthesized lipid A1-6. The series of structures of lipid 
A1 to A6 and the fragment ions, observed in ESI-QqQ-MS, ESI-FTICR-MS, and MALDI-
TOF/TOF-MS spectra obtained from LPS of the A. salmonicida SJ-113a (phage resistant) 
were never reported before. Accordingly, we have assigned these fragment ions as the 
series of [Mn-H]
- deprotonated molecules, represented as the following: LipA1 m/z 1768.20, 
LipA2 m/z 1688.17, LipA3 m/z 1586.12, LipA4 m/z 1506.09, LipA5 m/z 1359.79, LipA6 m/z 
1279.89, and m/z 892.55. 
The deprotonated molecules obtained from this heterogeneous mixture of lipid An 
were investigated by tandem mass spectrometry using low-energy collision SORI-CID-
MS/MS (tandem in time) and CID-MS/MS (tandem in space) instruments. Likewise, The 
MALDI-CID-TOF/TOF-MS/MS, CID-QqQ, and SORI-FTICR-MS/MS fragmentation 
studies of the different lipid A1-6 have shown the presence of diagnostic and unique C-C 
heterolytic fragmentation of the fatty acid chains. 
We have noticed that the SORI-MS/MS spectra of the various precursor 
deprotonated molecules were much simpler than those of the acquired CID-MS/MS with 
the MALDI-TOF/TOF and QqQ-instrument.  
The combined MS/MS studies indicate that all the proposed structures of the lipid 
A1 to A6 contain two phosphate groups at the position O-1 and O-4ʹ. They were built by a 
β-D-GlcpN-(1→6)-α-D-GlcpN disaccharide blueprint, which is substituted with (C14:0(3-
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OH)) at the N-2 and O-3 and contain different substitution permutations with (C14:0(3-O-
12:0)) at the N-2´, and the O-3 positions (Scheme 5.1.1).  
The presence of this mixture series of lipid An isolated from SJ-113a in the ESI- and 
MALDI-MS spectra is good indicator to incomplete biosynthesis of lipid A. Also, the 
presence of the monosaccharide backbone was reported in all of them, such as the 
deprotonated molecules at m/z 892. 
 In conclusion, the interaction between the bacteria and the bacteriophages lead to 
some mutation which leads to incomplete lipid A biosynthesis, due to the disruption in core 
biosynthesis process occurring at different stages. Such structural aberrations could affect 
bacteriophage adsorption which could increases the resistance of the bacteria to the 
bacteriophages. 
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Chapter 6 
Summary and Conclusions  
Biological mass spectrometry advancements have made significant strides over the 
past few decades, driven by its capacity to help with identification of novel complex 
biological compounds (Raetz et al., 2002, and li et al., 2006). Bacteria are well known to 
causes many serious human and animal diseases. Lipid A obtained from the LPS of such 
bacteria, and is considered the most toxic part within the LPS biomolecule.  
The biosynthesis of LPS is completely altered by infection with bacteriophages 
which are viruses that infect and duplicate within the host bacteria (Viertel et al., 2014). 
Lately, the physical interactions between tailed phages and Gram-negative bacterial 
pathogens have been used as models in the development of a phage therapeutic strategy for 
treatment of bacteria infections. For these reasons, the investigation of the effect of tailed 
bacteriophages was on the marine pathogen Gram-negative bacteria Aeromonas 
Liquefaciens SJ-19, hydrophilla SJ-55, and Salmonicidia SJ-113. 
 In these studies, the investigation was on the structures of lipid As extracted from 
different lipopolysaccharides (LPSs) of the Vibrionacaceae family. This investigation was 
specific to the molecular structures of the released lipid A portions of these LPSs, and the 
data presented here will help understanding the phages bio-mechanisms of action that 
govern the biosynthesis of cellular membrane of the bacteria. It is well known that LPS 
obtained from Gram-bacteria which are resistant to phage infections afford incomplete 
specific O-antigen and rough core oligosaccharides (Rakhuba et al., 2010, and Viertel et 
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al., 2014). No studies were ever undertaken to assess if the LPS biosynthesis deregulation 
by the phage affected the lipid A part of these LPSs. This structural investigation is an 
important task for the development of potential phage therapeutic strategy against marine 
bacterial infections. 
The investegation started by recording the ESI- and MALDI-MS (- ion mode) on 
the lipid A obtained from the LPS of the Gram-negative bacteria A. liquefactions SJ-19a 
(phage resistant). The recorded MS exhibited a series of deprotonated lipid As molecules 
which were assigned as lipid An (where n=1-5). The presence of the series of deprotonated 
molecules were tentatively assigned as being produced by an incomplete biosynthesis of 
their LPS. The various MS analyses were conducted with ESI-QqQ-MS, ESI-FTICR-MS, 
and MALDI-TOF/TOF-MS hybrid instruments using the negative ion mode. Similar 
studies were also used to investigate the structure of lipid An mixture extracted from the 
LPS of the Gram-negative bacteria A. hydrophilla SJ-55a (phage resistant), which once 
more exhibited an incomplete biosynthesized lipid An (where n=1-8). Finally, by using the 
same methodology described before, we investigated the lipid An (where n=1-6) mixture 
extracted from the LPS of the Gram-negative bacteria A. salmonicida SJ-113a (phage 
resistant). As tentatively proposed before, this lipid An mixture exhibited a series of 
incomplete biosynthesized lipid A1-6. The combined ESI- and MALDI-MS and MS/MS 
techinques allowed us to propose tentative structures for the lipid An extracted from LPSs 
of A. salmonicida SJ-113a, A. liquefactions SJ-19a and A. hydrophilla SJ-55a. These 
studies can be summarized as the following:  
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The major deprotonated molecule obtained from LipAn mixture of the LPSs was 
assigned as LipA1 as follows:  A. salmonicida SJ-113a at m/z 1768.20 (LipA1) and for the 
LPS of A. hydrophilla SJ-55a at m/z 1796.30 (LipA1) containing two phosphate groups at 
the position O-1 and O-4ʹ. This assignment was different for the LipA1 obtained from the 
LPS of A. liquefactions SJ-19a which appeared at m/z 1716.30 which was shown to contain 
one phosphate group located at O-4ˊ position. All of the individual members of the Lipid 
An isolated from these different LPSs were built on a β-D-GlcpN-(1→6)-α-D-GlcpN 
disaccharide backbone.  
The lipid An obtained from the LPS of A. liquefactions SJ-19a contains a β-D-
GlcpN-(1→6)-α-D-GlcpN disaccharide which was substituted by (C14:0(3-OH)) at the N-
2, N-2ˊ, O-3 and O-3ˊ and contained different substitution permutations by (C14:0(3-O-
12:0)) at the N-2´, and (C14:0(3-O-14:0)) at the O-3ˊ positions (Scheme 6.1.1).  
Whereas, the lipid An obtained from the LPS of A. hydrophilla SJ-55a contains a β-
D-GlcpN-(1→6)-α-D-GlcpN disaccharide substituted by (C14:0(3-OH)) at the N-2, O-3ˊ 
and O-3 position, and substituted by (C12:0(3-OH)) at N-2ˊ position. Also, these fatty acids 
contained substitution permutations by (C14:0(3-O-14:0)) at the N-2´ and O-3ˊ positions 
(Scheme 6.1.1).  
Finally, the lipid An obtained from the LPS of A. salmonicida SJ-113a contains β-
D-GlcpN-(1→6)-α-D-GlcpN disaccharide substituted by (C14:0(3-OH)) at the N-2, N-2ˊ, 
O-3, and O-3ˊ and contained different substitution permutations by (C14:0(3-O-12:0)) at 
the N-2´, and O-3 positions (Scheme 6.1.1).  
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   Confirmation of all proposed molecular structures of these series of heterogeneous 
mixture of lipid An  of A. salmonicida SJ-113a, A. liquefactions SJ-19a and A. hydrophilla 
SJ-55a were investigated using low-energy collision SORI-CID-MS/MS (tandem in time) 
and CID-MS/MS (tandem in space) tandem mass spectrometry. In general, it was observed 
that SORI-MS/MS spectra obtained with the FTICR-MS instrument gave simpler gas-
phase fragmentation than those of the acquired the low-energy CID-MS/MS (QqQ) and 
with the high collision CID-MS/MS analyses obtained with the MALDI-TOF/TOF 
instruments. It should be noticed that we have obtained the most characeristic prodcut ions 
using CID-QqQ-MS/MS techniques, however, the ESI-FTICR-MS and MS/MS gave the 
most accuate results in term of resolution and sensitivities. 
It important to mention that for the various mixtures of LipAn isolated from the 
LPSs SJ-19a, SJ-55a, and SJ-113a (lipid A1-5, lipid A1-8, and lipid A1-6), we noticed that 
their MS contained some deprotonated molecules sharing the same exact molecular 
weights. These identical masses deprotonated molecules turned out to be diastereomers and 
isobars.  
The origins of all the deprotonated molecules and fragment ions observed during 
single stage ESI- and MALDI-MS recording were also explored, to prove whether these 
were related or were unique individual structures. Indeed, MS/MS studies conducted on 
these series of deprotonated molecules confirmed that these ions were single unique 
diagnostic molecules that were not produced by further fragmentation from contiguous 
higher masses deprotonated molecules. For these reasons, each deprotonated molecule 
extracted form the LipAn mixtures were examined by performing their precursor ion scan 
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using only the ESI-QqQ-MS/MS instrument. Therefore, the obtained series of product ions 
excluded the possibility that they could be related to other examined precursor deprotonated 
molecules of the same lipid An mixture. These results were also confirmed by recording the 
parent ion scans of the different series of deprotonated molecules obtained from the various 
lipid An. 
In general, we surmise that the fatty acid distributions of the primary fatty acids on 
the β-D-GlcpN-(1→6)-α-D-GlcpN disaccharide of this entire lipid An mixtures are different 
with respect to their length and to their acylation positions on the GlcN disaccharide.  
 In conclusion, we have shown that these series of gram negative bacteria, which 
were phage treated, exhibited an incomplete biosynthesized of the lipid A portion of the 
LPS, affording lipid An mixtures, that included various number of different acylation sites 
with either myristic acid and/or lauric acid on the main GLcN disaccharide backbone.  
In addition, the phages treatment of these bacteria appeared to change the various 
phosphorylation degrees of these different lipids An mixtures.  This far-reaching study 
showed that the various mass spectrometry instruments were used resourcefully to 
distinguish between the main lipid An components of these series of complex lipid An 
mixtures, and allowed us to locate the fatty acid and the phosphate groups on their proper 
positions on the D-GlcN disaccharide.  
Finally, for comparison sake only, the following scheme 6.1.1 indicate the 
structures of the major deprotonated molecules obtained from the LPS of the bacteria SJ-
19a, SJ-55a, and SJ-113a. It also indicates the differences in their fatty acid acylation 
patterns. In addition, table 6.1.1 shows the various diastereomeric and isobaric 
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deprotonated molecules measured on the three-different lipid An mixtures with the ESI-
QqQ-MS hybrid instrument.  
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Scheme 6.1.1: Schematic representation of suggested structures of the highest masses for the 
deprotonated molecules of the lipid An mixture extracted from bacteria A. liquefactions SJ-19a, A. 
hydrophilla SJ-55a, and A. salmonicida SJ-113a.  
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